<html>
    <head>
        <meta charset="utf-8">
        
            <script>function neighbourhoodHighlight(params) {
  // console.log("in nieghbourhoodhighlight");
  allNodes = nodes.get({ returnType: "Object" });
  // originalNodes = JSON.parse(JSON.stringify(allNodes));
  // if something is selected:
  if (params.nodes.length > 0) {
    highlightActive = true;
    var i, j;
    var selectedNode = params.nodes[0];
    var degrees = 2;

    // mark all nodes as hard to read.
    for (let nodeId in allNodes) {
      // nodeColors[nodeId] = allNodes[nodeId].color;
      allNodes[nodeId].color = "rgba(200,200,200,0.5)";
      if (allNodes[nodeId].hiddenLabel === undefined) {
        allNodes[nodeId].hiddenLabel = allNodes[nodeId].label;
        allNodes[nodeId].label = undefined;
      }
    }
    var connectedNodes = network.getConnectedNodes(selectedNode);
    var allConnectedNodes = [];

    // get the second degree nodes
    for (i = 1; i < degrees; i++) {
      for (j = 0; j < connectedNodes.length; j++) {
        allConnectedNodes = allConnectedNodes.concat(
          network.getConnectedNodes(connectedNodes[j])
        );
      }
    }

    // all second degree nodes get a different color and their label back
    for (i = 0; i < allConnectedNodes.length; i++) {
      // allNodes[allConnectedNodes[i]].color = "pink";
      allNodes[allConnectedNodes[i]].color = "rgba(150,150,150,0.75)";
      if (allNodes[allConnectedNodes[i]].hiddenLabel !== undefined) {
        allNodes[allConnectedNodes[i]].label =
          allNodes[allConnectedNodes[i]].hiddenLabel;
        allNodes[allConnectedNodes[i]].hiddenLabel = undefined;
      }
    }

    // all first degree nodes get their own color and their label back
    for (i = 0; i < connectedNodes.length; i++) {
      // allNodes[connectedNodes[i]].color = undefined;
      allNodes[connectedNodes[i]].color = nodeColors[connectedNodes[i]];
      if (allNodes[connectedNodes[i]].hiddenLabel !== undefined) {
        allNodes[connectedNodes[i]].label =
          allNodes[connectedNodes[i]].hiddenLabel;
        allNodes[connectedNodes[i]].hiddenLabel = undefined;
      }
    }

    // the main node gets its own color and its label back.
    // allNodes[selectedNode].color = undefined;
    allNodes[selectedNode].color = nodeColors[selectedNode];
    if (allNodes[selectedNode].hiddenLabel !== undefined) {
      allNodes[selectedNode].label = allNodes[selectedNode].hiddenLabel;
      allNodes[selectedNode].hiddenLabel = undefined;
    }
  } else if (highlightActive === true) {
    // console.log("highlightActive was true");
    // reset all nodes
    for (let nodeId in allNodes) {
      // allNodes[nodeId].color = "purple";
      allNodes[nodeId].color = nodeColors[nodeId];
      // delete allNodes[nodeId].color;
      if (allNodes[nodeId].hiddenLabel !== undefined) {
        allNodes[nodeId].label = allNodes[nodeId].hiddenLabel;
        allNodes[nodeId].hiddenLabel = undefined;
      }
    }
    highlightActive = false;
  }

  // transform the object into an array
  var updateArray = [];
  if (params.nodes.length > 0) {
    for (let nodeId in allNodes) {
      if (allNodes.hasOwnProperty(nodeId)) {
        // console.log(allNodes[nodeId]);
        updateArray.push(allNodes[nodeId]);
      }
    }
    nodes.update(updateArray);
  } else {
    // console.log("Nothing was selected");
    for (let nodeId in allNodes) {
      if (allNodes.hasOwnProperty(nodeId)) {
        // console.log(allNodes[nodeId]);
        // allNodes[nodeId].color = {};
        updateArray.push(allNodes[nodeId]);
      }
    }
    nodes.update(updateArray);
  }
}

function filterHighlight(params) {
  allNodes = nodes.get({ returnType: "Object" });
  // if something is selected:
  if (params.nodes.length > 0) {
    filterActive = true;
    let selectedNodes = params.nodes;

    // hiding all nodes and saving the label
    for (let nodeId in allNodes) {
      allNodes[nodeId].hidden = true;
      if (allNodes[nodeId].savedLabel === undefined) {
        allNodes[nodeId].savedLabel = allNodes[nodeId].label;
        allNodes[nodeId].label = undefined;
      }
    }

    for (let i=0; i < selectedNodes.length; i++) {
      allNodes[selectedNodes[i]].hidden = false;
      if (allNodes[selectedNodes[i]].savedLabel !== undefined) {
        allNodes[selectedNodes[i]].label = allNodes[selectedNodes[i]].savedLabel;
        allNodes[selectedNodes[i]].savedLabel = undefined;
      }
    }

  } else if (filterActive === true) {
    // reset all nodes
    for (let nodeId in allNodes) {
      allNodes[nodeId].hidden = false;
      if (allNodes[nodeId].savedLabel !== undefined) {
        allNodes[nodeId].label = allNodes[nodeId].savedLabel;
        allNodes[nodeId].savedLabel = undefined;
      }
    }
    filterActive = false;
  }

  // transform the object into an array
  var updateArray = [];
  if (params.nodes.length > 0) {
    for (let nodeId in allNodes) {
      if (allNodes.hasOwnProperty(nodeId)) {
        updateArray.push(allNodes[nodeId]);
      }
    }
    nodes.update(updateArray);
  } else {
    for (let nodeId in allNodes) {
      if (allNodes.hasOwnProperty(nodeId)) {
        updateArray.push(allNodes[nodeId]);
      }
    }
    nodes.update(updateArray);
  }
}

function selectNode(nodes) {
  network.selectNodes(nodes);
  neighbourhoodHighlight({ nodes: nodes });
  return nodes;
}

function selectNodes(nodes) {
  network.selectNodes(nodes);
  filterHighlight({nodes: nodes});
  return nodes;
}

function highlightFilter(filter) {
  let selectedNodes = []
  let selectedProp = filter['property']
  if (filter['item'] === 'node') {
    let allNodes = nodes.get({ returnType: "Object" });
    for (let nodeId in allNodes) {
      if (allNodes[nodeId][selectedProp] && filter['value'].includes((allNodes[nodeId][selectedProp]).toString())) {
        selectedNodes.push(nodeId)
      }
    }
  }
  else if (filter['item'] === 'edge'){
    let allEdges = edges.get({returnType: 'object'});
    // check if the selected property exists for selected edge and select the nodes connected to the edge
    for (let edge in allEdges) {
      if (allEdges[edge][selectedProp] && filter['value'].includes((allEdges[edge][selectedProp]).toString())) {
        selectedNodes.push(allEdges[edge]['from'])
        selectedNodes.push(allEdges[edge]['to'])
      }
    }
  }
  selectNodes(selectedNodes)
}</script>
            <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/dist/vis-network.min.css" integrity="sha512-WgxfT5LWjfszlPHXRmBWHkV2eceiWTOBvrKCNbdgDYTHrT2AeLCGbF4sZlZw3UMN3WtL0tGUoIAKsu8mllg/XA==" crossorigin="anonymous" referrerpolicy="no-referrer" />
            <script src="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/vis-network.min.js" integrity="sha512-LnvoEWDFrqGHlHmDD2101OrLcbsfkrzoSpvtSQtxK3RMnRV0eOkhhBN2dXHKRrUU8p2DGRTk35n4O8nWSVe1mQ==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
            
            
            
            
            
            
                <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/tom-select/2.0.0-rc.4/css/tom-select.min.css" integrity="sha512-43fHB3GLgZfz8QXl1RPQ8O66oIgv3po9cJ5erMt1c4QISq9dYb195T3vr5ImnJPXuVroKcGBPXBFKETW8jrPNQ==" crossorigin="anonymous" referrerpolicy="no-referrer" />
                <script src="https://cdnjs.cloudflare.com/ajax/libs/tom-select/2.0.0-rc.4/js/tom-select.complete.js" integrity="sha512-jeF9CfnvzDiw9G9xiksVjxR2lib44Gnovvkv+3CgCG6NXCD4gqlA5nDAVW5WjpA+i+/zKsUWV5xNEbW1X/HH0Q==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
            

        
<center>
<h1></h1>
</center>

<!-- <link rel="stylesheet" href="../node_modules/vis/dist/vis.min.css" type="text/css" />
<script type="text/javascript" src="../node_modules/vis/dist/vis.js"> </script>-->
        <link
          href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/css/bootstrap.min.css"
          rel="stylesheet"
          integrity="sha384-eOJMYsd53ii+scO/bJGFsiCZc+5NDVN2yr8+0RDqr0Ql0h+rP48ckxlpbzKgwra6"
          crossorigin="anonymous"
        />
        <script
          src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/js/bootstrap.bundle.min.js"
          integrity="sha384-JEW9xMcG8R+pH31jmWH6WWP0WintQrMb4s7ZOdauHnUtxwoG2vI5DkLtS3qm9Ekf"
          crossorigin="anonymous"
        ></script>


        <center>
          <h1></h1>
        </center>
        <style type="text/css">

             #mynetwork {
                 width: 100%;
                 height: 900px;
                 background-color: #ffffff;
                 border: 1px solid lightgray;
                 position: relative;
                 float: left;
             }

             
             #loadingBar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width: 100%;
                 height: 900px;
                 background-color:rgba(200,200,200,0.8);
                 -webkit-transition: all 0.5s ease;
                 -moz-transition: all 0.5s ease;
                 -ms-transition: all 0.5s ease;
                 -o-transition: all 0.5s ease;
                 transition: all 0.5s ease;
                 opacity:1;
             }

             #bar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width:20px;
                 height:20px;
                 margin:auto auto auto auto;
                 border-radius:11px;
                 border:2px solid rgba(30,30,30,0.05);
                 background: rgb(0, 173, 246); /* Old browsers */
                 box-shadow: 2px 0px 4px rgba(0,0,0,0.4);
             }

             #border {
                 position:absolute;
                 top:10px;
                 left:10px;
                 width:500px;
                 height:23px;
                 margin:auto auto auto auto;
                 box-shadow: 0px 0px 4px rgba(0,0,0,0.2);
                 border-radius:10px;
             }

             #text {
                 position:absolute;
                 top:8px;
                 left:530px;
                 width:30px;
                 height:50px;
                 margin:auto auto auto auto;
                 font-size:22px;
                 color: #000000;
             }

             div.outerBorder {
                 position:relative;
                 top:400px;
                 width:600px;
                 height:44px;
                 margin:auto auto auto auto;
                 border:8px solid rgba(0,0,0,0.1);
                 background: rgb(252,252,252); /* Old browsers */
                 background: -moz-linear-gradient(top,  rgba(252,252,252,1) 0%, rgba(237,237,237,1) 100%); /* FF3.6+ */
                 background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,rgba(252,252,252,1)), color-stop(100%,rgba(237,237,237,1))); /* Chrome,Safari4+ */
                 background: -webkit-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Chrome10+,Safari5.1+ */
                 background: -o-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Opera 11.10+ */
                 background: -ms-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* IE10+ */
                 background: linear-gradient(to bottom,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* W3C */
                 filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#fcfcfc', endColorstr='#ededed',GradientType=0 ); /* IE6-9 */
                 border-radius:72px;
                 box-shadow: 0px 0px 10px rgba(0,0,0,0.2);
             }
             

             

             
        </style>
    </head>


    <body>
        <div class="card" style="width: 100%">
            
                <div id="select-menu" class="card-header">
                    <div class="row no-gutters">
                        <div class="col-10 pb-2">
                            <select
                            class="form-select"
                            aria-label="Default select example"
                            onchange="selectNode([value]);"
                            id="select-node"
                            placeholder="Select node..."
                            >
                                <option selected>Select a Node by ID</option>
                                
                                    <option value="*">*</option>
                                
                                    <option value="konstantinos gkiouras">konstantinos gkiouras</option>
                                
                                    <option value="dimitrios p . bogdanos">dimitrios p . bogdanos</option>
                                
                                    <option value="1000 iu vitamin d">1000 iu vitamin d</option>
                                
                                    <option value="placebo">placebo</option>
                                
                                    <option value="12, 2985">12, 2985</option>
                                
                                    <option value="nutrients 2020">nutrients 2020</option>
                                
                                    <option value="2 x 2 pomx caps">2 x 2 pomx caps</option>
                                
                                    <option value="2000 iu vitamin d">2000 iu vitamin d</option>
                                
                                    <option value="25(oh)d-pca association">25(oh)d-pca association</option>
                                
                                    <option value="testosterone">testosterone</option>
                                
                                    <option value="2×1 tomato extract caps (15 mg of lycopene)">2×1 tomato extract caps (15 mg of lycopene)</option>
                                
                                    <option value="2 ×1 tomato extract caps (40 mg soy isoﬂavone mixture)">2 ×1 tomato extract caps (40 mg soy isoﬂavone mixture)</option>
                                
                                    <option value="2×soy protein (20 g)">2×soy protein (20 g)</option>
                                
                                    <option value="se (100 µg)">se (100 µg)</option>
                                
                                    <option value="40 mg">40 mg</option>
                                
                                    <option value="isoﬂavones ons">isoﬂavones ons</option>
                                
                                    <option value="4000 iu vitamin d">4000 iu vitamin d</option>
                                
                                    <option value="5-alpha-reductase inhibitors">5-alpha-reductase inhibitors</option>
                                
                                    <option value="serenoa repens ons">serenoa repens ons</option>
                                
                                    <option value="60 mg sulforaphane ons">60 mg sulforaphane ons</option>
                                
                                    <option value="pca recurrence after prostatectomy">pca recurrence after prostatectomy</option>
                                
                                    <option value="psadt">psadt</option>
                                
                                    <option value="[84,85]">[84,85]</option>
                                
                                    <option value="lazarevic">lazarevic</option>
                                
                                    <option value="[89]">[89]</option>
                                
                                    <option value="dalais">dalais</option>
                                
                                    <option value="[90]">[90]</option>
                                
                                    <option value="kumar">kumar</option>
                                
                                    <option value="[91]">[91]</option>
                                
                                    <option value="[92]">[92]</option>
                                
                                    <option value="hamilton-reeves">hamilton-reeves</option>
                                
                                    <option value="adenocarcinoma">adenocarcinoma</option>
                                
                                    <option value="psa">psa</option>
                                
                                    <option value="adverse events">adverse events</option>
                                
                                    <option value="prostate study 2 (caps2)">prostate study 2 (caps2)</option>
                                
                                    <option value="agaricus blazei murill">agaricus blazei murill</option>
                                
                                    <option value="pca-rcts">pca-rcts</option>
                                
                                    <option value="age">age</option>
                                
                                    <option value="psa thresholds for testing for prostate cancer">psa thresholds for testing for prostate cancer</option>
                                
                                    <option value="aglycone isoflavones">aglycone isoflavones</option>
                                
                                    <option value="patients with localized prostate cancer">patients with localized prostate cancer</option>
                                
                                    <option value="ala">ala</option>
                                
                                    <option value="pca">pca</option>
                                
                                    <option value="psa concentrations">psa concentrations</option>
                                
                                    <option value="allen, k.">allen, k.</option>
                                
                                    <option value="prostate cancer">prostate cancer</option>
                                
                                    <option value="isoﬂavones">isoﬂavones</option>
                                
                                    <option value="androgen axis">androgen axis</option>
                                
                                    <option value="lycopene">lycopene</option>
                                
                                    <option value="androgen deprivation therapy">androgen deprivation therapy</option>
                                
                                    <option value="androgen precursors">androgen precursors</option>
                                
                                    <option value="resveratrol">resveratrol</option>
                                
                                    <option value="animal studies">animal studies</option>
                                
                                    <option value="anticancer properties">anticancer properties</option>
                                
                                    <option value="egcg">egcg</option>
                                
                                    <option value="antigen">antigen</option>
                                
                                    <option value="not pca-specific">not pca-specific</option>
                                
                                    <option value="antioxidant ons">antioxidant ons</option>
                                
                                    <option value="pca incidence">pca incidence</option>
                                
                                    <option value="antioxidant supplementation">antioxidant supplementation</option>
                                
                                    <option value="adverse health events">adverse health events</option>
                                
                                    <option value="antioxidants">antioxidants</option>
                                
                                    <option value="psa kinetics">psa kinetics</option>
                                
                                    <option value="flavonoids">flavonoids</option>
                                
                                    <option value="antwi">antwi</option>
                                
                                    <option value="arch. ital. urol. androl.">arch. ital. urol. androl.</option>
                                
                                    <option value="arms in pre-surgical psa">arms in pre-surgical psa</option>
                                
                                    <option value="baseline /pre-surgery psa">baseline /pre-surgery psa</option>
                                
                                    <option value="as">as</option>
                                
                                    <option value="as for disease management">as for disease management</option>
                                
                                    <option value="ascorbic acid">ascorbic acid</option>
                                
                                    <option value="menadione">menadione</option>
                                
                                    <option value="au">au</option>
                                
                                    <option value="no">no</option>
                                
                                    <option value="barry">barry</option>
                                
                                    <option value="saw palmetto (320 mg)">saw palmetto (320 mg)</option>
                                
                                    <option value="below 0.2 ng/ml">below 0.2 ng/ml</option>
                                
                                    <option value="benefits and harms">benefits and harms</option>
                                
                                    <option value="screening for prostate cancer">screening for prostate cancer</option>
                                
                                    <option value="benign prostate hyperplasia">benign prostate hyperplasia</option>
                                
                                    <option value="permixon">permixon</option>
                                
                                    <option value="benign prostatic hyperplasia">benign prostatic hyperplasia</option>
                                
                                    <option value="risk of prostate cancer and bladder cancer">risk of prostate cancer and bladder cancer</option>
                                
                                    <option value="radical prostatectomy">radical prostatectomy</option>
                                
                                    <option value="cicero">cicero</option>
                                
                                    <option value="saw palmetto">saw palmetto</option>
                                
                                    <option value="better prognosis">better prognosis</option>
                                
                                    <option value="bettuzzi et al. (2006)">bettuzzi et al. (2006)</option>
                                
                                    <option value="green tea catechins">green tea catechins</option>
                                
                                    <option value="biochemical recurrence">biochemical recurrence</option>
                                
                                    <option value="soy protein supplement">soy protein supplement</option>
                                
                                    <option value="biochemical recurrence after radical prostatectomy">biochemical recurrence after radical prostatectomy</option>
                                
                                    <option value="cipolla, b.g.">cipolla, b.g.</option>
                                
                                    <option value="biomarkers">biomarkers</option>
                                
                                    <option value="biopsy-proven pca">biopsy-proven pca</option>
                                
                                    <option value="diet">diet</option>
                                
                                    <option value="bmi">bmi</option>
                                
                                    <option value="pca or advanced pca risk">pca or advanced pca risk</option>
                                
                                    <option value="bph">bph</option>
                                
                                    <option value="body mass index">body mass index</option>
                                
                                    <option value="body mass index (bmi)">body mass index (bmi)</option>
                                
                                    <option value="body weight">body weight</option>
                                
                                    <option value="bosland">bosland</option>
                                
                                    <option value="bosland, m.c.">bosland, m.c.</option>
                                
                                    <option value="serenoa repens">serenoa repens</option>
                                
                                    <option value="bread">bread</option>
                                
                                    <option value="ht soy grits">ht soy grits</option>
                                
                                    <option value="brewed green and black tea">brewed green and black tea</option>
                                
                                    <option value="men with prostate cancer prior to prostatectomy">men with prostate cancer prior to prostatectomy</option>
                                
                                    <option value="bylund">bylund</option>
                                
                                    <option value="wheat bread">wheat bread</option>
                                
                                    <option value="calcitriol">calcitriol</option>
                                
                                    <option value="docetaxel">docetaxel</option>
                                
                                    <option value="placebo ons">placebo ons</option>
                                
                                    <option value="caloric restriction">caloric restriction</option>
                                
                                    <option value="weight management in men treated for prostate cancer">weight management in men treated for prostate cancer</option>
                                
                                    <option value="men electing prostatectomy for prostate cancer">men electing prostatectomy for prostate cancer</option>
                                
                                    <option value="standard diet">standard diet</option>
                                
                                    <option value="camus trial">camus trial</option>
                                
                                    <option value="escalating doses of saw palmetto extract compared with placebo">escalating doses of saw palmetto extract compared with placebo</option>
                                
                                    <option value="cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years">cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years</option>
                                
                                    <option value="32 cancer groups">32 cancer groups</option>
                                
                                    <option value="cancer inhibitory potential">cancer inhibitory potential</option>
                                
                                    <option value="cranberries">cranberries</option>
                                
                                    <option value="cancer-related symptoms">cancer-related symptoms</option>
                                
                                    <option value="lycopene intake">lycopene intake</option>
                                
                                    <option value="cantor, a.">cantor, a.</option>
                                
                                    <option value="cernitin">cernitin</option>
                                
                                    <option value="cipolla">cipolla</option>
                                
                                    <option value="circulating psa">circulating psa</option>
                                
                                    <option value="selected antioxidant supplementation">selected antioxidant supplementation</option>
                                
                                    <option value="γ-linolenic acid supplementation">γ-linolenic acid supplementation</option>
                                
                                    <option value="circulating psa among men with hormonally untreated pca and rising serum psa concentrations">circulating psa among men with hormonally untreated pca and rising serum psa concentrations</option>
                                
                                    <option value="ons with vitamin e (350 mg), selenium (200 µg), vitamin c (750 mg), and coenzyme q10 (coq10) (200 mg)">ons with vitamin e (350 mg), selenium (200 µg), vitamin c (750 mg), and coenzyme q10 (coq10) (200 mg)</option>
                                
                                    <option value="circulating psa concentrations">circulating psa concentrations</option>
                                
                                    <option value="combined effect of calcitriol and iv docetaxel">combined effect of calcitriol and iv docetaxel</option>
                                
                                    <option value="epa and dha supplementation">epa and dha supplementation</option>
                                
                                    <option value="cisplatin">cisplatin</option>
                                
                                    <option value="clinically localized pca">clinically localized pca</option>
                                
                                    <option value="localized">localized</option>
                                
                                    <option value="combined antioxidant supplementation">combined antioxidant supplementation</option>
                                
                                    <option value="combined e ﬀect of calcitriol and iv docetaxel">combined e ﬀect of calcitriol and iv docetaxel</option>
                                
                                    <option value="psa response">psa response</option>
                                
                                    <option value="duration of psa progression-free survival">duration of psa progression-free survival</option>
                                
                                    <option value="combined epa and dha supplementation">combined epa and dha supplementation</option>
                                
                                    <option value="combined supplementation">combined supplementation</option>
                                
                                    <option value="combined tamsulosin and saw palmetto therapy">combined tamsulosin and saw palmetto therapy</option>
                                
                                    <option value="concentrations being indicative of">concentrations being indicative of</option>
                                
                                    <option value="greater therapy response">greater therapy response</option>
                                
                                    <option value="concord grape juice">concord grape juice</option>
                                
                                    <option value="consumed bread again as a medium for supplementation">consumed bread again as a medium for supplementation</option>
                                
                                    <option value="men with pca">men with pca</option>
                                
                                    <option value="consumed whole grain and bran products, substituting 50% of their daily total energy intake (tei)">consumed whole grain and bran products, substituting 50% of their daily total energy intake (tei)</option>
                                
                                    <option value="counseling">counseling</option>
                                
                                    <option value="delivery of dietary and cooking classes">delivery of dietary and cooking classes</option>
                                
                                    <option value="pca therapy">pca therapy</option>
                                
                                    <option value="pca risk">pca risk</option>
                                
                                    <option value="prostate cancer patients prior to radical prostatectomy">prostate cancer patients prior to radical prostatectomy</option>
                                
                                    <option value="lower urinary tract symptoms">lower urinary tract symptoms</option>
                                
                                    <option value="protective effects against cancer and vascular diseases">protective effects against cancer and vascular diseases</option>
                                
                                    <option value="phytochemicals">phytochemicals</option>
                                
                                    <option value="cranberry fruit powder">cranberry fruit powder</option>
                                
                                    <option value="placebo powder">placebo powder</option>
                                
                                    <option value="dried powdered cranberries">dried powdered cranberries</option>
                                
                                    <option value="cross-over">cross-over</option>
                                
                                    <option value="phase ii trial">phase ii trial</option>
                                
                                    <option value="curcumin">curcumin</option>
                                
                                    <option value="curcumin ons">curcumin ons</option>
                                
                                    <option value="daidzein">daidzein</option>
                                
                                    <option value="genistein">genistein</option>
                                
                                    <option value="daily pomegranate intake">daily pomegranate intake</option>
                                
                                    <option value="advanced prostate cancer">advanced prostate cancer</option>
                                
                                    <option value="debruyne">debruyne</option>
                                
                                    <option value="mild-to-severe bph symptoms">mild-to-severe bph symptoms</option>
                                
                                    <option value="decrease">decrease</option>
                                
                                    <option value="lffo diet">lffo diet</option>
                                
                                    <option value="diet high in insoluble fiber">diet high in insoluble fiber</option>
                                
                                    <option value="diet high in soluble fiber">diet high in soluble fiber</option>
                                
                                    <option value="diet rich in phytoestrogens">diet rich in phytoestrogens</option>
                                
                                    <option value="men diagnosed with prostate cancer">men diagnosed with prostate cancer</option>
                                
                                    <option value="dietary factors">dietary factors</option>
                                
                                    <option value="eﬅacy">eﬅacy</option>
                                
                                    <option value="dietary intake of eicosapentaenoic (epa; 20:5n −3), docosahexaenoic (dha; 22:6n −3)">dietary intake of eicosapentaenoic (epa; 20:5n −3), docosahexaenoic (dha; 22:6n −3)</option>
                                
                                    <option value="dietary modifications, pa, and mindfulness-based stress reduction training">dietary modifications, pa, and mindfulness-based stress reduction training</option>
                                
                                    <option value="standard care">standard care</option>
                                
                                    <option value="dietary patterns">dietary patterns</option>
                                
                                    <option value="dietary supplements">dietary supplements</option>
                                
                                    <option value="polyphenols">polyphenols</option>
                                
                                    <option value="sulforaphane">sulforaphane</option>
                                
                                    <option value="diethylstilbestrol">diethylstilbestrol</option>
                                
                                    <option value="mixed antioxidant">mixed antioxidant</option>
                                
                                    <option value="dihydrotestosterone">dihydrotestosterone</option>
                                
                                    <option value="dihydrotestosterone levels">dihydrotestosterone levels</option>
                                
                                    <option value="disease progression">disease progression</option>
                                
                                    <option value="division of transplantation, immunology and mucosal biology">division of transplantation, immunology and mucosal biology</option>
                                
                                    <option value="mrc centre for transplantation">mrc centre for transplantation</option>
                                
                                    <option value="iv docetaxel">iv docetaxel</option>
                                
                                    <option value="doses of vitamin d 3">doses of vitamin d 3</option>
                                
                                    <option value="normal">normal</option>
                                
                                    <option value="doxercalciferol">doxercalciferol</option>
                                
                                    <option value="intravenous docetaxel cycles">intravenous docetaxel cycles</option>
                                
                                    <option value="no cranberry treatment">no cranberry treatment</option>
                                
                                    <option value="duration">duration</option>
                                
                                    <option value="were not the causes of null ﬁndings in the aforementioned trials">were not the causes of null ﬁndings in the aforementioned trials</option>
                                
                                    <option value="each increase in bmi by 5 kg /m2">each increase in bmi by 5 kg /m2</option>
                                
                                    <option value="reduction in psa concentrations equal to 5.88%">reduction in psa concentrations equal to 5.88%</option>
                                
                                    <option value="early diagnosis">early diagnosis</option>
                                
                                    <option value="ebrt">ebrt</option>
                                
                                    <option value="oral curcumin">oral curcumin</option>
                                
                                    <option value="epa">epa</option>
                                
                                    <option value="epa ons">epa ons</option>
                                
                                    <option value="epa supplementation">epa supplementation</option>
                                
                                    <option value="epidemiology">epidemiology</option>
                                
                                    <option value="comorbidities">comorbidities</option>
                                
                                    <option value="epigenetic modulators for prostate cancer prevention">epigenetic modulators for prostate cancer prevention</option>
                                
                                    <option value="escalating doses of vitamin d 3">escalating doses of vitamin d 3</option>
                                
                                    <option value="ethnic di ﬀerences">ethnic di ﬀerences</option>
                                
                                    <option value="fat content of the diet">fat content of the diet</option>
                                
                                    <option value="european randomized study of screening for prostate cancer">european randomized study of screening for prostate cancer</option>
                                
                                    <option value="evidence">evidence</option>
                                
                                    <option value="examining the effect of phytoestrogen ons on psa concentrations among men with pca, or increased pca risk.">examining the effect of phytoestrogen ons on psa concentrations among men with pca, or increased pca risk.</option>
                                
                                    <option value="rcts">rcts</option>
                                
                                    <option value="experts">experts</option>
                                
                                    <option value="sparked controversy on the usefulness of routine psa screening">sparked controversy on the usefulness of routine psa screening</option>
                                
                                    <option value="fa intake">fa intake</option>
                                
                                    <option value="pca aggressiveness">pca aggressiveness</option>
                                
                                    <option value="failed to report signiﬁcant changes between intervention arms">failed to report signiﬁcant changes between intervention arms</option>
                                
                                    <option value="treated pca">treated pca</option>
                                
                                    <option value="fatty acid content of the peri-prostatic adipose tissue">fatty acid content of the peri-prostatic adipose tissue</option>
                                
                                    <option value="fatty acids">fatty acids</option>
                                
                                    <option value="low fat /ﬁsh oil">low fat /ﬁsh oil</option>
                                
                                    <option value="favorable changes">favorable changes</option>
                                
                                    <option value="feasibility">feasibility</option>
                                
                                    <option value="rct">rct</option>
                                
                                    <option value="fish intake">fish intake</option>
                                
                                    <option value="pca morality">pca morality</option>
                                
                                    <option value="plant compounds">plant compounds</option>
                                
                                    <option value="food or drug?">food or drug?</option>
                                
                                    <option value="phytoestrogens">phytoestrogens</option>
                                
                                    <option value="fruit and fruit extracts">fruit and fruit extracts</option>
                                
                                    <option value="fruits">fruits</option>
                                
                                    <option value="ganoderma lucidum">ganoderma lucidum</option>
                                
                                    <option value="gastrointestinal events">gastrointestinal events</option>
                                
                                    <option value="high fruit intake">high fruit intake</option>
                                
                                    <option value="genistein, daidzein, and other isoﬂavones">genistein, daidzein, and other isoﬂavones</option>
                                
                                    <option value="pca on as">pca on as</option>
                                
                                    <option value="grape antioxidants">grape antioxidants</option>
                                
                                    <option value="zhou, k.">zhou, k.</option>
                                
                                    <option value="grape juice antioxidants">grape juice antioxidants</option>
                                
                                    <option value="grape skin and seeds extract">grape skin and seeds extract</option>
                                
                                    <option value="green tea">green tea</option>
                                
                                    <option value="men scheduled for radical prostatectomy">men scheduled for radical prostatectomy</option>
                                
                                    <option value="men on active surveillance (as)">men on active surveillance (as)</option>
                                
                                    <option value="green tea (camellia sinensis)">green tea (camellia sinensis)</option>
                                
                                    <option value="prevention of cancer">prevention of cancer</option>
                                
                                    <option value="men with pca or increased pca risk">men with pca or increased pca risk</option>
                                
                                    <option value="randomized, placebo-controlled trial of green tea catechins for prostate cancer prevention">randomized, placebo-controlled trial of green tea catechins for prostate cancer prevention</option>
                                
                                    <option value="micali et al. (2017)">micali et al. (2017)</option>
                                
                                    <option value="green tea drink (3 cups)">green tea drink (3 cups)</option>
                                
                                    <option value="green tea caps (blinded, 600 mg ﬂavan-3-ol egcg)">green tea caps (blinded, 600 mg ﬂavan-3-ol egcg)</option>
                                
                                    <option value="green tea extract">green tea extract</option>
                                
                                    <option value="kumar et al. (2018)">kumar et al. (2018)</option>
                                
                                    <option value="green tea polyphenols and metabolites">green tea polyphenols and metabolites</option>
                                
                                    <option value="cancer prevention">cancer prevention</option>
                                
                                    <option value="gtcs">gtcs</option>
                                
                                    <option value="pca prevention">pca prevention</option>
                                
                                    <option value="gtcs alternative">gtcs alternative</option>
                                
                                    <option value="polye">polye</option>
                                
                                    <option value="gtcs caps">gtcs caps</option>
                                
                                    <option value="hamilton-reeves, j.m.">hamilton-reeves, j.m.</option>
                                
                                    <option value="healthy dietary patterns">healthy dietary patterns</option>
                                
                                    <option value="hgpin">hgpin</option>
                                
                                    <option value="high doses of pomx">high doses of pomx</option>
                                
                                    <option value="lower doses of pomx">lower doses of pomx</option>
                                
                                    <option value="high fiber content">high fiber content</option>
                                
                                    <option value="li et al. [ 219]">li et al. [ 219]</option>
                                
                                    <option value="high lycopene sources">high lycopene sources</option>
                                
                                    <option value="high prostate cancer risk">high prostate cancer risk</option>
                                
                                    <option value="high psa concentrations">high psa concentrations</option>
                                
                                    <option value="high risk for pca recurrence">high risk for pca recurrence</option>
                                
                                    <option value="high soy diet">high soy diet</option>
                                
                                    <option value="low soy diet">low soy diet</option>
                                
                                    <option value="high-dose selenium ons">high-dose selenium ons</option>
                                
                                    <option value="increased psa velocity among men with high baseline plasma selenium concentrations">increased psa velocity among men with high baseline plasma selenium concentrations</option>
                                
                                    <option value="high-fiber diet">high-fiber diet</option>
                                
                                    <option value="low-carbohydrate diet">low-carbohydrate diet</option>
                                
                                    <option value="lcd">lcd</option>
                                
                                    <option value="high-grade prostatic intraepithelial neoplasia (hgpin) and /or atypical small acinar proliferation (asap)">high-grade prostatic intraepithelial neoplasia (hgpin) and /or atypical small acinar proliferation (asap)</option>
                                
                                    <option value="high-risk populations">high-risk populations</option>
                                
                                    <option value="regular psa tests">regular psa tests</option>
                                
                                    <option value="high-soy diet">high-soy diet</option>
                                
                                    <option value="high-ﬁber lfd">high-ﬁber lfd</option>
                                
                                    <option value="western diet">western diet</option>
                                
                                    <option value="histologically confirmed pca">histologically confirmed pca</option>
                                
                                    <option value="stenner-liewen">stenner-liewen</option>
                                
                                    <option value="indicated some eﬃcacy">indicated some eﬃcacy</option>
                                
                                    <option value="hyson">hyson</option>
                                
                                    <option value="human health">human health</option>
                                
                                    <option value="incidence of pca">incidence of pca</option>
                                
                                    <option value="men with high-grade prostatic intraepithelial neoplasia (hgpin) and /or atypical small acinar proliferation (asap)">men with high-grade prostatic intraepithelial neoplasia (hgpin) and /or atypical small acinar proliferation (asap)</option>
                                
                                    <option value="increased body mass index (bmi)">increased body mass index (bmi)</option>
                                
                                    <option value="lower psa concentrations">lower psa concentrations</option>
                                
                                    <option value="increased cancer risk">increased cancer risk</option>
                                
                                    <option value="increased number of men treated for pca">increased number of men treated for pca</option>
                                
                                    <option value="psa screening">psa screening</option>
                                
                                    <option value="individual counseling sessions">individual counseling sessions</option>
                                
                                    <option value="inflammation">inflammation</option>
                                
                                    <option value="systematic review">systematic review</option>
                                
                                    <option value="inflammation, prostatic cell growth, and stimulation of the apoptotic machinery">inflammation, prostatic cell growth, and stimulation of the apoptotic machinery</option>
                                
                                    <option value="initial psa">initial psa</option>
                                
                                    <option value="insoluble fiber">insoluble fiber</option>
                                
                                    <option value="soluble fiber">soluble fiber</option>
                                
                                    <option value="instead as control">instead as control</option>
                                
                                    <option value="intensive lifestyle intervention supporting an lfd supplemented with soy, fish oil, and antioxidant vitamins">intensive lifestyle intervention supporting an lfd supplemented with soy, fish oil, and antioxidant vitamins</option>
                                
                                    <option value="usual treatment">usual treatment</option>
                                
                                    <option value="intervention">intervention</option>
                                
                                    <option value="presurgical">presurgical</option>
                                
                                    <option value="intervention participants">intervention participants</option>
                                
                                    <option value="isoflavones">isoflavones</option>
                                
                                    <option value="soy products">soy products</option>
                                
                                    <option value="isoﬂavone supplementation">isoﬂavone supplementation</option>
                                
                                    <option value="null findings">null findings</option>
                                
                                    <option value="lack of efficacy">lack of efficacy</option>
                                
                                    <option value="kumar, n.b.">kumar, n.b.</option>
                                
                                    <option value="kang, l.">kang, l.</option>
                                
                                    <option value="pow-sang, j.">pow-sang, j.</option>
                                
                                    <option value="xu, p.">xu, p.</option>
                                
                                    <option value="klotz (2013)">klotz (2013)</option>
                                
                                    <option value="overdiagnosis of prostate cancer">overdiagnosis of prostate cancer</option>
                                
                                    <option value="prostate cancer risk">prostate cancer risk</option>
                                
                                    <option value="prostate specific antigen">prostate specific antigen</option>
                                
                                    <option value="landberg">landberg</option>
                                
                                    <option value="rye whole grain products">rye whole grain products</option>
                                
                                    <option value="usual diet and exercise patterns">usual diet and exercise patterns</option>
                                
                                    <option value="psa concentration">psa concentration</option>
                                
                                    <option value="psa values did not diﬀer between groups">psa values did not diﬀer between groups</option>
                                
                                    <option value="lfd">lfd</option>
                                
                                    <option value="standard brochure on what is considered as a ‘healthy’ diet">standard brochure on what is considered as a ‘healthy’ diet</option>
                                
                                    <option value="usual diet">usual diet</option>
                                
                                    <option value="soy">soy</option>
                                
                                    <option value="linseed">linseed</option>
                                
                                    <option value="plus 20 g of linseed">plus 20 g of linseed</option>
                                
                                    <option value="none">none</option>
                                
                                    <option value="localized prostate cancer">localized prostate cancer</option>
                                
                                    <option value="patients">patients</option>
                                
                                    <option value="long-chain n-6 fatty acids">long-chain n-6 fatty acids</option>
                                
                                    <option value="prostate tumor cell growth">prostate tumor cell growth</option>
                                
                                    <option value="low carbohydrate diets">low carbohydrate diets</option>
                                
                                    <option value="low impact on mortality">low impact on mortality</option>
                                
                                    <option value="low meat /dairy diet">low meat /dairy diet</option>
                                
                                    <option value="psa concentrations at 6 months post-intervention">psa concentrations at 6 months post-intervention</option>
                                
                                    <option value="saw palmetto extract">saw palmetto extract</option>
                                
                                    <option value="lower-dose walnut supplementation">lower-dose walnut supplementation</option>
                                
                                    <option value="psa concentrations among men with pca, increased pca risk, or bph">psa concentrations among men with pca, increased pca risk, or bph</option>
                                
                                    <option value="procomb trial">procomb trial</option>
                                
                                    <option value="no intervention">no intervention</option>
                                
                                    <option value="lycopene supplementation">lycopene supplementation</option>
                                
                                    <option value="prostate cancer prevention">prostate cancer prevention</option>
                                
                                    <option value="prostate cancer treatment">prostate cancer treatment</option>
                                
                                    <option value="primary prevention of prostate cancer">primary prevention of prostate cancer</option>
                                
                                    <option value="selenium and vitamin e">selenium and vitamin e</option>
                                
                                    <option value="lycopene (15 mg)">lycopene (15 mg)</option>
                                
                                    <option value="lycopene (30 mg)">lycopene (30 mg)</option>
                                
                                    <option value="lycopene ons">lycopene ons</option>
                                
                                    <option value="lycopene-combined therapies">lycopene-combined therapies</option>
                                
                                    <option value="pca following their usual diet">pca following their usual diet</option>
                                
                                    <option value="lycopene-rich foods (unblinded)">lycopene-rich foods (unblinded)</option>
                                
                                    <option value="lycopene (15 mg /d) caps (blinded)">lycopene (15 mg /d) caps (blinded)</option>
                                
                                    <option value="malignancy">malignancy</option>
                                
                                    <option value="maria g. grammatikopoulou">maria g. grammatikopoulou</option>
                                
                                    <option value="stefanos t. papageorgiou">stefanos t. papageorgiou</option>
                                
                                    <option value="marine fatty acid supplementation">marine fatty acid supplementation</option>
                                
                                    <option value="mc">mc</option>
                                
                                    <option value="mhgpin">mhgpin</option>
                                
                                    <option value="meat and dairy products">meat and dairy products</option>
                                
                                    <option value="medicinal mushrooms">medicinal mushrooms</option>
                                
                                    <option value="th">th</option>
                                
                                    <option value="men">men</option>
                                
                                    <option value="men at high risk of developing prostate cancer">men at high risk of developing prostate cancer</option>
                                
                                    <option value="men electing active surveillance for localized prostate cancer">men electing active surveillance for localized prostate cancer</option>
                                
                                    <option value="men on androgen deprivation therapy">men on androgen deprivation therapy</option>
                                
                                    <option value="men with biochemical recurrence of prostate cancer">men with biochemical recurrence of prostate cancer</option>
                                
                                    <option value="psa levels">psa levels</option>
                                
                                    <option value="men with histologic evidence of progressive androgen-independent pca">men with histologic evidence of progressive androgen-independent pca</option>
                                
                                    <option value="mixed antioxidant supplementation">mixed antioxidant supplementation</option>
                                
                                    <option value="men with localized prostate cancer">men with localized prostate cancer</option>
                                
                                    <option value="men with lower urinary tract symptoms (luts), elevated psa, but negative prostate biopsy [122]">men with lower urinary tract symptoms (luts), elevated psa, but negative prostate biopsy [122]</option>
                                
                                    <option value="reduction in psa after 6 months of daily intake">reduction in psa after 6 months of daily intake</option>
                                
                                    <option value="men with metastatic castration-resistant prostate cancer">men with metastatic castration-resistant prostate cancer</option>
                                
                                    <option value="men with newly diagnosed prostate cancer">men with newly diagnosed prostate cancer</option>
                                
                                    <option value="men with prostate cancer">men with prostate cancer</option>
                                
                                    <option value="rye whole grain and bran intake">rye whole grain and bran intake</option>
                                
                                    <option value="vitamin c">vitamin c</option>
                                
                                    <option value="mixed antioxidant therapy">mixed antioxidant therapy</option>
                                
                                    <option value="mixed supplementation with broccoli powder, curcumin, pomegranate, and green tea extract">mixed supplementation with broccoli powder, curcumin, pomegranate, and green tea extract</option>
                                
                                    <option value="pca after 6 months">pca after 6 months</option>
                                
                                    <option value="mol. nutr. food res.">mol. nutr. food res.</option>
                                
                                    <option value="meta-analysis">meta-analysis</option>
                                
                                    <option value="mushroom immunology">mushroom immunology</option>
                                
                                    <option value="mv">mv</option>
                                
                                    <option value="negri, m.">negri, m.</option>
                                
                                    <option value="vitamin d">vitamin d</option>
                                
                                    <option value="no di ﬀerences were noted in the psa concentrations of participants in both groups">no di ﬀerences were noted in the psa concentrations of participants in both groups</option>
                                
                                    <option value="non-prescribed antioxidant supplements">non-prescribed antioxidant supplements</option>
                                
                                    <option value="ns">ns</option>
                                
                                    <option value="pci">pci</option>
                                
                                    <option value="nutrients">nutrients</option>
                                
                                    <option value="randomized controlled trials (rcts)">randomized controlled trials (rcts)</option>
                                
                                    <option value="table 4.">table 4.</option>
                                
                                    <option value="obese men">obese men</option>
                                
                                    <option value="obesity">obesity</option>
                                
                                    <option value="prostate-specific antigen (psa)">prostate-specific antigen (psa)</option>
                                
                                    <option value="olivares-galván">olivares-galván</option>
                                
                                    <option value="marina">marina</option>
                                
                                    <option value="one in seven men undergoing psa screening demonstrates increased concentrations">one in seven men undergoing psa screening demonstrates increased concentrations</option>
                                
                                    <option value="sandhu and andriole (2012)">sandhu and andriole (2012)</option>
                                
                                    <option value="overweight men">overweight men</option>
                                
                                    <option value="paller, c.j.">paller, c.j.</option>
                                
                                    <option value="rising psa levels">rising psa levels</option>
                                
                                    <option value="pantuck">pantuck</option>
                                
                                    <option value="rising psa concentrations after primary pca therapy">rising psa concentrations after primary pca therapy</option>
                                
                                    <option value="pantuck, a.j.">pantuck, a.j.</option>
                                
                                    <option value="supplements">supplements</option>
                                
                                    <option value="prostatic intraepithelial neoplasia">prostatic intraepithelial neoplasia</option>
                                
                                    <option value="rye bran">rye bran</option>
                                
                                    <option value="vitis vinifera">vitis vinifera</option>
                                
                                    <option value="pomx">pomx</option>
                                
                                    <option value="pin">pin</option>
                                
                                    <option value="zn">zn</option>
                                
                                    <option value="walnut consumption">walnut consumption</option>
                                
                                    <option value="usual diet +walnut ons">usual diet +walnut ons</option>
                                
                                    <option value="typical western diet">typical western diet</option>
                                
                                    <option value="prostatectomy">prostatectomy</option>
                                
                                    <option value="radiation">radiation</option>
                                
                                    <option value="recurrence">recurrence</option>
                                
                                    <option value="pca diagnosis">pca diagnosis</option>
                                
                                    <option value="tomato products containing 30 mg of lycopene or tomato products plus selenium, n-3 fatty acids, soy isoﬂavones, grape /pomegranate juice, and green /black tea">tomato products containing 30 mg of lycopene or tomato products plus selenium, n-3 fatty acids, soy isoﬂavones, grape /pomegranate juice, and green /black tea</option>
                                
                                    <option value="supplementation with soy protein, vitamin e, and selenium for 3 years">supplementation with soy protein, vitamin e, and selenium for 3 years</option>
                                
                                    <option value="selenium ons">selenium ons</option>
                                
                                    <option value="selenium">selenium</option>
                                
                                    <option value="serum 25(oh)d concentrations">serum 25(oh)d concentrations</option>
                                
                                    <option value="pca-mortality">pca-mortality</option>
                                
                                    <option value="retropubic prostatectomy">retropubic prostatectomy</option>
                                
                                    <option value="silymarin">silymarin</option>
                                
                                    <option value="persistent elevated psa concentrations">persistent elevated psa concentrations</option>
                                
                                    <option value="prostate biopsy and diagnostic imaging">prostate biopsy and diagnostic imaging</option>
                                
                                    <option value="phytoestrogen ons">phytoestrogen ons</option>
                                
                                    <option value="soy isoflavones">soy isoflavones</option>
                                
                                    <option value="vitamin d3 analog">vitamin d3 analog</option>
                                
                                    <option value="prevent trial">prevent trial</option>
                                
                                    <option value="placebo group">placebo group</option>
                                
                                    <option value="psa increases >20% at 6 months">psa increases >20% at 6 months</option>
                                
                                    <option value="placebo groups">placebo groups</option>
                                
                                    <option value="trial">trial</option>
                                
                                    <option value="plant derived bioactive compounds">plant derived bioactive compounds</option>
                                
                                    <option value="poulsen et al. (2020)">poulsen et al. (2020)</option>
                                
                                    <option value="8 oz liquid pomx">8 oz liquid pomx</option>
                                
                                    <option value="pomx pills">pomx pills</option>
                                
                                    <option value="prostate cancer before radical prostatectomy">prostate cancer before radical prostatectomy</option>
                                
                                    <option value="tocopherol supplementation">tocopherol supplementation</option>
                                
                                    <option value="promotion and progression">promotion and progression</option>
                                
                                    <option value="psa test">psa test</option>
                                
                                    <option value="psa-based screening intervention">psa-based screening intervention</option>
                                
                                    <option value="prostatectomy for prostate cancer">prostatectomy for prostate cancer</option>
                                
                                    <option value="vitamin e">vitamin e</option>
                                
                                    <option value="rye bran bread">rye bran bread</option>
                                
                                    <option value="ratha, p.">ratha, p.</option>
                                
                                    <option value="trump, d.l.">trump, d.l.</option>
                                
                                    <option value="vitamin d concentration">vitamin d concentration</option>
                                
                                    <option value="prostate cancer cells sensitivity to cisplatin">prostate cancer cells sensitivity to cisplatin</option>
                                
                                    <option value="prostate cancer overdiagnosis">prostate cancer overdiagnosis</option>
                                
                                    <option value="overtreatment">overtreatment</option>
                                
                                    <option value="prostate size">prostate size</option>
                                
                                    <option value="serum psa concentrations">serum psa concentrations</option>
                                
                                    <option value="saw palmetto fruit extract">saw palmetto fruit extract</option>
                                
                                    <option value="prostate volume">prostate volume</option>
                                
                                    <option value="prostate-specific antigen">prostate-specific antigen</option>
                                
                                    <option value="prostatectomyn">prostatectomyn</option>
                                
                                    <option value="tomato extract">tomato extract</option>
                                
                                    <option value="tomato extract (30 mg of lycopene)">tomato extract (30 mg of lycopene)</option>
                                
                                    <option value="serum 25-hydroxyvitamin d (25(oh)d)">serum 25-hydroxyvitamin d (25(oh)d)</option>
                                
                                    <option value="trials">trials</option>
                                
                                    <option value="select trial">select trial</option>
                                
                                    <option value="saw palmetto, selenium, and lycopene or tamsulosin">saw palmetto, selenium, and lycopene or tamsulosin</option>
                                
                                    <option value="tamsulosin">tamsulosin</option>
                                
                                    <option value="remain asymptomatic">remain asymptomatic</option>
                                
                                    <option value="second sample for verification purposes">second sample for verification purposes</option>
                                
                                    <option value="weight-loss">weight-loss</option>
                                
                                    <option value="psa results">psa results</option>
                                
                                    <option value="soy protein beverages with high or low genistein and daidzein">soy protein beverages with high or low genistein and daidzein</option>
                                
                                    <option value="α-receptor blocker (αrb)">α-receptor blocker (αrb)</option>
                                
                                    <option value="vitamin d analogs ons">vitamin d analogs ons</option>
                                
                                    <option value="tomato products">tomato products</option>
                                
                                    <option value="walnut supplementation">walnut supplementation</option>
                                
                                    <option value="reduction">reduction</option>
                                
                                    <option value="telephone counseling promoting an increased vegetable intake">telephone counseling promoting an increased vegetable intake</option>
                                
                                    <option value="psa elevation following radical prostatectomy">psa elevation following radical prostatectomy</option>
                                
                                    <option value="progression after psa elevation following radical prostatectomy">progression after psa elevation following radical prostatectomy</option>
                                
                                    <option value="men with a history of prostate cancer">men with a history of prostate cancer</option>
                                
                                    <option value="small reduction in 10-year disease-speciﬁc mortality">small reduction in 10-year disease-speciﬁc mortality</option>
                                
                                    <option value="reduces relative risk for pca by 9%">reduces relative risk for pca by 9%</option>
                                
                                    <option value="new biomarkers for prostate cancer">new biomarkers for prostate cancer</option>
                                
                                    <option value="total psadt">total psadt</option>
                                
                                    <option value="psa≤2.5ng /ml">psa≤2.5ng /ml</option>
                                
                                    <option value="se (240 µg)">se (240 µg)</option>
                                
                                    <option value="randomized controlled trials">randomized controlled trials</option>
                                
                                    <option value="review">review</option>
                                
                                    <option value="se">se</option>
                                
                                    <option value="time">time</option>
                                
                                    <option value="tei">tei</option>
                                
                                    <option value="ttp">ttp</option>
                                
                                    <option value="men with metabolic syndrome">men with metabolic syndrome</option>
                                
                                    <option value="testosterone levels">testosterone levels</option>
                                
                                    <option value="resveratrol (1000 mg /d)">resveratrol (1000 mg /d)</option>
                                
                                    <option value="resveratrol (150 mg /d)">resveratrol (150 mg /d)</option>
                                
                                    <option value="rising psa level after local therapy">rising psa level after local therapy</option>
                                
                                    <option value="options">options</option>
                                
                                    <option value="ryu">ryu</option>
                                
                                    <option value="symptomatic bph">symptomatic bph</option>
                                
                                    <option value="saw palmetto herbal blend">saw palmetto herbal blend</option>
                                
                                    <option value="symptomatic benign prostatic hyperplasia">symptomatic benign prostatic hyperplasia</option>
                                
                                    <option value="selenium overload">selenium overload</option>
                                
                                    <option value="serum selenium levels">serum selenium levels</option>
                                
                                    <option value="selenium intake">selenium intake</option>
                                
                                    <option value="exceeds 400 mg daily">exceeds 400 mg daily</option>
                                
                                    <option value="selenium supplementation">selenium supplementation</option>
                                
                                    <option value="pca mortality">pca mortality</option>
                                
                                    <option value="serum psa">serum psa</option>
                                
                                    <option value="total psa">total psa</option>
                                
                                    <option value="soy pro drink">soy pro drink</option>
                                
                                    <option value="serum vitamin d concentrations">serum vitamin d concentrations</option>
                                
                                    <option value="specific cancers">specific cancers</option>
                                
                                    <option value="soy pro beverages with high micronutrient content">soy pro beverages with high micronutrient content</option>
                                
                                    <option value="urban">urban</option>
                                
                                    <option value="synthesis of evidence">synthesis of evidence</option>
                                
                                    <option value="great heterogeneity observed in supplementation regime and design of included trials">great heterogeneity observed in supplementation regime and design of included trials</option>
                                
                                    <option value="rcts as the only primary studies">rcts as the only primary studies</option>
                                
                                    <option value="tagliaferri, s.">tagliaferri, s.</option>
                                
                                    <option value="vitamin d3">vitamin d3</option>
                                
                                    <option value="tea catechins">tea catechins</option>
                                
                                    <option value="cancer signaling pathways">cancer signaling pathways</option>
                                
                                    <option value="usda">usda</option>
                                
                                    <option value="time to progression">time to progression</option>
                                
                                    <option value="tomato oleoresin extract">tomato oleoresin extract</option>
                                
                                    <option value="tumor size">tumor size</option>
                                
                                    <option value="anti-tumor eﬀect">anti-tumor eﬀect</option>
                                
                            </select>
                        </div>
                        <div class="col-2 pb-2">
                            <button type="button" class="btn btn-primary btn-block" onclick="neighbourhoodHighlight({nodes: []});">Reset Selection</button>
                        </div>
                    </div>
                </div>
            
            
              <div id="filter-menu" class="card-header">
                <div class="row no-gutters">
                  <div class="col-3 pb-2">
                    <select
                            class="form-select"
                            aria-label="Default select example"
                            onchange="updateFilter(value, 'item')"
                            id="select-item"
                        >
                        <option value="">Select a network item</option>
                        <option value="edge">edge</option>
                        <option value="node">node</option>
                    </select>
                  </div>
                  <div class="col-3 pb-2">
                    <select
                            class="form-select"
                            aria-label="Default select example"
                            onchange="updateFilter(value, 'property')"
                            id="select-property"
                        >
                        <option value="">Select a property...</option>
                    </select>
                  </div>
                  <div class="col-3 pb-2">
                    <select
                            class="form-select"
                            aria-label="Default select example"
                            id="select-value"
                        >
                        <option value="">Select value(s)...</option>
                    </select>
                  </div>
                  <div class="col-1 pb-2">
                    <button type="button" class="btn btn-primary btn-block" onclick="highlightFilter(filter);">Filter</button>
                  </div>
                  <div class="col-2 pb-2">
                    <button type="button" class="btn btn-primary btn-block" onclick="clearFilter(true)">Reset Selection</button>
                  </div>
                </div>
              </div>
            
            <div id="mynetwork" class="card-body"></div>
        </div>

        
            <div id="loadingBar">
              <div class="outerBorder">
                <div id="text">0%</div>
                <div id="border">
                  <div id="bar"></div>
                </div>
              </div>
            </div>
        
        

        <script type="text/javascript">

              // initialize global variables.
              var edges;
              var nodes;
              var allNodes;
              var allEdges;
              var nodeColors;
              var originalNodes;
              var network;
              var container;
              var options, data;
              var filter = {
                  item : '',
                  property : '',
                  value : []
              };

              
                  new TomSelect("#select-node",{
                      create: false,
                      sortField: {
                          field: "text",
                          direction: "asc"
                      }
                  });
              

              
                  // explicitly using onItemAdd and this function as we need to save multiple values
                  let updateValueFilter = function() {
                      return function () {
                      filter['value'].push(arguments[0])
                      }
                  }

                  let valueControl = new TomSelect("#select-value",{
                      maxItems: null,
                      valueField: 'id',
                      labelField: 'title',
                      searchField: 'title',
                      create: false,
                      sortField: {
                          field: "text",
                          direction: "asc"
                      },
                      onItemAdd: updateValueFilter()
                  });

                  let addValues = function() {
                      return function () {
                          // clear the current value options and add the selected attribute values
                          // tom-select handles duplicates
                          let selectedProperty = arguments[0];
                          valueControl.clear();
                          valueControl.clearOptions();
                          filter['value'] = []
                          if (filter['item'] === 'node') {
                              for (let each in allNodes) {
                                  valueControl.addOption({
                                      id:allNodes[each][selectedProperty],
                                      title:allNodes[each][selectedProperty]
                                  })
                              }
                          }
                          else if (filter['item'] === 'edge') {
                              for (let each in allEdges) {
                                  valueControl.addOption({
                                      id:allEdges[each][selectedProperty],
                                      title:allEdges[each][selectedProperty]
                                  })
                              }
                          }
                      }
                  };

                  let propControl = new TomSelect("#select-property",{
                      valueField: 'id',
                      labelField: 'title',
                      searchField: 'title',
                      create: false,
                      sortField: {
                          field: "text",
                          direction: "asc"
                      },
                      onItemAdd: addValues()
                  });

                  let addProperties = function() {
                      return function () {
                          // loops through the selected network item and adds the attributes to dropdown
                          // tom-select handles duplicates
                          clearFilter(false)
                          if (arguments[0] === 'edge') {
                              for (let each in allEdges) {
                                  if (allEdges.hasOwnProperty(each)) {
                                      for (let eachProp in allEdges[each]) {
                                          if (allEdges[each].hasOwnProperty(eachProp)) {
                                              propControl.addOption({id: eachProp, title: eachProp})
                                          }
                                      }
                                  }
                              }
                          }
                          else if (arguments[0] === 'node') {
                              for (let each in allNodes) {
                                  if (allNodes.hasOwnProperty(each)) {
                                      for (let eachProp in allNodes[each]) {
                                          if (allNodes[each].hasOwnProperty(eachProp)
                                              && (eachProp !== 'hidden' && eachProp !== 'savedLabel'
                                                  && eachProp !== 'hiddenLabel')) {
                                              propControl.addOption({id: eachProp, title: eachProp})

                                          }
                                      }
                                  }
                              }
                          }
                      }
                  };

                  let itemControl = new TomSelect("#select-item",{
                      create: false,
                      sortField:{
                          field: "text",
                          direction: "asc"
                      },
                      onItemAdd: addProperties()
                  });

                  function clearFilter(reset) {
                      // utility function to clear all the selected filter options
                      // if reset is set to true, the existing filter will be removed
                      // else, only the dropdown options are cleared
                      propControl.clear();
                      propControl.clearOptions();
                      valueControl.clear();
                      valueControl.clearOptions();
                      filter = {
                          item : '',
                          property : '',
                          value : []
                      }
                      if (reset) {
                          itemControl.clear();
                          filterHighlight({nodes: []})
                      }
                  }

                  function updateFilter(value, key) {
                      // key could be 'item' or 'property' and value is as selected in dropdown
                      filter[key] = value
                  }

              

              // This method is responsible for drawing the graph, returns the drawn network
              function drawGraph() {
                  var container = document.getElementById('mynetwork');

                  

                  // parsing and collecting nodes and edges from the python
                  nodes = new vis.DataSet([{"group": 1, "id": "*", "label": "*", "shape": "dot", "size": 2}, {"group": 1, "id": "konstantinos gkiouras", "label": "konstantinos gkiouras", "shape": "dot", "size": 1}, {"group": 1, "id": "dimitrios p . bogdanos", "label": "dimitrios p . bogdanos", "shape": "dot", "size": 1}, {"group": 2, "id": "1000 iu vitamin d", "label": "1000 iu vitamin d", "shape": "dot", "size": 1}, {"group": 2, "id": "placebo", "label": "placebo", "shape": "dot", "size": 15}, {"group": 2, "id": "12, 2985", "label": "12, 2985", "shape": "dot", "size": 1}, {"group": 2, "id": "nutrients 2020", "label": "nutrients 2020", "shape": "dot", "size": 5}, {"group": 2, "id": "2 x 2 pomx caps", "label": "2 x 2 pomx caps", "shape": "dot", "size": 1}, {"group": 2, "id": "2000 iu vitamin d", "label": "2000 iu vitamin d", "shape": "dot", "size": 1}, {"group": 4, "id": "25(oh)d-pca association", "label": "25(oh)d-pca association", "shape": "dot", "size": 1}, {"group": 4, "id": "testosterone", "label": "testosterone", "shape": "dot", "size": 2}, {"group": 3, "id": "2\u00d71 tomato extract caps (15 mg of lycopene)", "label": "2\u00d71 tomato extract caps (15 mg of lycopene)", "shape": "dot", "size": 1}, {"group": 3, "id": "2 \u00d71 tomato extract caps (40 mg soy iso\ufb02avone mixture)", "label": "2 \u00d71 tomato extract caps (40 mg soy iso\ufb02avone mixture)", "shape": "dot", "size": 1}, {"group": 5, "id": "2\u00d7soy protein (20 g)", "label": "2\u00d7soy protein (20 g)", "shape": "dot", "size": 1}, {"group": 5, "id": "se (100 \u00b5g)", "label": "se (100 \u00b5g)", "shape": "dot", "size": 1}, {"group": 7, "id": "40 mg", "label": "40 mg", "shape": "dot", "size": 1}, {"group": 7, "id": "iso\ufb02avones ons", "label": "iso\ufb02avones ons", "shape": "dot", "size": 1}, {"group": 2, "id": "4000 iu vitamin d", "label": "4000 iu vitamin d", "shape": "dot", "size": 1}, {"group": 2, "id": "5-alpha-reductase inhibitors", "label": "5-alpha-reductase inhibitors", "shape": "dot", "size": 1}, {"group": 2, "id": "serenoa repens ons", "label": "serenoa repens ons", "shape": "dot", "size": 3}, {"group": 2, "id": "60 mg sulforaphane ons", "label": "60 mg sulforaphane ons", "shape": "dot", "size": 2}, {"group": 2, "id": "pca recurrence after prostatectomy", "label": "pca recurrence after prostatectomy", "shape": "dot", "size": 1}, {"group": 2, "id": "psadt", "label": "psadt", "shape": "dot", "size": 3}, {"group": 8, "id": "[84,85]", "label": "[84,85]", "shape": "dot", "size": 1}, {"group": 8, "id": "lazarevic", "label": "lazarevic", "shape": "dot", "size": 2}, {"group": 8, "id": "[89]", "label": "[89]", "shape": "dot", "size": 1}, {"group": 8, "id": "dalais", "label": "dalais", "shape": "dot", "size": 2}, {"group": 2, "id": "[90]", "label": "[90]", "shape": "dot", "size": 1}, {"group": 2, "id": "kumar", "label": "kumar", "shape": "dot", "size": 3}, {"group": 2, "id": "[91]", "label": "[91]", "shape": "dot", "size": 1}, {"group": 9, "id": "[92]", "label": "[92]", "shape": "dot", "size": 1}, {"group": 9, "id": "hamilton-reeves", "label": "hamilton-reeves", "shape": "dot", "size": 1}, {"group": 2, "id": "adenocarcinoma", "label": "adenocarcinoma", "shape": "dot", "size": 1}, {"group": 2, "id": "psa", "label": "psa", "shape": "dot", "size": 32}, {"group": 11, "id": "adverse events", "label": "adverse events", "shape": "dot", "size": 1}, {"group": 11, "id": "prostate study 2 (caps2)", "label": "prostate study 2 (caps2)", "shape": "dot", "size": 2}, {"group": 2, "id": "agaricus blazei murill", "label": "agaricus blazei murill", "shape": "dot", "size": 1}, {"group": 2, "id": "pca-rcts", "label": "pca-rcts", "shape": "dot", "size": 7}, {"group": 2, "id": "age", "label": "age", "shape": "dot", "size": 2}, {"group": 2, "id": "psa thresholds for testing for prostate cancer", "label": "psa thresholds for testing for prostate cancer", "shape": "dot", "size": 1}, {"group": 13, "id": "aglycone isoflavones", "label": "aglycone isoflavones", "shape": "dot", "size": 1}, {"group": 13, "id": "patients with localized prostate cancer", "label": "patients with localized prostate cancer", "shape": "dot", "size": 1}, {"group": 2, "id": "ala", "label": "ala", "shape": "dot", "size": 2}, {"group": 2, "id": "pca", "label": "pca", "shape": "dot", "size": 53}, {"group": 2, "id": "psa concentrations", "label": "psa concentrations", "shape": "dot", "size": 47}, {"group": 4, "id": "allen, k.", "label": "allen, k.", "shape": "dot", "size": 2}, {"group": 4, "id": "prostate cancer", "label": "prostate cancer", "shape": "dot", "size": 38}, {"group": 4, "id": "iso\ufb02avones", "label": "iso\ufb02avones", "shape": "dot", "size": 11}, {"group": 2, "id": "androgen axis", "label": "androgen axis", "shape": "dot", "size": 1}, {"group": 2, "id": "lycopene", "label": "lycopene", "shape": "dot", "size": 20}, {"group": 2, "id": "androgen deprivation therapy", "label": "androgen deprivation therapy", "shape": "dot", "size": 1}, {"group": 4, "id": "androgen precursors", "label": "androgen precursors", "shape": "dot", "size": 1}, {"group": 4, "id": "resveratrol", "label": "resveratrol", "shape": "dot", "size": 11}, {"group": 2, "id": "animal studies", "label": "animal studies", "shape": "dot", "size": 1}, {"group": 15, "id": "anticancer properties", "label": "anticancer properties", "shape": "dot", "size": 1}, {"group": 15, "id": "egcg", "label": "egcg", "shape": "dot", "size": 1}, {"group": 16, "id": "antigen", "label": "antigen", "shape": "dot", "size": 1}, {"group": 16, "id": "not pca-specific", "label": "not pca-specific", "shape": "dot", "size": 1}, {"group": 2, "id": "antioxidant ons", "label": "antioxidant ons", "shape": "dot", "size": 2}, {"group": 2, "id": "pca incidence", "label": "pca incidence", "shape": "dot", "size": 2}, {"group": 12, "id": "antioxidant supplementation", "label": "antioxidant supplementation", "shape": "dot", "size": 1}, {"group": 12, "id": "adverse health events", "label": "adverse health events", "shape": "dot", "size": 1}, {"group": 2, "id": "antioxidants", "label": "antioxidants", "shape": "dot", "size": 3}, {"group": 2, "id": "psa kinetics", "label": "psa kinetics", "shape": "dot", "size": 1}, {"group": 2, "id": "flavonoids", "label": "flavonoids", "shape": "dot", "size": 4}, {"group": 2, "id": "antwi", "label": "antwi", "shape": "dot", "size": 1}, {"group": 4, "id": "arch. ital. urol. androl.", "label": "arch. ital. urol. androl.", "shape": "dot", "size": 1}, {"group": 17, "id": "arms in pre-surgical psa", "label": "arms in pre-surgical psa", "shape": "dot", "size": 1}, {"group": 17, "id": "baseline /pre-surgery psa", "label": "baseline /pre-surgery psa", "shape": "dot", "size": 1}, {"group": 2, "id": "as", "label": "as", "shape": "dot", "size": 1}, {"group": 2, "id": "as for disease management", "label": "as for disease management", "shape": "dot", "size": 1}, {"group": 18, "id": "ascorbic acid", "label": "ascorbic acid", "shape": "dot", "size": 1}, {"group": 18, "id": "menadione", "label": "menadione", "shape": "dot", "size": 2}, {"group": 19, "id": "au", "label": "au", "shape": "dot", "size": 1}, {"group": 19, "id": "no", "label": "no", "shape": "dot", "size": 1}, {"group": 20, "id": "barry", "label": "barry", "shape": "dot", "size": 1}, {"group": 20, "id": "saw palmetto (320 mg)", "label": "saw palmetto (320 mg)", "shape": "dot", "size": 1}, {"group": 2, "id": "below 0.2 ng/ml", "label": "below 0.2 ng/ml", "shape": "dot", "size": 1}, {"group": 21, "id": "benefits and harms", "label": "benefits and harms", "shape": "dot", "size": 1}, {"group": 21, "id": "screening for prostate cancer", "label": "screening for prostate cancer", "shape": "dot", "size": 1}, {"group": 2, "id": "benign prostate hyperplasia", "label": "benign prostate hyperplasia", "shape": "dot", "size": 2}, {"group": 2, "id": "permixon", "label": "permixon", "shape": "dot", "size": 1}, {"group": 2, "id": "benign prostatic hyperplasia", "label": "benign prostatic hyperplasia", "shape": "dot", "size": 4}, {"group": 2, "id": "risk of prostate cancer and bladder cancer", "label": "risk of prostate cancer and bladder cancer", "shape": "dot", "size": 1}, {"group": 2, "id": "radical prostatectomy", "label": "radical prostatectomy", "shape": "dot", "size": 2}, {"group": 2, "id": "cicero", "label": "cicero", "shape": "dot", "size": 1}, {"group": 2, "id": "saw palmetto", "label": "saw palmetto", "shape": "dot", "size": 6}, {"group": 2, "id": "better prognosis", "label": "better prognosis", "shape": "dot", "size": 1}, {"group": 22, "id": "bettuzzi et al. (2006)", "label": "bettuzzi et al. (2006)", "shape": "dot", "size": 1}, {"group": 22, "id": "green tea catechins", "label": "green tea catechins", "shape": "dot", "size": 4}, {"group": 23, "id": "biochemical recurrence", "label": "biochemical recurrence", "shape": "dot", "size": 1}, {"group": 23, "id": "soy protein supplement", "label": "soy protein supplement", "shape": "dot", "size": 1}, {"group": 4, "id": "biochemical recurrence after radical prostatectomy", "label": "biochemical recurrence after radical prostatectomy", "shape": "dot", "size": 1}, {"group": 4, "id": "cipolla, b.g.", "label": "cipolla, b.g.", "shape": "dot", "size": 2}, {"group": 4, "id": "biomarkers", "label": "biomarkers", "shape": "dot", "size": 1}, {"group": 2, "id": "biopsy-proven pca", "label": "biopsy-proven pca", "shape": "dot", "size": 1}, {"group": 2, "id": "diet", "label": "diet", "shape": "dot", "size": 3}, {"group": 2, "id": "bmi", "label": "bmi", "shape": "dot", "size": 4}, {"group": 2, "id": "pca or advanced pca risk", "label": "pca or advanced pca risk", "shape": "dot", "size": 1}, {"group": 2, "id": "bph", "label": "bph", "shape": "dot", "size": 4}, {"group": 2, "id": "body mass index", "label": "body mass index", "shape": "dot", "size": 1}, {"group": 2, "id": "body mass index (bmi)", "label": "body mass index (bmi)", "shape": "dot", "size": 1}, {"group": 2, "id": "body weight", "label": "body weight", "shape": "dot", "size": 1}, {"group": 2, "id": "bosland", "label": "bosland", "shape": "dot", "size": 1}, {"group": 4, "id": "bosland, m.c.", "label": "bosland, m.c.", "shape": "dot", "size": 2}, {"group": 2, "id": "serenoa repens", "label": "serenoa repens", "shape": "dot", "size": 3}, {"group": 24, "id": "bread", "label": "bread", "shape": "dot", "size": 1}, {"group": 24, "id": "ht soy grits", "label": "ht soy grits", "shape": "dot", "size": 2}, {"group": 25, "id": "brewed green and black tea", "label": "brewed green and black tea", "shape": "dot", "size": 1}, {"group": 25, "id": "men with prostate cancer prior to prostatectomy", "label": "men with prostate cancer prior to prostatectomy", "shape": "dot", "size": 1}, {"group": 26, "id": "bylund", "label": "bylund", "shape": "dot", "size": 1}, {"group": 26, "id": "wheat bread", "label": "wheat bread", "shape": "dot", "size": 2}, {"group": 2, "id": "calcitriol", "label": "calcitriol", "shape": "dot", "size": 2}, {"group": 2, "id": "docetaxel", "label": "docetaxel", "shape": "dot", "size": 2}, {"group": 2, "id": "placebo ons", "label": "placebo ons", "shape": "dot", "size": 2}, {"group": 2, "id": "caloric restriction", "label": "caloric restriction", "shape": "dot", "size": 4}, {"group": 2, "id": "weight management in men treated for prostate cancer", "label": "weight management in men treated for prostate cancer", "shape": "dot", "size": 1}, {"group": 2, "id": "men electing prostatectomy for prostate cancer", "label": "men electing prostatectomy for prostate cancer", "shape": "dot", "size": 1}, {"group": 2, "id": "standard diet", "label": "standard diet", "shape": "dot", "size": 1}, {"group": 27, "id": "camus trial", "label": "camus trial", "shape": "dot", "size": 1}, {"group": 27, "id": "escalating doses of saw palmetto extract compared with placebo", "label": "escalating doses of saw palmetto extract compared with placebo", "shape": "dot", "size": 1}, {"group": 6, "id": "cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years", "label": "cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years", "shape": "dot", "size": 1}, {"group": 6, "id": "32 cancer groups", "label": "32 cancer groups", "shape": "dot", "size": 1}, {"group": 2, "id": "cancer inhibitory potential", "label": "cancer inhibitory potential", "shape": "dot", "size": 1}, {"group": 2, "id": "cranberries", "label": "cranberries", "shape": "dot", "size": 8}, {"group": 30, "id": "cancer-related symptoms", "label": "cancer-related symptoms", "shape": "dot", "size": 1}, {"group": 30, "id": "lycopene intake", "label": "lycopene intake", "shape": "dot", "size": 1}, {"group": 4, "id": "cantor, a.", "label": "cantor, a.", "shape": "dot", "size": 2}, {"group": 2, "id": "cernitin", "label": "cernitin", "shape": "dot", "size": 1}, {"group": 2, "id": "cipolla", "label": "cipolla", "shape": "dot", "size": 1}, {"group": 31, "id": "circulating psa", "label": "circulating psa", "shape": "dot", "size": 2}, {"group": 31, "id": "selected antioxidant supplementation", "label": "selected antioxidant supplementation", "shape": "dot", "size": 1}, {"group": 31, "id": "\u03b3-linolenic acid supplementation", "label": "\u03b3-linolenic acid supplementation", "shape": "dot", "size": 1}, {"group": 32, "id": "circulating psa among men with hormonally untreated pca and rising serum psa concentrations", "label": "circulating psa among men with hormonally untreated pca and rising serum psa concentrations", "shape": "dot", "size": 1}, {"group": 32, "id": "ons with vitamin e (350 mg), selenium (200 \u00b5g), vitamin c (750 mg), and coenzyme q10 (coq10) (200 mg)", "label": "ons with vitamin e (350 mg), selenium (200 \u00b5g), vitamin c (750 mg), and coenzyme q10 (coq10) (200 mg)", "shape": "dot", "size": 1}, {"group": 33, "id": "circulating psa concentrations", "label": "circulating psa concentrations", "shape": "dot", "size": 2}, {"group": 33, "id": "combined effect of calcitriol and iv docetaxel", "label": "combined effect of calcitriol and iv docetaxel", "shape": "dot", "size": 1}, {"group": 33, "id": "epa and dha supplementation", "label": "epa and dha supplementation", "shape": "dot", "size": 1}, {"group": 4, "id": "cisplatin", "label": "cisplatin", "shape": "dot", "size": 1}, {"group": 34, "id": "clinically localized pca", "label": "clinically localized pca", "shape": "dot", "size": 1}, {"group": 34, "id": "localized", "label": "localized", "shape": "dot", "size": 1}, {"group": 2, "id": "combined antioxidant supplementation", "label": "combined antioxidant supplementation", "shape": "dot", "size": 1}, {"group": 35, "id": "combined e \ufb00ect of calcitriol and iv docetaxel", "label": "combined e \ufb00ect of calcitriol and iv docetaxel", "shape": "dot", "size": 2}, {"group": 35, "id": "psa response", "label": "psa response", "shape": "dot", "size": 1}, {"group": 35, "id": "duration of psa progression-free survival", "label": "duration of psa progression-free survival", "shape": "dot", "size": 1}, {"group": 2, "id": "combined epa and dha supplementation", "label": "combined epa and dha supplementation", "shape": "dot", "size": 1}, {"group": 2, "id": "combined supplementation", "label": "combined supplementation", "shape": "dot", "size": 1}, {"group": 2, "id": "combined tamsulosin and saw palmetto therapy", "label": "combined tamsulosin and saw palmetto therapy", "shape": "dot", "size": 1}, {"group": 37, "id": "concentrations being indicative of", "label": "concentrations being indicative of", "shape": "dot", "size": 1}, {"group": 37, "id": "greater therapy response", "label": "greater therapy response", "shape": "dot", "size": 1}, {"group": 2, "id": "concord grape juice", "label": "concord grape juice", "shape": "dot", "size": 1}, {"group": 2, "id": "consumed bread again as a medium for supplementation", "label": "consumed bread again as a medium for supplementation", "shape": "dot", "size": 1}, {"group": 2, "id": "men with pca", "label": "men with pca", "shape": "dot", "size": 3}, {"group": 2, "id": "consumed whole grain and bran products, substituting 50% of their daily total energy intake (tei)", "label": "consumed whole grain and bran products, substituting 50% of their daily total energy intake (tei)", "shape": "dot", "size": 1}, {"group": 2, "id": "counseling", "label": "counseling", "shape": "dot", "size": 1}, {"group": 2, "id": "delivery of dietary and cooking classes", "label": "delivery of dietary and cooking classes", "shape": "dot", "size": 2}, {"group": 2, "id": "pca therapy", "label": "pca therapy", "shape": "dot", "size": 1}, {"group": 2, "id": "pca risk", "label": "pca risk", "shape": "dot", "size": 5}, {"group": 2, "id": "prostate cancer patients prior to radical prostatectomy", "label": "prostate cancer patients prior to radical prostatectomy", "shape": "dot", "size": 1}, {"group": 2, "id": "lower urinary tract symptoms", "label": "lower urinary tract symptoms", "shape": "dot", "size": 3}, {"group": 2, "id": "protective effects against cancer and vascular diseases", "label": "protective effects against cancer and vascular diseases", "shape": "dot", "size": 1}, {"group": 2, "id": "phytochemicals", "label": "phytochemicals", "shape": "dot", "size": 2}, {"group": 38, "id": "cranberry fruit powder", "label": "cranberry fruit powder", "shape": "dot", "size": 2}, {"group": 38, "id": "placebo powder", "label": "placebo powder", "shape": "dot", "size": 1}, {"group": 38, "id": "dried powdered cranberries", "label": "dried powdered cranberries", "shape": "dot", "size": 2}, {"group": 39, "id": "cross-over", "label": "cross-over", "shape": "dot", "size": 1}, {"group": 39, "id": "phase ii trial", "label": "phase ii trial", "shape": "dot", "size": 1}, {"group": 2, "id": "curcumin", "label": "curcumin", "shape": "dot", "size": 4}, {"group": 2, "id": "curcumin ons", "label": "curcumin ons", "shape": "dot", "size": 2}, {"group": 2, "id": "daidzein", "label": "daidzein", "shape": "dot", "size": 1}, {"group": 2, "id": "genistein", "label": "genistein", "shape": "dot", "size": 3}, {"group": 10, "id": "daily pomegranate intake", "label": "daily pomegranate intake", "shape": "dot", "size": 1}, {"group": 10, "id": "advanced prostate cancer", "label": "advanced prostate cancer", "shape": "dot", "size": 1}, {"group": 40, "id": "debruyne", "label": "debruyne", "shape": "dot", "size": 1}, {"group": 40, "id": "mild-to-severe bph symptoms", "label": "mild-to-severe bph symptoms", "shape": "dot", "size": 1}, {"group": 2, "id": "decrease", "label": "decrease", "shape": "dot", "size": 1}, {"group": 2, "id": "lffo diet", "label": "lffo diet", "shape": "dot", "size": 1}, {"group": 41, "id": "diet high in insoluble fiber", "label": "diet high in insoluble fiber", "shape": "dot", "size": 1}, {"group": 41, "id": "diet high in soluble fiber", "label": "diet high in soluble fiber", "shape": "dot", "size": 1}, {"group": 42, "id": "diet rich in phytoestrogens", "label": "diet rich in phytoestrogens", "shape": "dot", "size": 1}, {"group": 42, "id": "men diagnosed with prostate cancer", "label": "men diagnosed with prostate cancer", "shape": "dot", "size": 1}, {"group": 2, "id": "dietary factors", "label": "dietary factors", "shape": "dot", "size": 2}, {"group": 2, "id": "e\ufb05acy", "label": "e\ufb05acy", "shape": "dot", "size": 1}, {"group": 2, "id": "dietary intake of eicosapentaenoic (epa; 20:5n \u22123), docosahexaenoic (dha; 22:6n \u22123)", "label": "dietary intake of eicosapentaenoic (epa; 20:5n \u22123), docosahexaenoic (dha; 22:6n \u22123)", "shape": "dot", "size": 1}, {"group": 43, "id": "dietary modifications, pa, and mindfulness-based stress reduction training", "label": "dietary modifications, pa, and mindfulness-based stress reduction training", "shape": "dot", "size": 1}, {"group": 43, "id": "standard care", "label": "standard care", "shape": "dot", "size": 1}, {"group": 2, "id": "dietary patterns", "label": "dietary patterns", "shape": "dot", "size": 1}, {"group": 2, "id": "dietary supplements", "label": "dietary supplements", "shape": "dot", "size": 3}, {"group": 2, "id": "polyphenols", "label": "polyphenols", "shape": "dot", "size": 3}, {"group": 2, "id": "sulforaphane", "label": "sulforaphane", "shape": "dot", "size": 1}, {"group": 44, "id": "diethylstilbestrol", "label": "diethylstilbestrol", "shape": "dot", "size": 1}, {"group": 44, "id": "mixed antioxidant", "label": "mixed antioxidant", "shape": "dot", "size": 1}, {"group": 4, "id": "dihydrotestosterone", "label": "dihydrotestosterone", "shape": "dot", "size": 1}, {"group": 4, "id": "dihydrotestosterone levels", "label": "dihydrotestosterone levels", "shape": "dot", "size": 1}, {"group": 2, "id": "disease progression", "label": "disease progression", "shape": "dot", "size": 1}, {"group": 45, "id": "division of transplantation, immunology and mucosal biology", "label": "division of transplantation, immunology and mucosal biology", "shape": "dot", "size": 1}, {"group": 45, "id": "mrc centre for transplantation", "label": "mrc centre for transplantation", "shape": "dot", "size": 1}, {"group": 2, "id": "iv docetaxel", "label": "iv docetaxel", "shape": "dot", "size": 3}, {"group": 46, "id": "doses of vitamin d 3", "label": "doses of vitamin d 3", "shape": "dot", "size": 1}, {"group": 46, "id": "normal", "label": "normal", "shape": "dot", "size": 1}, {"group": 47, "id": "doxercalciferol", "label": "doxercalciferol", "shape": "dot", "size": 1}, {"group": 47, "id": "intravenous docetaxel cycles", "label": "intravenous docetaxel cycles", "shape": "dot", "size": 1}, {"group": 38, "id": "no cranberry treatment", "label": "no cranberry treatment", "shape": "dot", "size": 1}, {"group": 48, "id": "duration", "label": "duration", "shape": "dot", "size": 1}, {"group": 48, "id": "were not the causes of null \ufb01ndings in the aforementioned trials", "label": "were not the causes of null \ufb01ndings in the aforementioned trials", "shape": "dot", "size": 1}, {"group": 49, "id": "each increase in bmi by 5 kg /m2", "label": "each increase in bmi by 5 kg /m2", "shape": "dot", "size": 1}, {"group": 49, "id": "reduction in psa concentrations equal to 5.88%", "label": "reduction in psa concentrations equal to 5.88%", "shape": "dot", "size": 1}, {"group": 2, "id": "early diagnosis", "label": "early diagnosis", "shape": "dot", "size": 1}, {"group": 2, "id": "ebrt", "label": "ebrt", "shape": "dot", "size": 1}, {"group": 2, "id": "oral curcumin", "label": "oral curcumin", "shape": "dot", "size": 2}, {"group": 2, "id": "epa", "label": "epa", "shape": "dot", "size": 2}, {"group": 2, "id": "epa ons", "label": "epa ons", "shape": "dot", "size": 1}, {"group": 2, "id": "epa supplementation", "label": "epa supplementation", "shape": "dot", "size": 1}, {"group": 36, "id": "epidemiology", "label": "epidemiology", "shape": "dot", "size": 1}, {"group": 36, "id": "comorbidities", "label": "comorbidities", "shape": "dot", "size": 1}, {"group": 2, "id": "epigenetic modulators for prostate cancer prevention", "label": "epigenetic modulators for prostate cancer prevention", "shape": "dot", "size": 1}, {"group": 2, "id": "escalating doses of vitamin d 3", "label": "escalating doses of vitamin d 3", "shape": "dot", "size": 1}, {"group": 50, "id": "ethnic di \ufb00erences", "label": "ethnic di \ufb00erences", "shape": "dot", "size": 1}, {"group": 50, "id": "fat content of the diet", "label": "fat content of the diet", "shape": "dot", "size": 1}, {"group": 4, "id": "european randomized study of screening for prostate cancer", "label": "european randomized study of screening for prostate cancer", "shape": "dot", "size": 1}, {"group": 2, "id": "evidence", "label": "evidence", "shape": "dot", "size": 1}, {"group": 2, "id": "examining the effect of phytoestrogen ons on psa concentrations among men with pca, or increased pca risk.", "label": "examining the effect of phytoestrogen ons on psa concentrations among men with pca, or increased pca risk.", "shape": "dot", "size": 1}, {"group": 2, "id": "rcts", "label": "rcts", "shape": "dot", "size": 4}, {"group": 52, "id": "experts", "label": "experts", "shape": "dot", "size": 1}, {"group": 52, "id": "sparked controversy on the usefulness of routine psa screening", "label": "sparked controversy on the usefulness of routine psa screening", "shape": "dot", "size": 1}, {"group": 53, "id": "fa intake", "label": "fa intake", "shape": "dot", "size": 1}, {"group": 53, "id": "pca aggressiveness", "label": "pca aggressiveness", "shape": "dot", "size": 2}, {"group": 54, "id": "failed to report signi\ufb01cant changes between intervention arms", "label": "failed to report signi\ufb01cant changes between intervention arms", "shape": "dot", "size": 1}, {"group": 54, "id": "treated pca", "label": "treated pca", "shape": "dot", "size": 1}, {"group": 53, "id": "fatty acid content of the peri-prostatic adipose tissue", "label": "fatty acid content of the peri-prostatic adipose tissue", "shape": "dot", "size": 1}, {"group": 55, "id": "fatty acids", "label": "fatty acids", "shape": "dot", "size": 1}, {"group": 55, "id": "low fat /\ufb01sh oil", "label": "low fat /\ufb01sh oil", "shape": "dot", "size": 1}, {"group": 2, "id": "favorable changes", "label": "favorable changes", "shape": "dot", "size": 1}, {"group": 56, "id": "feasibility", "label": "feasibility", "shape": "dot", "size": 1}, {"group": 56, "id": "rct", "label": "rct", "shape": "dot", "size": 5}, {"group": 57, "id": "fish intake", "label": "fish intake", "shape": "dot", "size": 1}, {"group": 57, "id": "pca morality", "label": "pca morality", "shape": "dot", "size": 1}, {"group": 2, "id": "plant compounds", "label": "plant compounds", "shape": "dot", "size": 1}, {"group": 58, "id": "food or drug?", "label": "food or drug?", "shape": "dot", "size": 1}, {"group": 58, "id": "phytoestrogens", "label": "phytoestrogens", "shape": "dot", "size": 1}, {"group": 2, "id": "fruit and fruit extracts", "label": "fruit and fruit extracts", "shape": "dot", "size": 1}, {"group": 2, "id": "fruits", "label": "fruits", "shape": "dot", "size": 2}, {"group": 2, "id": "ganoderma lucidum", "label": "ganoderma lucidum", "shape": "dot", "size": 1}, {"group": 59, "id": "gastrointestinal events", "label": "gastrointestinal events", "shape": "dot", "size": 1}, {"group": 59, "id": "high fruit intake", "label": "high fruit intake", "shape": "dot", "size": 1}, {"group": 60, "id": "genistein, daidzein, and other iso\ufb02avones", "label": "genistein, daidzein, and other iso\ufb02avones", "shape": "dot", "size": 1}, {"group": 60, "id": "pca on as", "label": "pca on as", "shape": "dot", "size": 1}, {"group": 61, "id": "grape antioxidants", "label": "grape antioxidants", "shape": "dot", "size": 1}, {"group": 61, "id": "zhou, k.", "label": "zhou, k.", "shape": "dot", "size": 1}, {"group": 2, "id": "grape juice antioxidants", "label": "grape juice antioxidants", "shape": "dot", "size": 1}, {"group": 2, "id": "grape skin and seeds extract", "label": "grape skin and seeds extract", "shape": "dot", "size": 1}, {"group": 2, "id": "green tea", "label": "green tea", "shape": "dot", "size": 4}, {"group": 2, "id": "men scheduled for radical prostatectomy", "label": "men scheduled for radical prostatectomy", "shape": "dot", "size": 1}, {"group": 2, "id": "men on active surveillance (as)", "label": "men on active surveillance (as)", "shape": "dot", "size": 1}, {"group": 63, "id": "green tea (camellia sinensis)", "label": "green tea (camellia sinensis)", "shape": "dot", "size": 1}, {"group": 63, "id": "prevention of cancer", "label": "prevention of cancer", "shape": "dot", "size": 1}, {"group": 22, "id": "men with pca or increased pca risk", "label": "men with pca or increased pca risk", "shape": "dot", "size": 1}, {"group": 22, "id": "randomized, placebo-controlled trial of green tea catechins for prostate cancer prevention", "label": "randomized, placebo-controlled trial of green tea catechins for prostate cancer prevention", "shape": "dot", "size": 1}, {"group": 22, "id": "micali et al. (2017)", "label": "micali et al. (2017)", "shape": "dot", "size": 1}, {"group": 64, "id": "green tea drink (3 cups)", "label": "green tea drink (3 cups)", "shape": "dot", "size": 1}, {"group": 64, "id": "green tea caps (blinded, 600 mg \ufb02avan-3-ol egcg)", "label": "green tea caps (blinded, 600 mg \ufb02avan-3-ol egcg)", "shape": "dot", "size": 1}, {"group": 65, "id": "green tea extract", "label": "green tea extract", "shape": "dot", "size": 1}, {"group": 65, "id": "kumar et al. (2018)", "label": "kumar et al. (2018)", "shape": "dot", "size": 1}, {"group": 28, "id": "green tea polyphenols and metabolites", "label": "green tea polyphenols and metabolites", "shape": "dot", "size": 1}, {"group": 28, "id": "cancer prevention", "label": "cancer prevention", "shape": "dot", "size": 1}, {"group": 2, "id": "gtcs", "label": "gtcs", "shape": "dot", "size": 2}, {"group": 2, "id": "pca prevention", "label": "pca prevention", "shape": "dot", "size": 2}, {"group": 2, "id": "gtcs alternative", "label": "gtcs alternative", "shape": "dot", "size": 1}, {"group": 2, "id": "polye", "label": "polye", "shape": "dot", "size": 2}, {"group": 2, "id": "gtcs caps", "label": "gtcs caps", "shape": "dot", "size": 1}, {"group": 4, "id": "hamilton-reeves, j.m.", "label": "hamilton-reeves, j.m.", "shape": "dot", "size": 2}, {"group": 2, "id": "healthy dietary patterns", "label": "healthy dietary patterns", "shape": "dot", "size": 1}, {"group": 2, "id": "hgpin", "label": "hgpin", "shape": "dot", "size": 2}, {"group": 66, "id": "high doses of pomx", "label": "high doses of pomx", "shape": "dot", "size": 1}, {"group": 66, "id": "lower doses of pomx", "label": "lower doses of pomx", "shape": "dot", "size": 1}, {"group": 11, "id": "high fiber content", "label": "high fiber content", "shape": "dot", "size": 1}, {"group": 11, "id": "li et al. [ 219]", "label": "li et al. [ 219]", "shape": "dot", "size": 5}, {"group": 2, "id": "high lycopene sources", "label": "high lycopene sources", "shape": "dot", "size": 1}, {"group": 4, "id": "high prostate cancer risk", "label": "high prostate cancer risk", "shape": "dot", "size": 1}, {"group": 2, "id": "high psa concentrations", "label": "high psa concentrations", "shape": "dot", "size": 1}, {"group": 11, "id": "high risk for pca recurrence", "label": "high risk for pca recurrence", "shape": "dot", "size": 1}, {"group": 67, "id": "high soy diet", "label": "high soy diet", "shape": "dot", "size": 1}, {"group": 67, "id": "low soy diet", "label": "low soy diet", "shape": "dot", "size": 1}, {"group": 68, "id": "high-dose selenium ons", "label": "high-dose selenium ons", "shape": "dot", "size": 1}, {"group": 68, "id": "increased psa velocity among men with high baseline plasma selenium concentrations", "label": "increased psa velocity among men with high baseline plasma selenium concentrations", "shape": "dot", "size": 1}, {"group": 11, "id": "high-fiber diet", "label": "high-fiber diet", "shape": "dot", "size": 2}, {"group": 11, "id": "low-carbohydrate diet", "label": "low-carbohydrate diet", "shape": "dot", "size": 4}, {"group": 11, "id": "lcd", "label": "lcd", "shape": "dot", "size": 4}, {"group": 2, "id": "high-grade prostatic intraepithelial neoplasia (hgpin) and /or atypical small acinar proliferation (asap)", "label": "high-grade prostatic intraepithelial neoplasia (hgpin) and /or atypical small acinar proliferation (asap)", "shape": "dot", "size": 1}, {"group": 4, "id": "high-risk populations", "label": "high-risk populations", "shape": "dot", "size": 2}, {"group": 4, "id": "regular psa tests", "label": "regular psa tests", "shape": "dot", "size": 3}, {"group": 2, "id": "high-soy diet", "label": "high-soy diet", "shape": "dot", "size": 1}, {"group": 69, "id": "high-\ufb01ber lfd", "label": "high-\ufb01ber lfd", "shape": "dot", "size": 1}, {"group": 69, "id": "western diet", "label": "western diet", "shape": "dot", "size": 1}, {"group": 2, "id": "histologically confirmed pca", "label": "histologically confirmed pca", "shape": "dot", "size": 2}, {"group": 2, "id": "stenner-liewen", "label": "stenner-liewen", "shape": "dot", "size": 1}, {"group": 24, "id": "indicated some e\ufb03cacy", "label": "indicated some e\ufb03cacy", "shape": "dot", "size": 1}, {"group": 70, "id": "hyson", "label": "hyson", "shape": "dot", "size": 1}, {"group": 70, "id": "human health", "label": "human health", "shape": "dot", "size": 1}, {"group": 71, "id": "incidence of pca", "label": "incidence of pca", "shape": "dot", "size": 1}, {"group": 71, "id": "men with high-grade prostatic intraepithelial neoplasia (hgpin) and /or atypical small acinar proliferation (asap)", "label": "men with high-grade prostatic intraepithelial neoplasia (hgpin) and /or atypical small acinar proliferation (asap)", "shape": "dot", "size": 1}, {"group": 72, "id": "increased body mass index (bmi)", "label": "increased body mass index (bmi)", "shape": "dot", "size": 1}, {"group": 72, "id": "lower psa concentrations", "label": "lower psa concentrations", "shape": "dot", "size": 1}, {"group": 4, "id": "increased cancer risk", "label": "increased cancer risk", "shape": "dot", "size": 1}, {"group": 73, "id": "increased number of men treated for pca", "label": "increased number of men treated for pca", "shape": "dot", "size": 1}, {"group": 73, "id": "psa screening", "label": "psa screening", "shape": "dot", "size": 5}, {"group": 11, "id": "individual counseling sessions", "label": "individual counseling sessions", "shape": "dot", "size": 1}, {"group": 2, "id": "inflammation", "label": "inflammation", "shape": "dot", "size": 1}, {"group": 2, "id": "systematic review", "label": "systematic review", "shape": "dot", "size": 3}, {"group": 2, "id": "inflammation, prostatic cell growth, and stimulation of the apoptotic machinery", "label": "inflammation, prostatic cell growth, and stimulation of the apoptotic machinery", "shape": "dot", "size": 1}, {"group": 2, "id": "initial psa", "label": "initial psa", "shape": "dot", "size": 1}, {"group": 74, "id": "insoluble fiber", "label": "insoluble fiber", "shape": "dot", "size": 1}, {"group": 74, "id": "soluble fiber", "label": "soluble fiber", "shape": "dot", "size": 1}, {"group": 26, "id": "instead as control", "label": "instead as control", "shape": "dot", "size": 1}, {"group": 75, "id": "intensive lifestyle intervention supporting an lfd supplemented with soy, fish oil, and antioxidant vitamins", "label": "intensive lifestyle intervention supporting an lfd supplemented with soy, fish oil, and antioxidant vitamins", "shape": "dot", "size": 1}, {"group": 75, "id": "usual treatment", "label": "usual treatment", "shape": "dot", "size": 1}, {"group": 76, "id": "intervention", "label": "intervention", "shape": "dot", "size": 1}, {"group": 76, "id": "presurgical", "label": "presurgical", "shape": "dot", "size": 1}, {"group": 2, "id": "intervention participants", "label": "intervention participants", "shape": "dot", "size": 1}, {"group": 77, "id": "isoflavones", "label": "isoflavones", "shape": "dot", "size": 1}, {"group": 77, "id": "soy products", "label": "soy products", "shape": "dot", "size": 1}, {"group": 78, "id": "iso\ufb02avone supplementation", "label": "iso\ufb02avone supplementation", "shape": "dot", "size": 2}, {"group": 78, "id": "null findings", "label": "null findings", "shape": "dot", "size": 1}, {"group": 78, "id": "lack of efficacy", "label": "lack of efficacy", "shape": "dot", "size": 1}, {"group": 4, "id": "kumar, n.b.", "label": "kumar, n.b.", "shape": "dot", "size": 4}, {"group": 4, "id": "kang, l.", "label": "kang, l.", "shape": "dot", "size": 2}, {"group": 4, "id": "pow-sang, j.", "label": "pow-sang, j.", "shape": "dot", "size": 2}, {"group": 4, "id": "xu, p.", "label": "xu, p.", "shape": "dot", "size": 2}, {"group": 79, "id": "klotz (2013)", "label": "klotz (2013)", "shape": "dot", "size": 1}, {"group": 79, "id": "overdiagnosis of prostate cancer", "label": "overdiagnosis of prostate cancer", "shape": "dot", "size": 2}, {"group": 4, "id": "prostate cancer risk", "label": "prostate cancer risk", "shape": "dot", "size": 1}, {"group": 4, "id": "prostate specific antigen", "label": "prostate specific antigen", "shape": "dot", "size": 3}, {"group": 80, "id": "landberg", "label": "landberg", "shape": "dot", "size": 1}, {"group": 80, "id": "rye whole grain products", "label": "rye whole grain products", "shape": "dot", "size": 1}, {"group": 11, "id": "usual diet and exercise patterns", "label": "usual diet and exercise patterns", "shape": "dot", "size": 2}, {"group": 11, "id": "psa concentration", "label": "psa concentration", "shape": "dot", "size": 2}, {"group": 11, "id": "psa values did not di\ufb00er between groups", "label": "psa values did not di\ufb00er between groups", "shape": "dot", "size": 2}, {"group": 11, "id": "lfd", "label": "lfd", "shape": "dot", "size": 5}, {"group": 11, "id": "standard brochure on what is considered as a \u2018healthy\u2019 diet", "label": "standard brochure on what is considered as a \u2018healthy\u2019 diet", "shape": "dot", "size": 1}, {"group": 11, "id": "usual diet", "label": "usual diet", "shape": "dot", "size": 1}, {"group": 2, "id": "soy", "label": "soy", "shape": "dot", "size": 3}, {"group": 81, "id": "linseed", "label": "linseed", "shape": "dot", "size": 2}, {"group": 81, "id": "plus 20 g of linseed", "label": "plus 20 g of linseed", "shape": "dot", "size": 1}, {"group": 81, "id": "none", "label": "none", "shape": "dot", "size": 1}, {"group": 82, "id": "localized prostate cancer", "label": "localized prostate cancer", "shape": "dot", "size": 1}, {"group": 82, "id": "patients", "label": "patients", "shape": "dot", "size": 1}, {"group": 83, "id": "long-chain n-6 fatty acids", "label": "long-chain n-6 fatty acids", "shape": "dot", "size": 1}, {"group": 83, "id": "prostate tumor cell growth", "label": "prostate tumor cell growth", "shape": "dot", "size": 1}, {"group": 2, "id": "low carbohydrate diets", "label": "low carbohydrate diets", "shape": "dot", "size": 1}, {"group": 73, "id": "low impact on mortality", "label": "low impact on mortality", "shape": "dot", "size": 1}, {"group": 84, "id": "low meat /dairy diet", "label": "low meat /dairy diet", "shape": "dot", "size": 1}, {"group": 84, "id": "psa concentrations at 6 months post-intervention", "label": "psa concentrations at 6 months post-intervention", "shape": "dot", "size": 1}, {"group": 2, "id": "saw palmetto extract", "label": "saw palmetto extract", "shape": "dot", "size": 1}, {"group": 2, "id": "lower-dose walnut supplementation", "label": "lower-dose walnut supplementation", "shape": "dot", "size": 1}, {"group": 2, "id": "psa concentrations among men with pca, increased pca risk, or bph", "label": "psa concentrations among men with pca, increased pca risk, or bph", "shape": "dot", "size": 5}, {"group": 2, "id": "procomb trial", "label": "procomb trial", "shape": "dot", "size": 2}, {"group": 2, "id": "no intervention", "label": "no intervention", "shape": "dot", "size": 2}, {"group": 4, "id": "lycopene supplementation", "label": "lycopene supplementation", "shape": "dot", "size": 2}, {"group": 2, "id": "prostate cancer prevention", "label": "prostate cancer prevention", "shape": "dot", "size": 1}, {"group": 2, "id": "prostate cancer treatment", "label": "prostate cancer treatment", "shape": "dot", "size": 1}, {"group": 2, "id": "primary prevention of prostate cancer", "label": "primary prevention of prostate cancer", "shape": "dot", "size": 1}, {"group": 2, "id": "selenium and vitamin e", "label": "selenium and vitamin e", "shape": "dot", "size": 1}, {"group": 2, "id": "lycopene (15 mg)", "label": "lycopene (15 mg)", "shape": "dot", "size": 2}, {"group": 2, "id": "lycopene (30 mg)", "label": "lycopene (30 mg)", "shape": "dot", "size": 2}, {"group": 2, "id": "lycopene ons", "label": "lycopene ons", "shape": "dot", "size": 1}, {"group": 86, "id": "lycopene-combined therapies", "label": "lycopene-combined therapies", "shape": "dot", "size": 1}, {"group": 86, "id": "pca following their usual diet", "label": "pca following their usual diet", "shape": "dot", "size": 3}, {"group": 85, "id": "lycopene-rich foods (unblinded)", "label": "lycopene-rich foods (unblinded)", "shape": "dot", "size": 1}, {"group": 85, "id": "lycopene (15 mg /d) caps (blinded)", "label": "lycopene (15 mg /d) caps (blinded)", "shape": "dot", "size": 1}, {"group": 2, "id": "malignancy", "label": "malignancy", "shape": "dot", "size": 1}, {"group": 87, "id": "maria g. grammatikopoulou", "label": "maria g. grammatikopoulou", "shape": "dot", "size": 1}, {"group": 87, "id": "stefanos t. papageorgiou", "label": "stefanos t. papageorgiou", "shape": "dot", "size": 1}, {"group": 2, "id": "marine fatty acid supplementation", "label": "marine fatty acid supplementation", "shape": "dot", "size": 2}, {"group": 2, "id": "mc", "label": "mc", "shape": "dot", "size": 2}, {"group": 2, "id": "mhgpin", "label": "mhgpin", "shape": "dot", "size": 1}, {"group": 2, "id": "meat and dairy products", "label": "meat and dairy products", "shape": "dot", "size": 1}, {"group": 89, "id": "medicinal mushrooms", "label": "medicinal mushrooms", "shape": "dot", "size": 1}, {"group": 89, "id": "th", "label": "th", "shape": "dot", "size": 1}, {"group": 2, "id": "men", "label": "men", "shape": "dot", "size": 2}, {"group": 4, "id": "men at high risk of developing prostate cancer", "label": "men at high risk of developing prostate cancer", "shape": "dot", "size": 2}, {"group": 4, "id": "men electing active surveillance for localized prostate cancer", "label": "men electing active surveillance for localized prostate cancer", "shape": "dot", "size": 1}, {"group": 2, "id": "men on androgen deprivation therapy", "label": "men on androgen deprivation therapy", "shape": "dot", "size": 1}, {"group": 4, "id": "men with biochemical recurrence of prostate cancer", "label": "men with biochemical recurrence of prostate cancer", "shape": "dot", "size": 1}, {"group": 4, "id": "psa levels", "label": "psa levels", "shape": "dot", "size": 5}, {"group": 90, "id": "men with histologic evidence of progressive androgen-independent pca", "label": "men with histologic evidence of progressive androgen-independent pca", "shape": "dot", "size": 1}, {"group": 90, "id": "mixed antioxidant supplementation", "label": "mixed antioxidant supplementation", "shape": "dot", "size": 1}, {"group": 4, "id": "men with localized prostate cancer", "label": "men with localized prostate cancer", "shape": "dot", "size": 1}, {"group": 91, "id": "men with lower urinary tract symptoms (luts), elevated psa, but negative prostate biopsy [122]", "label": "men with lower urinary tract symptoms (luts), elevated psa, but negative prostate biopsy [122]", "shape": "dot", "size": 1}, {"group": 91, "id": "reduction in psa after 6 months of daily intake", "label": "reduction in psa after 6 months of daily intake", "shape": "dot", "size": 1}, {"group": 4, "id": "men with metastatic castration-resistant prostate cancer", "label": "men with metastatic castration-resistant prostate cancer", "shape": "dot", "size": 1}, {"group": 4, "id": "men with newly diagnosed prostate cancer", "label": "men with newly diagnosed prostate cancer", "shape": "dot", "size": 1}, {"group": 4, "id": "men with prostate cancer", "label": "men with prostate cancer", "shape": "dot", "size": 2}, {"group": 4, "id": "rye whole grain and bran intake", "label": "rye whole grain and bran intake", "shape": "dot", "size": 1}, {"group": 18, "id": "vitamin c", "label": "vitamin c", "shape": "dot", "size": 1}, {"group": 2, "id": "mixed antioxidant therapy", "label": "mixed antioxidant therapy", "shape": "dot", "size": 1}, {"group": 93, "id": "mixed supplementation with broccoli powder, curcumin, pomegranate, and green tea extract", "label": "mixed supplementation with broccoli powder, curcumin, pomegranate, and green tea extract", "shape": "dot", "size": 1}, {"group": 93, "id": "pca after 6 months", "label": "pca after 6 months", "shape": "dot", "size": 1}, {"group": 92, "id": "mol. nutr. food res.", "label": "mol. nutr. food res.", "shape": "dot", "size": 1}, {"group": 92, "id": "meta-analysis", "label": "meta-analysis", "shape": "dot", "size": 1}, {"group": 2, "id": "mushroom immunology", "label": "mushroom immunology", "shape": "dot", "size": 1}, {"group": 2, "id": "mv", "label": "mv", "shape": "dot", "size": 1}, {"group": 14, "id": "negri, m.", "label": "negri, m.", "shape": "dot", "size": 1}, {"group": 14, "id": "vitamin d", "label": "vitamin d", "shape": "dot", "size": 3}, {"group": 2, "id": "no di \ufb00erences were noted in the psa concentrations of participants in both groups", "label": "no di \ufb00erences were noted in the psa concentrations of participants in both groups", "shape": "dot", "size": 1}, {"group": 2, "id": "non-prescribed antioxidant supplements", "label": "non-prescribed antioxidant supplements", "shape": "dot", "size": 1}, {"group": 94, "id": "ns", "label": "ns", "shape": "dot", "size": 1}, {"group": 94, "id": "pci", "label": "pci", "shape": "dot", "size": 1}, {"group": 2, "id": "nutrients", "label": "nutrients", "shape": "dot", "size": 1}, {"group": 2, "id": "randomized controlled trials (rcts)", "label": "randomized controlled trials (rcts)", "shape": "dot", "size": 1}, {"group": 2, "id": "table 4.", "label": "table 4.", "shape": "dot", "size": 1}, {"group": 2, "id": "obese men", "label": "obese men", "shape": "dot", "size": 1}, {"group": 11, "id": "obesity", "label": "obesity", "shape": "dot", "size": 2}, {"group": 11, "id": "prostate-specific antigen (psa)", "label": "prostate-specific antigen (psa)", "shape": "dot", "size": 1}, {"group": 88, "id": "olivares-galv\u00e1n", "label": "olivares-galv\u00e1n", "shape": "dot", "size": 1}, {"group": 88, "id": "marina", "label": "marina", "shape": "dot", "size": 1}, {"group": 2, "id": "one in seven men undergoing psa screening demonstrates increased concentrations", "label": "one in seven men undergoing psa screening demonstrates increased concentrations", "shape": "dot", "size": 1}, {"group": 79, "id": "sandhu and andriole (2012)", "label": "sandhu and andriole (2012)", "shape": "dot", "size": 1}, {"group": 2, "id": "overweight men", "label": "overweight men", "shape": "dot", "size": 1}, {"group": 97, "id": "paller, c.j.", "label": "paller, c.j.", "shape": "dot", "size": 1}, {"group": 97, "id": "rising psa levels", "label": "rising psa levels", "shape": "dot", "size": 1}, {"group": 98, "id": "pantuck", "label": "pantuck", "shape": "dot", "size": 1}, {"group": 98, "id": "rising psa concentrations after primary pca therapy", "label": "rising psa concentrations after primary pca therapy", "shape": "dot", "size": 1}, {"group": 4, "id": "pantuck, a.j.", "label": "pantuck, a.j.", "shape": "dot", "size": 1}, {"group": 2, "id": "supplements", "label": "supplements", "shape": "dot", "size": 1}, {"group": 2, "id": "prostatic intraepithelial neoplasia", "label": "prostatic intraepithelial neoplasia", "shape": "dot", "size": 1}, {"group": 2, "id": "rye bran", "label": "rye bran", "shape": "dot", "size": 1}, {"group": 2, "id": "vitis vinifera", "label": "vitis vinifera", "shape": "dot", "size": 1}, {"group": 2, "id": "pomx", "label": "pomx", "shape": "dot", "size": 2}, {"group": 2, "id": "pin", "label": "pin", "shape": "dot", "size": 1}, {"group": 2, "id": "zn", "label": "zn", "shape": "dot", "size": 1}, {"group": 2, "id": "walnut consumption", "label": "walnut consumption", "shape": "dot", "size": 1}, {"group": 2, "id": "usual diet +walnut ons", "label": "usual diet +walnut ons", "shape": "dot", "size": 1}, {"group": 2, "id": "typical western diet", "label": "typical western diet", "shape": "dot", "size": 2}, {"group": 2, "id": "prostatectomy", "label": "prostatectomy", "shape": "dot", "size": 1}, {"group": 2, "id": "radiation", "label": "radiation", "shape": "dot", "size": 1}, {"group": 2, "id": "recurrence", "label": "recurrence", "shape": "dot", "size": 1}, {"group": 2, "id": "pca diagnosis", "label": "pca diagnosis", "shape": "dot", "size": 1}, {"group": 86, "id": "tomato products containing 30 mg of lycopene or tomato products plus selenium, n-3 fatty acids, soy iso\ufb02avones, grape /pomegranate juice, and green /black tea", "label": "tomato products containing 30 mg of lycopene or tomato products plus selenium, n-3 fatty acids, soy iso\ufb02avones, grape /pomegranate juice, and green /black tea", "shape": "dot", "size": 1}, {"group": 86, "id": "supplementation with soy protein, vitamin e, and selenium for 3 years", "label": "supplementation with soy protein, vitamin e, and selenium for 3 years", "shape": "dot", "size": 1}, {"group": 2, "id": "selenium ons", "label": "selenium ons", "shape": "dot", "size": 2}, {"group": 2, "id": "selenium", "label": "selenium", "shape": "dot", "size": 7}, {"group": 2, "id": "serum 25(oh)d concentrations", "label": "serum 25(oh)d concentrations", "shape": "dot", "size": 1}, {"group": 2, "id": "pca-mortality", "label": "pca-mortality", "shape": "dot", "size": 1}, {"group": 2, "id": "retropubic prostatectomy", "label": "retropubic prostatectomy", "shape": "dot", "size": 2}, {"group": 2, "id": "silymarin", "label": "silymarin", "shape": "dot", "size": 1}, {"group": 100, "id": "persistent elevated psa concentrations", "label": "persistent elevated psa concentrations", "shape": "dot", "size": 1}, {"group": 100, "id": "prostate biopsy and diagnostic imaging", "label": "prostate biopsy and diagnostic imaging", "shape": "dot", "size": 1}, {"group": 101, "id": "phytoestrogen ons", "label": "phytoestrogen ons", "shape": "dot", "size": 1}, {"group": 101, "id": "soy isoflavones", "label": "soy isoflavones", "shape": "dot", "size": 1}, {"group": 2, "id": "vitamin d3 analog", "label": "vitamin d3 analog", "shape": "dot", "size": 1}, {"group": 2, "id": "prevent trial", "label": "prevent trial", "shape": "dot", "size": 3}, {"group": 102, "id": "placebo group", "label": "placebo group", "shape": "dot", "size": 1}, {"group": 102, "id": "psa increases \u003e20% at 6 months", "label": "psa increases \u003e20% at 6 months", "shape": "dot", "size": 1}, {"group": 2, "id": "placebo groups", "label": "placebo groups", "shape": "dot", "size": 1}, {"group": 2, "id": "trial", "label": "trial", "shape": "dot", "size": 3}, {"group": 103, "id": "plant derived bioactive compounds", "label": "plant derived bioactive compounds", "shape": "dot", "size": 1}, {"group": 103, "id": "poulsen et al. (2020)", "label": "poulsen et al. (2020)", "shape": "dot", "size": 1}, {"group": 2, "id": "8 oz liquid pomx", "label": "8 oz liquid pomx", "shape": "dot", "size": 1}, {"group": 104, "id": "pomx pills", "label": "pomx pills", "shape": "dot", "size": 1}, {"group": 104, "id": "prostate cancer before radical prostatectomy", "label": "prostate cancer before radical prostatectomy", "shape": "dot", "size": 1}, {"group": 2, "id": "tocopherol supplementation", "label": "tocopherol supplementation", "shape": "dot", "size": 1}, {"group": 4, "id": "promotion and progression", "label": "promotion and progression", "shape": "dot", "size": 1}, {"group": 4, "id": "psa test", "label": "psa test", "shape": "dot", "size": 1}, {"group": 4, "id": "psa-based screening intervention", "label": "psa-based screening intervention", "shape": "dot", "size": 1}, {"group": 4, "id": "prostatectomy for prostate cancer", "label": "prostatectomy for prostate cancer", "shape": "dot", "size": 1}, {"group": 2, "id": "vitamin e", "label": "vitamin e", "shape": "dot", "size": 3}, {"group": 4, "id": "rye bran bread", "label": "rye bran bread", "shape": "dot", "size": 1}, {"group": 4, "id": "ratha, p.", "label": "ratha, p.", "shape": "dot", "size": 2}, {"group": 4, "id": "trump, d.l.", "label": "trump, d.l.", "shape": "dot", "size": 1}, {"group": 4, "id": "vitamin d concentration", "label": "vitamin d concentration", "shape": "dot", "size": 1}, {"group": 4, "id": "prostate cancer cells sensitivity to cisplatin", "label": "prostate cancer cells sensitivity to cisplatin", "shape": "dot", "size": 1}, {"group": 96, "id": "prostate cancer overdiagnosis", "label": "prostate cancer overdiagnosis", "shape": "dot", "size": 1}, {"group": 96, "id": "overtreatment", "label": "overtreatment", "shape": "dot", "size": 1}, {"group": 2, "id": "prostate size", "label": "prostate size", "shape": "dot", "size": 1}, {"group": 2, "id": "serum psa concentrations", "label": "serum psa concentrations", "shape": "dot", "size": 3}, {"group": 4, "id": "saw palmetto fruit extract", "label": "saw palmetto fruit extract", "shape": "dot", "size": 1}, {"group": 4, "id": "prostate volume", "label": "prostate volume", "shape": "dot", "size": 1}, {"group": 4, "id": "prostate-specific antigen", "label": "prostate-specific antigen", "shape": "dot", "size": 1}, {"group": 2, "id": "prostatectomyn", "label": "prostatectomyn", "shape": "dot", "size": 1}, {"group": 2, "id": "tomato extract", "label": "tomato extract", "shape": "dot", "size": 1}, {"group": 2, "id": "tomato extract (30 mg of lycopene)", "label": "tomato extract (30 mg of lycopene)", "shape": "dot", "size": 1}, {"group": 2, "id": "serum 25-hydroxyvitamin d (25(oh)d)", "label": "serum 25-hydroxyvitamin d (25(oh)d)", "shape": "dot", "size": 1}, {"group": 2, "id": "trials", "label": "trials", "shape": "dot", "size": 2}, {"group": 2, "id": "select trial", "label": "select trial", "shape": "dot", "size": 3}, {"group": 2, "id": "saw palmetto, selenium, and lycopene or tamsulosin", "label": "saw palmetto, selenium, and lycopene or tamsulosin", "shape": "dot", "size": 1}, {"group": 2, "id": "tamsulosin", "label": "tamsulosin", "shape": "dot", "size": 5}, {"group": 2, "id": "remain asymptomatic", "label": "remain asymptomatic", "shape": "dot", "size": 1}, {"group": 2, "id": "second sample for verification purposes", "label": "second sample for verification purposes", "shape": "dot", "size": 1}, {"group": 2, "id": "weight-loss", "label": "weight-loss", "shape": "dot", "size": 1}, {"group": 2, "id": "psa results", "label": "psa results", "shape": "dot", "size": 1}, {"group": 2, "id": "soy protein beverages with high or low genistein and daidzein", "label": "soy protein beverages with high or low genistein and daidzein", "shape": "dot", "size": 1}, {"group": 2, "id": "\u03b1-receptor blocker (\u03b1rb)", "label": "\u03b1-receptor blocker (\u03b1rb)", "shape": "dot", "size": 1}, {"group": 2, "id": "vitamin d analogs ons", "label": "vitamin d analogs ons", "shape": "dot", "size": 1}, {"group": 2, "id": "tomato products", "label": "tomato products", "shape": "dot", "size": 2}, {"group": 2, "id": "walnut supplementation", "label": "walnut supplementation", "shape": "dot", "size": 1}, {"group": 2, "id": "reduction", "label": "reduction", "shape": "dot", "size": 1}, {"group": 2, "id": "telephone counseling promoting an increased vegetable intake", "label": "telephone counseling promoting an increased vegetable intake", "shape": "dot", "size": 2}, {"group": 105, "id": "psa elevation following radical prostatectomy", "label": "psa elevation following radical prostatectomy", "shape": "dot", "size": 1}, {"group": 105, "id": "progression after psa elevation following radical prostatectomy", "label": "progression after psa elevation following radical prostatectomy", "shape": "dot", "size": 1}, {"group": 4, "id": "men with a history of prostate cancer", "label": "men with a history of prostate cancer", "shape": "dot", "size": 1}, {"group": 73, "id": "small reduction in 10-year disease-speci\ufb01c mortality", "label": "small reduction in 10-year disease-speci\ufb01c mortality", "shape": "dot", "size": 1}, {"group": 73, "id": "reduces relative risk for pca by 9%", "label": "reduces relative risk for pca by 9%", "shape": "dot", "size": 1}, {"group": 73, "id": "new biomarkers for prostate cancer", "label": "new biomarkers for prostate cancer", "shape": "dot", "size": 1}, {"group": 2, "id": "total psadt", "label": "total psadt", "shape": "dot", "size": 1}, {"group": 106, "id": "psa\u22642.5ng /ml", "label": "psa\u22642.5ng /ml", "shape": "dot", "size": 1}, {"group": 106, "id": "se (240 \u00b5g)", "label": "se (240 \u00b5g)", "shape": "dot", "size": 1}, {"group": 107, "id": "randomized controlled trials", "label": "randomized controlled trials", "shape": "dot", "size": 1}, {"group": 107, "id": "review", "label": "review", "shape": "dot", "size": 1}, {"group": 56, "id": "se", "label": "se", "shape": "dot", "size": 1}, {"group": 56, "id": "time", "label": "time", "shape": "dot", "size": 1}, {"group": 56, "id": "tei", "label": "tei", "shape": "dot", "size": 2}, {"group": 56, "id": "ttp", "label": "ttp", "shape": "dot", "size": 1}, {"group": 4, "id": "men with metabolic syndrome", "label": "men with metabolic syndrome", "shape": "dot", "size": 1}, {"group": 4, "id": "testosterone levels", "label": "testosterone levels", "shape": "dot", "size": 1}, {"group": 108, "id": "resveratrol (1000 mg /d)", "label": "resveratrol (1000 mg /d)", "shape": "dot", "size": 1}, {"group": 108, "id": "resveratrol (150 mg /d)", "label": "resveratrol (150 mg /d)", "shape": "dot", "size": 1}, {"group": 95, "id": "rising psa level after local therapy", "label": "rising psa level after local therapy", "shape": "dot", "size": 1}, {"group": 95, "id": "options", "label": "options", "shape": "dot", "size": 1}, {"group": 109, "id": "ryu", "label": "ryu", "shape": "dot", "size": 1}, {"group": 109, "id": "symptomatic bph", "label": "symptomatic bph", "shape": "dot", "size": 1}, {"group": 110, "id": "saw palmetto herbal blend", "label": "saw palmetto herbal blend", "shape": "dot", "size": 1}, {"group": 110, "id": "symptomatic benign prostatic hyperplasia", "label": "symptomatic benign prostatic hyperplasia", "shape": "dot", "size": 1}, {"group": 2, "id": "selenium overload", "label": "selenium overload", "shape": "dot", "size": 1}, {"group": 2, "id": "serum selenium levels", "label": "serum selenium levels", "shape": "dot", "size": 1}, {"group": 51, "id": "selenium intake", "label": "selenium intake", "shape": "dot", "size": 1}, {"group": 51, "id": "exceeds 400 mg daily", "label": "exceeds 400 mg daily", "shape": "dot", "size": 1}, {"group": 99, "id": "selenium supplementation", "label": "selenium supplementation", "shape": "dot", "size": 1}, {"group": 99, "id": "pca mortality", "label": "pca mortality", "shape": "dot", "size": 1}, {"group": 111, "id": "serum psa", "label": "serum psa", "shape": "dot", "size": 1}, {"group": 111, "id": "total psa", "label": "total psa", "shape": "dot", "size": 1}, {"group": 2, "id": "soy pro drink", "label": "soy pro drink", "shape": "dot", "size": 1}, {"group": 112, "id": "serum vitamin d concentrations", "label": "serum vitamin d concentrations", "shape": "dot", "size": 1}, {"group": 112, "id": "specific cancers", "label": "specific cancers", "shape": "dot", "size": 1}, {"group": 113, "id": "soy pro beverages with high micronutrient content", "label": "soy pro beverages with high micronutrient content", "shape": "dot", "size": 1}, {"group": 113, "id": "urban", "label": "urban", "shape": "dot", "size": 1}, {"group": 62, "id": "synthesis of evidence", "label": "synthesis of evidence", "shape": "dot", "size": 1}, {"group": 62, "id": "great heterogeneity observed in supplementation regime and design of included trials", "label": "great heterogeneity observed in supplementation regime and design of included trials", "shape": "dot", "size": 1}, {"group": 2, "id": "rcts as the only primary studies", "label": "rcts as the only primary studies", "shape": "dot", "size": 1}, {"group": 14, "id": "tagliaferri, s.", "label": "tagliaferri, s.", "shape": "dot", "size": 1}, {"group": 2, "id": "vitamin d3", "label": "vitamin d3", "shape": "dot", "size": 1}, {"group": 29, "id": "tea catechins", "label": "tea catechins", "shape": "dot", "size": 1}, {"group": 29, "id": "cancer signaling pathways", "label": "cancer signaling pathways", "shape": "dot", "size": 1}, {"group": 56, "id": "usda", "label": "usda", "shape": "dot", "size": 1}, {"group": 2, "id": "time to progression", "label": "time to progression", "shape": "dot", "size": 1}, {"group": 114, "id": "tomato oleoresin extract", "label": "tomato oleoresin extract", "shape": "dot", "size": 1}, {"group": 114, "id": "tumor size", "label": "tumor size", "shape": "dot", "size": 1}, {"group": 14, "id": "anti-tumor e\ufb00ect", "label": "anti-tumor e\ufb00ect", "shape": "dot", "size": 1}]);
                  edges = new vis.DataSet([{"from": "*", "title": "Also known as", "to": "konstantinos gkiouras", "width": 1.0}, {"from": "*", "title": "Also known as", "to": "dimitrios p . bogdanos", "width": 1.0}, {"from": "1000 iu vitamin d", "title": "given to n=21 patients in double-blind 3 mo NOD trial", "to": "placebo", "width": 1.0}, {"from": "12, 2985", "title": "The article \u0027Nutrients 2020\u0027 is published in volume 12 and page number 2985.", "to": "nutrients 2020", "width": 1.0}, {"from": "2 x 2 pomx caps", "title": "Freedland\u2020 [134]US Double-blind 4 wksn=63 men with PCa, scheduled for prostatectomy ( \u003e2 wks), no di\ufb00erences between arms in pre-surgical PSA or the ratio of baseline /pre-surgery PSA.", "to": "placebo", "width": 1.0}, {"from": "2000 iu vitamin d", "title": "given to n=28 patients in double-blind 3 mo NOD trial", "to": "placebo", "width": 1.0}, {"from": "25(oh)d-pca association", "title": "Based on the androgen hypothesis, it was suggested that testosterone might modulate the 25(OH)D-PCa association, indicating a possible interrelationship between these factors.", "to": "testosterone", "width": 1.0}, {"from": "2\u00d71 tomato extract caps (15 mg of lycopene)", "title": "no decline in serum PSA was noted in either group.", "to": "2 \u00d71 tomato extract caps (40 mg soy iso\ufb02avone mixture)", "width": 1.0}, {"from": "2\u00d7soy protein (20 g)", "title": "no decline in serum PSA was noted in either group.", "to": "se (100 \u00b5g)", "width": 1.0}, {"from": "40 mg", "title": "Kumar failed to produce PSA changes following aglycone iso\ufb02avones ONS (40 mg), compared with placebo, until the date of radical prostatectomy", "to": "iso\ufb02avones ons", "width": 1.0}, {"from": "4000 iu vitamin d", "title": "given to n=29 patients in double-blind 3 mo NOD trial", "to": "placebo", "width": 1.0}, {"from": "5-alpha-reductase inhibitors", "title": "compared in this context, and saw palmetto ONS failed to induce any changes while finasteride intake reduced PSA concentrations", "to": "serenoa repens ons", "width": 1.0}, {"from": "60 mg sulforaphane ons", "title": "Prolongs PSA doubling time by 86% compared to placebo among men with increasing PSA concentrations after prostatectomy", "to": "pca recurrence after prostatectomy", "width": 1.0}, {"from": "60 mg sulforaphane ons", "title": "Prolongs PSADT by 86% compared to placebo among men with increasing PSA concentrations after prostatectomy", "to": "psadt", "width": 1.0}, {"from": "[84,85]", "title": "The reference numbers [84,85] correspond to Lazarevic\u0027s research studies.", "to": "lazarevic", "width": 1.0}, {"from": "[89]", "title": "The reference number [89] corresponds to Dalais\u0027s research study.", "to": "dalais", "width": 1.0}, {"from": "[90]", "title": "The reference number [90] corresponds to Kumar\u0027s research study.", "to": "kumar", "width": 1.0}, {"from": "[91]", "title": "The reference number [91] corresponds to a subsequent research study by Kumar.", "to": "kumar", "width": 1.0}, {"from": "[92]", "title": "The reference number [92] corresponds to Hamilton-Reeves\u0027s research study.", "to": "hamilton-reeves", "width": 1.0}, {"from": "adenocarcinoma", "title": "expression of PSA in adenocarcinoma", "to": "psa", "width": 1.0}, {"from": "adverse events", "title": "The low carbohydrate content of the diets induced mild adverse events, including constipation and fatigue; however, all were reported to be diminished by the end of the 6-month intervention.", "to": "prostate study 2 (caps2)", "width": 1.0}, {"from": "agaricus blazei murill", "title": "Extracts from the Agaricus blazei Murill mushroom were examined in a study involving men with biochemical failure after radical treatment for non-metastasized PCa, but did not induce a di\ufb00erent PSA response.", "to": "pca-rcts", "width": 1.0}, {"from": "age", "title": "Investigating the prostate specific antigen, body mass index and age relationship: Is an age-BMI adjusted PSA model clinically useful?", "to": "psa", "width": 1.0}, {"from": "age", "title": "Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer", "to": "psa thresholds for testing for prostate cancer", "width": 1.0}, {"from": "aglycone isoflavones", "title": "phase II randomized clinical trial mentioned in Oncotarget (2020) where the relationship between aglycone isoflavones and patients with localized prostate cancer is explored", "to": "patients with localized prostate cancer", "width": 1.0}, {"from": "ala", "title": "Brouwer [200] NL Double-blind 40 months=162.\nOrigins: Brouwer.\nMasking: Not reported.\nDuration: 40 months.\nPatients: 162 men with a history of MI (60\u201380 years) with an initial PSA \u003c4 ng/mL.\nInterventions: ALA (2g/day) in margarine spreads, n=807;\nPlacebo in margarine spreads, n=815.\nResults: Mean serum PSA increased by 0.42", "to": "pca", "width": 1.0}, {"from": "ala", "title": "No di\ufffderences were observed in the PSA concentrations between the two groups.", "to": "psa concentrations", "width": 1.0}, {"from": "allen, k.", "title": "Results of a randomized phase I dose-finding trial of several doses of iso\ufb02avones in men with localized prostate cancer: Administration prior to radical prostatectomy.", "to": "prostate cancer", "width": 1.0}, {"from": "allen, k.", "title": "Results of a randomized phase I dose-finding trial of several doses of iso\ufb02avones in men with localized prostate cancer: Administration prior to radical prostatectomy.", "to": "iso\ufb02avones", "width": 1.0}, {"from": "androgen axis", "title": "Animal and cell culture studies reviewed by Applegate et al. (2019) suggest that lycopene may impact the androgen axis in prostate cancer.", "to": "lycopene", "width": 1.0}, {"from": "androgen deprivation therapy", "title": "Participants either reduced the carbohydrate content of their diets and increased their physical activity level, or retained their usual diet, for 6 months. No di \ufb00erences were exhibited in the PSA concentrations of participants in the intervention, or usual diet arms.", "to": "pca", "width": 1.0}, {"from": "androgen precursors", "title": "Kjaer et al. (2015) observed that resveratrol reduced the levels of circulating androgen precursors in middle-aged men.", "to": "resveratrol", "width": 1.0}, {"from": "animal studies", "title": "Based mainly on results from animal studies [ 215,216], the intake of low carbohydrate diets was proposed as a hypothesis, to reverse the Warburg phenomenon and subsequently, inhibit tumor growth in a multicellular environment.", "to": "pca", "width": 1.0}, {"from": "anticancer properties", "title": "Green-tea catechins (GTCs), which contain 85-95% total catechins and 56-72% as EGCG, have been found to have anticancer properties.", "to": "egcg", "width": 1.0}, {"from": "antigen", "title": "Antigen being not specific to PCa in context", "to": "not pca-specific", "width": 1.0}, {"from": "antioxidant ons", "title": "did not affect according to the SU.VI.MAX trial [ 175]", "to": "psa concentrations", "width": 1.0}, {"from": "antioxidant ons", "title": "according to few trials [ 61,65,176], antioxidant ONS might increase PSA and the risk for PCa, especially when baseline serum concentrations are high, and caution should be taken before consuming non-prescribed antioxidant supplements.", "to": "pca incidence", "width": 1.0}, {"from": "antioxidant supplementation", "title": "should not be unattended, or unprescribed as several antioxidants are toxic at intake levels exceeding the recommended daily allowance (RDA), and this toxicity might reverse any e \ufb03cacy, lead to poisoning (for some substances) and snowball adverse health events", "to": "adverse health events", "width": 1.0}, {"from": "antioxidants", "title": "Plenty of RCTs have assessed the effects of selected antioxidant supplementation in circulating PSA.", "to": "psa kinetics", "width": 1.0}, {"from": "antioxidants", "title": "Antioxidants have been examined in several PCa-RCTs, specifically in a tertiary prevention placebo-controlled trial that demonstrated an increase in PSA doubling time among men with a history of PCa and rising PSA post-radical prostatectomy or radiotherapy.", "to": "pca-rcts", "width": 1.0}, {"from": "antioxidants", "title": "J. Nat. Prod. 2000 ,63, 1035\u20131042.", "to": "flavonoids", "width": 1.0}, {"from": "antwi", "title": "The study involved 54 men with a history of PCa and rising PSA concentrations. No di\ufb00erences were observed in the PSA concentrations between the participating groups.", "to": "psa concentrations", "width": 1.0}, {"from": "arch. ital. urol. androl.", "title": "This study by Cicero et al. Also explores the relationship between nutraceuticals and prostate cancer prevention.", "to": "prostate cancer", "width": 1.0}, {"from": "arms in pre-surgical psa", "title": "relationship between the measurement of PSA levels before surgery and during pre-surgery", "to": "baseline /pre-surgery psa", "width": 1.0}, {"from": "as", "title": "PCa was present on AS in this context.", "to": "pca", "width": 1.0}, {"from": "as for disease management", "title": "First Author Origin Masking Duration Patients Interventions Results\nChan [196] US Double-blind 3 mon=84 men with low-burden PCa or increased PCa risk. Origins: Chan.\nMasking: Double-blind.\nDuration: 3 months.\nPatients: 84 men with low-burden PCa or increased PCa risk.\nInterventions: 1) 3x1g fish oil capsules/day (1098mg EPA +549mg DHA), n=27;\n2) 2x15mg lycopene capsules/day, n=29;\n3) Placebo, n=28.\nResults: No difference observed in \u2206PSA concentrations post-intervention between lycopene or fish oil.", "to": "pca", "width": 1.0}, {"from": "ascorbic acid", "title": "combined short-term ascorbic acid\u2013menadione therapy produced an immediate drop in both tumor cell numbers and PSA concentrations among men with PCa, suggesting that autoschizis (cancer cell death characterized by a reduction in cell size that occurs due to the loss of cytoplasm through self-excision) can also be induced.", "to": "menadione", "width": 1.0}, {"from": "au", "title": "The locations where the studies by Lazarevic and Dalais were conducted are \u0027NO\u0027 and \u0027AU\u0027, respectively.", "to": "no", "width": 1.0}, {"from": "barry", "title": "this refers to a dietary supplement used in the study, along with its dosage", "to": "saw palmetto (320 mg)", "width": 1.0}, {"from": "below 0.2 ng/ml", "title": "In the study by Hejazi et al., PSA concentrations were reduced below 0.2 ng/mL in both the curcumin and placebo groups.", "to": "psa concentrations", "width": 1.0}, {"from": "benefits and harms", "title": "The quality of evidence from the ERSPC and PLCO studies regarding screening for prostate cancer has been discussed in various publications, including Wirth et al. (2014) and Ilic (2014).", "to": "screening for prostate cancer", "width": 1.0}, {"from": "benign prostate hyperplasia", "title": "Benign prostate hyperplasia (BPH) and PCa are both related to the prostate gland, but BPH is a benign enlargement of the prostate, whereas PCa is a malignant growth.", "to": "pca", "width": 1.0}, {"from": "benign prostate hyperplasia", "title": "In the study by Carraro et al. (1996), Permixon (a brand of saw palmetto) was found to be effective in treating benign prostate hyperplasia.", "to": "permixon", "width": 1.0}, {"from": "benign prostatic hyperplasia", "title": "Dai et al. (2016) conducted a meta-analysis to examine the relationship between benign prostatic hyperplasia and the risk of prostate cancer and bladder cancer.", "to": "risk of prostate cancer and bladder cancer", "width": 1.0}, {"from": "benign prostatic hyperplasia", "title": "Prior to undergoing radical prostatectomy, some patients with benign prostatic hyperplasia may benefit from lycopene supplementation, as suggested by the study by Schwarz et al. (2008).", "to": "radical prostatectomy", "width": 1.0}, {"from": "benign prostatic hyperplasia", "title": "The paper by Cicero et al. Examines the use of nutraceuticals for treating benign prostatic hyperplasia and preventing prostate cancer.", "to": "cicero", "width": 1.0}, {"from": "benign prostatic hyperplasia", "title": "In the study by Bent et al. (2006), saw palmetto was found to have an effect on benign prostatic hyperplasia, which is a condition where the prostate gland becomes enlarged.", "to": "saw palmetto", "width": 1.0}, {"from": "better prognosis", "title": "Importance of harboring PCa for better prognosis in context", "to": "pca", "width": 1.0}, {"from": "bettuzzi et al. (2006)", "title": "This study by Bettuzzi et al. (2006) investigated the chemopreventive effect of green tea catechins on human prostate cancer in volunteers with high-grade prostate intraepithelial neoplasia.", "to": "green tea catechins", "width": 1.0}, {"from": "biochemical recurrence", "title": "Incidence similar among groups on secondary prevention level", "to": "soy protein supplement", "width": 1.0}, {"from": "biochemical recurrence after radical prostatectomy", "title": "E \ufb00ect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy.", "to": "cipolla, b.g.", "width": 1.0}, {"from": "biomarkers", "title": "This study focused on biomarkers in men with prostate cancer (Villanueva et al., 2017).", "to": "prostate cancer", "width": 1.0}, {"from": "biopsy-proven pca", "title": "Kellogg Parsons", "to": "diet", "width": 1.0}, {"from": "bmi", "title": "does not appear to have any association with", "to": "pca or advanced pca risk", "width": 1.0}, {"from": "bmi", "title": "According to a preponderance of published evidence, it has been suggested that obesity and metabolic syndrome markedly increase prostatic tissue in\ufb02ammation, prostate volume, and prevalence of BPH.", "to": "bph", "width": 1.0}, {"from": "bmi", "title": "When BPH and increased body weight are apparent, PSA concentrations are reduced due to the aforementioned hemodilution phenomenon.", "to": "psa concentrations", "width": 1.0}, {"from": "bmi", "title": "Seo et al. (2017) reported that there is a correlation between BMI and routine parameters in men over fifty, which may be related to prostate cancer risk.", "to": "prostate cancer", "width": 1.0}, {"from": "body mass index", "title": "Presurgical weight loss a affects tumour traits and circulating biomarkers in men with prostate cancer", "to": "psa", "width": 1.0}, {"from": "body mass index (bmi)", "title": "Harrison et al. (2017) investigated the relationship between BMI, PSA, and age, but their findings were not explicitly stated.", "to": "psa", "width": 1.0}, {"from": "body weight", "title": "In the given context, it is mentioned that with increasing body weight, there is a reduction in PSA due to hemodilution. This suggests a negative correlation between PSA and body weight.", "to": "psa", "width": 1.0}, {"from": "bosland", "title": "In a US double-blind study with 151 men at high-recurrence risk, the rate of biochemical recurrence within 2 years was not significantly different between the group consuming soy protein (PRO) and the placebo group.", "to": "placebo", "width": 1.0}, {"from": "bosland, m.c.", "title": "Results of a randomized phase I dose-finding trial of several doses of iso\ufb02avones in men with localized prostate cancer: Administration prior to radical prostatectomy.", "to": "prostate cancer", "width": 1.0}, {"from": "bosland, m.c.", "title": "Results of a randomized phase I dose-finding trial of several doses of iso\ufb02avones in men with localized prostate cancer: Administration prior to radical prostatectomy.", "to": "iso\ufb02avones", "width": 1.0}, {"from": "bph", "title": "Serenoa repens (commonly known as saw palmetto) is a natural supplement used to treat BPH, but its effectiveness is still being studied.", "to": "serenoa repens", "width": 1.0}, {"from": "bph", "title": "Schwarz et al. Failed to induce any di\ufb00erences in PSA concentrations of men with histologically proven BPH, free of PCa, receiving lycopene supplementation.", "to": "lycopene", "width": 1.0}, {"from": "bph", "title": "According to a recent Chinese meta-analysis, saw palmetto was more effective in reducing PSA concentrations among men with BPH as compared with tamsulosin; however, non-randomized trials were analyzed together with RCTs.", "to": "saw palmetto", "width": 1.0}, {"from": "bread", "title": "Both bread and HT soy grits are food items used as dietary supplements in some of the RCTs.", "to": "ht soy grits", "width": 1.0}, {"from": "brewed green and black tea", "title": "A randomized clinical trial was conducted to evaluate the potential chemopreventive activities of brewed green and black tea in men with prostate cancer prior to prostatectomy.", "to": "men with prostate cancer prior to prostatectomy", "width": 1.0}, {"from": "bylund", "title": "In a Swedish non-randomized study with 8 men with conservatively treated prostate cancer, there was no significant change in total PSA between the group consuming 295 g of rye bran bread per day and the group consuming 275 g of wheat bread per day after 3 weeks.", "to": "wheat bread", "width": 1.0}, {"from": "calcitriol", "title": "taken 1 d before docetaxel in n=125 patients", "to": "docetaxel", "width": 1.0}, {"from": "calcitriol", "title": "in n=389 na\u00efve BPH patients with moderate /severe symptoms", "to": "placebo ons", "width": 1.0}, {"from": "caloric restriction", "title": "One RCT comparing a 6-week caloric restriction vs. standard diet among overweight men with newly diagnosed PCa did not report any change in PSA concentrations.", "to": "psa concentrations", "width": 1.0}, {"from": "caloric restriction", "title": "A self-help diet and physical activity intervention with dietetic support for weight management in men treated for prostate cancer was explored in a pilot study (Mohamad et al., 2019). This study built upon previous research on caloric restriction (Wright et al., 2013) as a method to manage weight in overweight men with newly diagnosed prostate cancer.", "to": "weight management in men treated for prostate cancer", "width": 1.0}, {"from": "caloric restriction", "title": "A randomized controlled trial explored the feasibility outcomes of a presurgical intervention involving caloric restriction and increased physical activity in men electing prostatectomy for prostate cancer (Mohamad et al., 2016).", "to": "men electing prostatectomy for prostate cancer", "width": 1.0}, {"from": "caloric restriction", "title": "A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer was conducted (Wright et al., 2013).", "to": "standard diet", "width": 1.0}, {"from": "camus trial", "title": "recorded in this context", "to": "escalating doses of saw palmetto extract compared with placebo", "width": 1.0}, {"from": "cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years", "title": "Fitzmaurice et al. (2017) conducted a systematic analysis to determine global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups from 1990 to 2015.", "to": "32 cancer groups", "width": 1.0}, {"from": "cancer inhibitory potential", "title": "Weh, K.M.; Clarke, J.; Kresty, L.A. Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents. Antioxidants 2016 ,5, 27.", "to": "cranberries", "width": 1.0}, {"from": "cancer-related symptoms", "title": "Frequent lycopene intake has been suggested to reduce cancer-related symptoms according to meta-analyses.", "to": "lycopene intake", "width": 1.0}, {"from": "cantor, a.", "title": "Results of a randomized phase I dose-finding trial of several doses of iso\ufb02avones in men with localized prostate cancer: Administration prior to radical prostatectomy.", "to": "prostate cancer", "width": 1.0}, {"from": "cantor, a.", "title": "Results of a randomized phase I dose-finding trial of several doses of iso\ufb02avones in men with localized prostate cancer: Administration prior to radical prostatectomy.", "to": "iso\ufb02avones", "width": 1.0}, {"from": "cernitin", "title": "In BPH, cernitin, saw palmetto, B-sitosterol, and vitamin E combined therapy was ine \ufb00ective in altering circulating PSA.", "to": "saw palmetto", "width": 1.0}, {"from": "cipolla", "title": "In a French double-blind study with 39 men post-prostatectomy, prostate-specific antigen (PSA) doubling time was longer in the group receiving sulforaphane for 1 week followed by no oral nutritional supplements (ONS) for 2 weeks compared to the placebo group after 8 months.", "to": "placebo", "width": 1.0}, {"from": "cipolla, b.g.", "title": "E \ufb00ect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy.", "to": "prostate cancer", "width": 1.0}, {"from": "circulating psa", "title": "Plenty of RCTs have assessed the effects of selected antioxidant supplementation in circulating PSA.", "to": "selected antioxidant supplementation", "width": 1.0}, {"from": "circulating psa", "title": "Increased among participants in the same Iranian trial, indicating that not all fatty acids are effective or risk-free", "to": "\u03b3-linolenic acid supplementation", "width": 1.0}, {"from": "circulating psa among men with hormonally untreated pca and rising serum psa concentrations", "title": "did not affect", "to": "ons with vitamin e (350 mg), selenium (200 \u00b5g), vitamin c (750 mg), and coenzyme q10 (coq10) (200 mg)", "width": 1.0}, {"from": "circulating psa concentrations", "title": "comparison or contrast between the effect of combined therapy vs placebo", "to": "combined effect of calcitriol and iv docetaxel", "width": 1.0}, {"from": "circulating psa concentrations", "title": "Based on the MENS trial, three months of EPA and DHA supplementation did not induce changes in circulating PSA concentrations compared with lycopene ONS among men with a PCa diagnosis.", "to": "epa and dha supplementation", "width": 1.0}, {"from": "cisplatin", "title": "Cisplatin is commonly used in the treatment of prostate cancer.", "to": "prostate cancer", "width": 1.0}, {"from": "clinically localized pca", "title": "Both \u0027localized\u0027 and \u0027clinically localized PCa\u0027 indicate that the cancer is contained within a specific area of the prostate.", "to": "localized", "width": 1.0}, {"from": "combined antioxidant supplementation", "title": "In RCTs examining the effect of combined antioxidant supplementation on PSA concentrations among men with PCa or increased PCa risk, no significant differences in PSA concentrations were observed between intervention and control groups in studies by Paur [177] and Grainger [178]. In a study by Hoenjet [179], ONS with a combination of vitamin E, Se, vitamin C, and CoQ10 did not affect serum PSA concentrations. However, in another study by Oh et al. [182] on men with histologic evidence of progressive androgen-independent PCa, 3x3 PC-SPES caps containing a herbal combination showed no effect on PSA concentrations.", "to": "psa concentrations", "width": 1.0}, {"from": "combined e \ufb00ect of calcitriol and iv docetaxel", "title": "lack of difference in PSA response between the combined therapy and placebo", "to": "psa response", "width": 1.0}, {"from": "combined e \ufb00ect of calcitriol and iv docetaxel", "title": "lack of difference in duration of PSA progression-free survival between the combined therapy and placebo", "to": "duration of psa progression-free survival", "width": 1.0}, {"from": "combined epa and dha supplementation", "title": "Reduced PSA among apparently healthy participants without PCa-specific risk factors following a 12-week Iranian trial", "to": "psa concentrations", "width": 1.0}, {"from": "combined supplementation", "title": "A 6-month combined supplementation of lycopene, selenium, and GTCs among patients with primary multifocal HGPIN and /or ASAP was also ine \ufb00ective concerning PSA kinetics.", "to": "lycopene", "width": 1.0}, {"from": "combined tamsulosin and saw palmetto therapy", "title": "According to a meta-analysis, combined tamsulosin and saw palmetto therapy were also ineffective in reducing PSA compared with tamsulosin alone.", "to": "psa concentrations", "width": 1.0}, {"from": "concentrations being indicative of", "title": "causal relationship between higher concentrations and better treatment outcomes", "to": "greater therapy response", "width": 1.0}, {"from": "concord grape juice", "title": "Relationship between Concord grape juice and Placebo in the context, as both are compared in a double-blind RCT to study their effects on PCa.", "to": "placebo", "width": 1.0}, {"from": "consumed bread again as a medium for supplementation", "title": "participants consumed bread supplemented with 50 g of heat-treated (HT) soy grits", "to": "men with pca", "width": 1.0}, {"from": "consumed whole grain and bran products, substituting 50% of their daily total energy intake (tei)", "title": "when men with PCa were randomized to consume whole grain and bran products", "to": "men with pca", "width": 1.0}, {"from": "counseling", "title": "When men previously treated for PCa and their partners were randomized to a combined intervention including dietary modi\ufb01cations, increased physical activity and stress-reduction or standard care, no di \ufb00erences were noted in the PSA concentrations between groups. However, delivery of dietary and cooking classes for 3 months did not alter the rate of participants with increased PSA concentrations compared with no intervention, but e\ufb00ectively prolonged PSADT.", "to": "delivery of dietary and cooking classes", "width": 1.0}, {"from": "cranberries", "title": "Daily cranberry powder ONS has been shown to be an effective adjuvant PCa therapy in a RCT, resulting in a 22.5% reduction of PSA concentrations after 30 days of supplementation.", "to": "pca therapy", "width": 1.0}, {"from": "cranberries", "title": "A RCT found that daily intake of cranberry powder ONS for 6 months reduced PSA in men with lower urinary tract symptoms, elevated PSA, and negative prostate biopsy.", "to": "pca risk", "width": 1.0}, {"from": "cranberries", "title": "In BPH and PCa, cranberries are expected to exhibit antiproliferative, anti-androgenic, and anti-estrogenic properties in addition to their antioxidant and anti-inflammatory properties.", "to": "pca", "width": 1.0}, {"from": "cranberries", "title": "Student, V .; Vidlar, A.; Bouchal, J.; Vrbkova, J.; Kolar, Z.; Kral, M.; Kosina, P .; V ostalova, J. Cranberry intervention in patients with prostate cancer prior to radical prostatectomy. Clinical, pathological and laboratory findings. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech. Repub. 2016 ,160, 559\u2013565.", "to": "prostate cancer patients prior to radical prostatectomy", "width": 1.0}, {"from": "cranberries", "title": "Vidlar, A.; Vostalova, J.; Ulrichova, J.; Student, V .; Stejskal, D.; Reichenbach, R.; Vrbkova, J.; Ruzicka, F.; Simanek, V . The e \ufb00ectiveness of dried cranberries ( Vaccinium macrocarpon ) in men with lower urinary tract symptoms. Br. J. Nutr. 2010 ,104, 1181\u20131189.", "to": "lower urinary tract symptoms", "width": 1.0}, {"from": "cranberries", "title": "Neto, C.C. Cranberry and blueberry: Evidence for protective e \ufb00ects against cancer and vascular diseases. Mol. Nutr. Food Res. 2007 ,51, 652\u2013664.", "to": "protective effects against cancer and vascular diseases", "width": 1.0}, {"from": "cranberries", "title": "Pappas, E.; Schaich, K.M. Phytochemicals of cranberries and cranberry products: Characterization, potential health e \ufb00ects, and processing stability. Crit. Rev. Food Sci. Nutr. 2009 ,49, 741\u2013781.", "to": "phytochemicals", "width": 1.0}, {"from": "cranberry fruit powder", "title": "First Author [121] CZ Double-blind 30 dn=64 men with PCa, prior to surgery, serum PSA concentrations decreased by 22.5% in the cranberry intervention arm.", "to": "placebo powder", "width": 1.0}, {"from": "cranberry fruit powder", "title": "Stenner-Liewen [135]CH Double-blind 4 wksn=87 men with BPH, no di\ufb00erences in PSA concentrations between arms.", "to": "dried powdered cranberries", "width": 1.0}, {"from": "cross-over", "title": "This phase II trial is designed as a cross-over study, where each participant receives both the experimental and control interventions.", "to": "phase ii trial", "width": 1.0}, {"from": "curcumin", "title": "Curcumin has been suggested to entail chemopreventive and anticancer properties related to PCa. However, two placebo-controlled trials failed to induce any differences in circulating PSA after 3 and 6 months of supplementation, respectively.", "to": "pca", "width": 1.0}, {"from": "curcumin", "title": "In a placebo-controlled trial, curcumin and iso\ufb02avones synergistically reduced PSA concentrations among men who underwent systematic prostate biopsy due to elevated circulating PSA.", "to": "iso\ufb02avones", "width": 1.0}, {"from": "curcumin", "title": "When the combined ONS included curcumin, resveratrol, GTC, and broccoli, no effect in PSA kinetics was noted among men with biochemically recurrent PCa and a moderate rise rate PSA, compared with placebo.", "to": "psa", "width": 1.0}, {"from": "curcumin", "title": "A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation.", "to": "prostate cancer", "width": 1.0}, {"from": "curcumin ons", "title": "In Table 3, men with PCa receiving IAD1 and oral curcumin (1.44 g /d) are compared to those receiving placebo in a double-blind study by Choi et al., where the % of patients with PSA progression was lower in the curcumin arm.", "to": "pca", "width": 1.0}, {"from": "curcumin ons", "title": "In Table 3, Choi et al. Found that although PSA did not differ between curcumin and placebo groups in their study, the % of patients with PSA progression was lower in the curcumin arm.", "to": "psa concentrations", "width": 1.0}, {"from": "daidzein", "title": "Both genistein and daidzein are iso\ufb02avones mentioned in the same sentence as potential treatments for PCa.", "to": "genistein", "width": 1.0}, {"from": "daily pomegranate intake", "title": "Stenner-Liewen et al. (2013) conducted a phase IIb randomized controlled trial examining the impact of daily pomegranate intake on PSA levels in patients with advanced prostate cancer, as reported in Journal of Cancer.", "to": "advanced prostate cancer", "width": 1.0}, {"from": "dalais", "title": "Both Lazarevic and Dalais are first authors of research papers.", "to": "lazarevic", "width": 1.0}, {"from": "debruyne", "title": "BPH refers to an enlargement of the prostate gland, and this element describes the severity of symptoms experienced by study participants", "to": "mild-to-severe bph symptoms", "width": 1.0}, {"from": "decrease", "title": "In the GTCs arm, a reduction was noted in PSA at 6 and 12 months.", "to": "psa", "width": 1.0}, {"from": "delivery of dietary and cooking classes", "title": "When men previously treated for PCa and their partners were randomized to a combined intervention including dietary modi\ufb01cations, increased physical activity and stress-reduction or standard care, no di \ufb00erences were noted in the PSA concentrations between groups. However, delivery of dietary and cooking classes for 3 months did not alter the rate of participants with increased PSA concentrations compared with no intervention, but e\ufb00ectively prolonged PSADT.", "to": "pca", "width": 1.0}, {"from": "diet", "title": "Aronson [213]", "to": "lffo diet", "width": 1.0}, {"from": "diet", "title": "Shike found no di\ufb00erence in serum PSA concentrations by dietary intervention, but Eastham noted no di\ufb00erence in serum PSA concentrations by dietary intervention.", "to": "psa concentrations", "width": 1.0}, {"from": "diet high in insoluble fiber", "title": "Serum PSA concentration was lower with the diet high in soluble fiber (approx. 25\u201330 g fiber/1000 kcal, \u226420% fat, \u226420% PRO, \u226560% CHO) than the diet high in insoluble fiber (approx. 25\u201330 g fiber/1000 kcal, \u226420% fat, \u226420% PRO, \u226560% CHO) in healthy men with hyperlipidemia", "to": "diet high in soluble fiber", "width": 1.0}, {"from": "diet rich in phytoestrogens", "title": "study in Urology (2004) where the relationship between a diet rich in phytoestrogens and men diagnosed with prostate cancer is examined", "to": "men diagnosed with prostate cancer", "width": 1.0}, {"from": "dietary factors", "title": "Influencing", "to": "psa concentrations", "width": 1.0}, {"from": "dietary factors", "title": "The evidence supporting the effectiveness of most dietary factors in preventing PCa appears to be inadequate, despite the variety of examined interventions.", "to": "e\ufb05acy", "width": 1.0}, {"from": "dietary intake of eicosapentaenoic (epa; 20:5n \u22123), docosahexaenoic (dha; 22:6n \u22123)", "title": "may decrease the risk of PCa according to observational cohort studies", "to": "pca", "width": 1.0}, {"from": "dietary modifications, pa, and mindfulness-based stress reduction training", "title": "The study compared a group of 29 men who received dietary modifications, PA, and mindfulness-based stress reduction training with a standard care group of 25 men. No di\ufb00erences were observed in the PSA concentrations between the two groups.", "to": "standard care", "width": 1.0}, {"from": "dietary patterns", "title": "The quest for dietary patterns efficient in down-regulating prostate-specific antigen (PSA) concentrations among men with prostate cancer (PCa) or increased PCa risk has been long.", "to": "pca", "width": 1.0}, {"from": "dietary supplements", "title": "The evidence supporting the effectiveness of most dietary supplements in preventing PCa appears to be inadequate, despite their widespread use.", "to": "pca", "width": 1.0}, {"from": "dietary supplements", "title": "Polyphenols are a type of dietary supplement that have been studied for their potential cancer-preventive effects, but the evidence supporting their effectiveness is inconclusive.", "to": "polyphenols", "width": 1.0}, {"from": "dietary supplements", "title": "Sulforaphane is a type of dietary supplement found in cruciferous vegetables that has been studied for its potential cancer-preventive effects, but the evidence supporting its effectiveness is inconsistent.", "to": "sulforaphane", "width": 1.0}, {"from": "diethylstilbestrol", "title": "Both the mixed antioxidant and diethylstilbestrol were being compared in a clinical trial for their effects on PCa.", "to": "mixed antioxidant", "width": 1.0}, {"from": "dihydrotestosterone", "title": "Kjaer et al. (2015) found that resveratrol did not affect dihydrotestosterone levels in middle-aged men.", "to": "resveratrol", "width": 1.0}, {"from": "dihydrotestosterone levels", "title": "Kjaer et al. (2015) found that resveratrol did not affect dihydrotestosterone levels in middle-aged men.", "to": "resveratrol", "width": 1.0}, {"from": "disease progression", "title": "The intake of nutrients protecting against cancer development might also entail anti-carcinogenic effects post-diagnosis by halting disease progression according to the text.", "to": "lycopene", "width": 1.0}, {"from": "division of transplantation, immunology and mucosal biology", "title": "Affiliated with", "to": "mrc centre for transplantation", "width": 1.0}, {"from": "docetaxel", "title": "36 mg/m2/wk for 3 wks of a 4-wk cycle", "to": "iv docetaxel", "width": 1.0}, {"from": "doses of vitamin d 3", "title": "comparison or contrast between different dosages of vitamin D", "to": "normal", "width": 1.0}, {"from": "doxercalciferol", "title": "combination therapy of doxercalciferol and intravenous docetaxel cycles in chemotherapy-naive men with metastatic androgen-independent prostate cancer", "to": "intravenous docetaxel cycles", "width": 1.0}, {"from": "dried powdered cranberries", "title": "Vidlar [122] CZ NR 6 mon=42 men at risk of PCa with LUTS, elevated PSA and negative biopsy, the cranberry group experienced a reduction in PSA concentrations on d 180.", "to": "no cranberry treatment", "width": 1.0}, {"from": "duration", "title": "Similarly, a lack of e\ufb00ect was even evident in double-blind RCTs of greater duration", "to": "were not the causes of null \ufb01ndings in the aforementioned trials", "width": 1.0}, {"from": "each increase in bmi by 5 kg /m2", "title": "is associated with", "to": "reduction in psa concentrations equal to 5.88%", "width": 1.0}, {"from": "early diagnosis", "title": "Importance of harboring PCa for early diagnosis in context", "to": "pca", "width": 1.0}, {"from": "ebrt", "title": "In a randomized controlled trial by Hejazi et al., oral curcumin (3 g /d) was administered to patients with PCa on EBRT (\u003c74 Gy) and compared to placebo.", "to": "oral curcumin", "width": 1.0}, {"from": "epa", "title": "Higashihara\n[197] JP NR 2 years n=62 men with PCa and post-surgical PSA \u003c0.2 ng/mL.\nOrigins: Higashihara.\nMasking: Not reported.\nDuration: 2 years.\nPatients: 62 men with PCa and post-surgical PSA \u003c0.2 ng/mL.\nInterventions: EPA (2.4g/day), n=32.\nResults: Recurrence-free survival rate did not differ between groups.", "to": "pca", "width": 1.0}, {"from": "epa", "title": "No di\ufb0eences were observed in the PSA concentrations between the two groups.", "to": "psa concentrations", "width": 1.0}, {"from": "epa ons", "title": "In a Japanese trial without a comparator intervention, two years of EPA ONS failed to reduce PSA among men with PCa and low post-surgical PSA concentrations.", "to": "psa", "width": 1.0}, {"from": "epa supplementation", "title": "Did not demonstrate differences in older adults following a 40-month randomized trial with EPA spread-based \u03b1-linolenic acid supplementation compared to placebo", "to": "psa concentrations", "width": 1.0}, {"from": "epidemiology", "title": "McVary (2006) discussed the epidemiology and comorbidities associated with benign prostatic hyperplasia.", "to": "comorbidities", "width": 1.0}, {"from": "epigenetic modulators for prostate cancer prevention", "title": "Nutrients 2020 ,12, 1010.", "to": "flavonoids", "width": 1.0}, {"from": "escalating doses of vitamin d 3", "title": "causal relationship between increased vitamin D intake and decrease in PSA levels", "to": "psa concentrations", "width": 1.0}, {"from": "ethnic di \ufb00erences", "title": "not related to the incidence of PCa in the sample", "to": "fat content of the diet", "width": 1.0}, {"from": "european randomized study of screening for prostate cancer", "title": "The European Randomized Study of Screening for Prostate Cancer (ERSPC) found a decrease in prostate cancer mortality after 13 years of follow-up, as reported in The Lancet (Schr\u00f6der et al., 2014).", "to": "prostate cancer", "width": 1.0}, {"from": "evidence", "title": "Despite the plethora of trials and the variety of examined interventions, the evidence", "to": "pca", "width": 1.0}, {"from": "examining the effect of phytoestrogen ons on psa concentrations among men with pca, or increased pca risk.", "title": "RCTs investigate the relationship between phytoestrogen oral nutritional supplements and changes in prostate-specific antigen (PSA) levels in men with prostate cancer (PCa) or an increased risk of PCa.", "to": "rcts", "width": 1.0}, {"from": "experts", "title": "Controversy sparked by experts regarding the usefulness of routine PSA screening in context", "to": "sparked controversy on the usefulness of routine psa screening", "width": 1.0}, {"from": "fa intake", "title": "Despite ample research conducted, a salient explanation of the effect of FA intake on PCa is yet expected.", "to": "pca aggressiveness", "width": 1.0}, {"from": "failed to report signi\ufb01cant changes between intervention arms", "title": "no di\ufb00erences were recorded in the PSA change from baseline between treatment arms", "to": "treated pca", "width": 1.0}, {"from": "fatty acid content of the peri-prostatic adipose tissue", "title": "decreases with PCa aggressiveness according to observational cohort studies", "to": "pca aggressiveness", "width": 1.0}, {"from": "fatty acids", "title": "The context does not provide information on the relation between fatty acids and low fat /\ufb01sh oil in this study.", "to": "low fat /\ufb01sh oil", "width": 1.0}, {"from": "favorable changes", "title": "Serum PSA decreased from baseline in the treatment arm, but increased in the control group.", "to": "pca", "width": 1.0}, {"from": "feasibility", "title": "The first RCT reported a tendency for increased PSA concentrations among intervention participants.", "to": "rct", "width": 1.0}, {"from": "fish intake", "title": "Synthesis of cohort and case-control studies suggested an association between higher fish intake and decreased risk of PCa morality.", "to": "pca morality", "width": 1.0}, {"from": "flavonoids", "title": "Flavonoids are bioactive molecules occurring in plants that retain radical-scavenging ability even after ingestion.", "to": "plant compounds", "width": 1.0}, {"from": "flavonoids", "title": "Physiology-wise, flavonoids have been suggested to target oncogenes and tumor suppressor genes, while restoring both miRNA and lncRNA expression, which is altered during disease progress.", "to": "pca", "width": 1.0}, {"from": "food or drug?", "title": "Clin. Cases Miner. Bone Metab. 2007 ,4, 123\u2013130.", "to": "phytoestrogens", "width": 1.0}, {"from": "fruit and fruit extracts", "title": "Relationship between Nutrients 2020 and Fruit and fruit extracts in the context, as both are discussed together.", "to": "nutrients 2020", "width": 1.0}, {"from": "fruits", "title": "Fruits are rich sources of phytochemicals carrying multiple antioxidant and anti-inflammatory properties.", "to": "phytochemicals", "width": 1.0}, {"from": "fruits", "title": "In BPH and PCa, fruits are expected to exhibit antiproliferative, anti-androgenic, and anti-estrogenic properties in addition to their antioxidant and anti-inflammatory properties.", "to": "pca", "width": 1.0}, {"from": "ganoderma lucidum", "title": "Extracts from the Ganoderma lucidum mushroom were examined in a study involving men with biochemical failure after radical treatment for non-metastasized PCa, but did not induce a di\ufb00erent PSA response.", "to": "pca-rcts", "width": 1.0}, {"from": "gastrointestinal events", "title": "associated with each other, leading to reduced compliance rate and increased risk of dropping out from trials due to adverse effects such as nausea, constipation, diarrhea, and decreased appetite", "to": "high fruit intake", "width": 1.0}, {"from": "genistein", "title": "Genistein is a type of polyphenol found in soy products that has been studied for its potential cancer-preventive effects, but the evidence supporting its effectiveness is inconsistent.", "to": "polyphenols", "width": 1.0}, {"from": "genistein", "title": "Among men with localized PCa scheduled for radical prostatectomy, supplementation with 30 mg of synthetic genistein until the operation failed to reduce PSA concentrations of participants, compared with a placebo. However, this lack of genistein efficacy in PCa in vivo studies is even extended in non-RCTs, with genistein ONS presenting null efficacy.", "to": "pca", "width": 1.0}, {"from": "genistein, daidzein, and other iso\ufb02avones", "title": "failed to affect circulating PSA among men with localized PCa after 6 months", "to": "pca on as", "width": 1.0}, {"from": "grape antioxidants", "title": "Potential anticancer properties of grape antioxidants.", "to": "zhou, k.", "width": 1.0}, {"from": "grape juice antioxidants", "title": "Spettel et al. (2013) conducted a prospective randomized double-blind trial investigating the effect of grape juice antioxidants on men with lower urinary tract symptoms, as reported in Neurourology and Urodynamics.", "to": "lower urinary tract symptoms", "width": 1.0}, {"from": "grape skin and seeds extract", "title": "Relationship between Grape skin and seeds extract and PCa in the context, as both are mentioned in relation to each other because of their antioxidant content.", "to": "pca", "width": 1.0}, {"from": "green tea", "title": "PSA results were not reported.", "to": "psa concentrations", "width": 1.0}, {"from": "green tea", "title": "Daily consumption of green tea on the weeks preceding prostatectomy induced a significant reduction in PSA compared with black tea, or water drinkers", "to": "psa", "width": 1.0}, {"from": "green tea", "title": "Catechins supplementation from green tea was not effective in inducing differences in PSA concentrations compared with controls among men scheduled for radical prostatectomy", "to": "men scheduled for radical prostatectomy", "width": 1.0}, {"from": "green tea", "title": "Daily GTCs supplementation for a year decreased serum PSA concentrations compared with placebo among men on active surveillance (AS)", "to": "men on active surveillance (as)", "width": 1.0}, {"from": "green tea (camellia sinensis)", "title": "Green tea has been investigated for its potential in preventing cancer.", "to": "prevention of cancer", "width": 1.0}, {"from": "green tea catechins", "title": "GTCs appear to have inhibitory effects on PCa and cancer cell growth, however, overall effect on PSA concentrations in men with PCa or increased PCa risk is unclear due to conflicting results from RCTs.", "to": "men with pca or increased pca risk", "width": 1.0}, {"from": "green tea catechins", "title": "Kumar et al. (2015) conducted a randomized, placebo-controlled trial to investigate the efficacy of green tea catechins in preventing prostate cancer.", "to": "randomized, placebo-controlled trial of green tea catechins for prostate cancer prevention", "width": 1.0}, {"from": "green tea catechins", "title": "Micali et al. (2017) conducted a short-term double-blind placebo-controlled phase II clinical trial to examine the effect of green tea catechins on patients with high-grade prostatic intraepithelial neoplasia.", "to": "micali et al. (2017)", "width": 1.0}, {"from": "green tea drink (3 cups)", "title": "PSA concentrations did not differ between lycopene, green tea, or placebo groups at 6 months.", "to": "green tea caps (blinded, 600 mg \ufb02avan-3-ol egcg)", "width": 1.0}, {"from": "green tea extract", "title": "Kumar et al. (2018) investigated the potential of green tea extract for preventing prostate cancer progression in patients on active surveillance.", "to": "kumar et al. (2018)", "width": 1.0}, {"from": "green tea polyphenols and metabolites", "title": "Green tea polyphenols and their metabolites have been found to be associated with cancer prevention.", "to": "cancer prevention", "width": 1.0}, {"from": "gtcs", "title": "A reduction was noted in PSA of the GTCs arm at 6 and 12 mo.", "to": "psa concentrations", "width": 1.0}, {"from": "gtcs", "title": "A phase II trial has shown that GTCs (600 mg/d) may have potential in preventing PCa.", "to": "pca prevention", "width": 1.0}, {"from": "gtcs alternative", "title": "Polyphenon E (PolyE), a formulation of GTCs, may serve as an alternative to GTCs.", "to": "polye", "width": 1.0}, {"from": "gtcs caps", "title": "PSA did not change between the two arms.", "to": "psa concentrations", "width": 1.0}, {"from": "hamilton-reeves, j.m.", "title": "Short-term soy iso\ufb02avone intervention in patients with localized prostate cancer: A randomized, double-blind, placebo-controlled trial.", "to": "prostate cancer", "width": 1.0}, {"from": "hamilton-reeves, j.m.", "title": "Short-term soy iso\ufb02avone intervention in patients with localized prostate cancer: A randomized, double-blind, placebo-controlled trial.", "to": "iso\ufb02avones", "width": 1.0}, {"from": "healthy dietary patterns", "title": "According to a recent meta-analysis of cohort studies, adherence to traditionally considered \u2018healthy\u2019 dietary models as the Mediterranean diet did not significantly affect the incidence of PCa. However, in the Prostate testing for cancer and treatment (ProtecT) trial, adherence to the PCa-speci\ufb01c dietary recommendations issued by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) was associated with decreased risk of PCa and lower PSA concentrations.", "to": "pca", "width": 1.0}, {"from": "hgpin", "title": "In some cases, HGPIN may lead to the development of PCa.", "to": "pca", "width": 1.0}, {"from": "hgpin", "title": "In HGPIN, supplementation with tomato products did not alter PSA compared with soy.", "to": "lycopene", "width": 1.0}, {"from": "high doses of pomx", "title": "Relationship between High doses of POMx and Lower doses of POMx in the context, as both are compared in relation to their effects on PCa.", "to": "lower doses of pomx", "width": 1.0}, {"from": "high fiber content", "title": "The study tested the effectiveness of an LFD, with a high fiber content, supplemented with soy, among men at high risk for PCa recurrence after prostatectomy.", "to": "li et al. [ 219]", "width": 1.0}, {"from": "high lycopene sources", "title": "When men at risk for PCa were recruited (Table 9), high lycopene sources induced similar effects to PSA as soy-rich foods.", "to": "psa", "width": 1.0}, {"from": "high prostate cancer risk", "title": "A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk (context: 48)", "to": "prostate cancer", "width": 1.0}, {"from": "high psa concentrations", "title": "No di\ufb00erence was observed in the distributions of the PSA slopes, the PSA slopes per se, or the % of high PSA concentrations between groups.", "to": "psa", "width": 1.0}, {"from": "high risk for pca recurrence", "title": "The study tested the effectiveness of an LFD, with a high fiber content, supplemented with soy and supported by individual counseling sessions among men at high risk for PCa recurrence after prostatectomy.", "to": "li et al. [ 219]", "width": 1.0}, {"from": "high soy diet", "title": "Fail to reveal significant differences in PSA concentrations among groups on primary prevention level", "to": "low soy diet", "width": 1.0}, {"from": "high-dose selenium ons", "title": "indicates that high-dose selenium ONS appears to be a risk factor for increased PSA velocity among men with high baseline plasma selenium concentrations as reported in Table 2 of the context [65].", "to": "increased psa velocity among men with high baseline plasma selenium concentrations", "width": 1.0}, {"from": "high-fiber diet", "title": "Patients with post-prostatectomy, at high risk for recurrence who followed a low-carbohydrate diet (\u226420g CHO/d) supplemented with 40 g soy protein and had individual counseling sessions had no signi\ufb01cant changes in PSA compared to those who followed the USDA recommended diet", "to": "low-carbohydrate diet", "width": 1.0}, {"from": "high-fiber diet", "title": "Patients with post-prostatectomy, at high risk for recurrence who followed a low-carbohydrate diet (\u226420g CHO/d) supplemented with 40 g soy protein and had individual counseling sessions had no signi\ufb01cant changes in PSA compared to those who followed a high-fiber diet (18 g/1000 kcal)", "to": "lcd", "width": 1.0}, {"from": "high-grade prostatic intraepithelial neoplasia (hgpin) and /or atypical small acinar proliferation (asap)", "title": "Daily GTCs supplementation for a year decreased serum PSA concentrations compared with placebo in two trials among men with high-grade prostatic intraepithelial neoplasia (HGPIN) and /or atypical small acinar proliferation (ASAP)", "to": "psa", "width": 1.0}, {"from": "high-risk populations", "title": "According to Carter et al. (2013), regular prostate-specific antigen (PSA) tests are recommended for men at high risk of developing prostate cancer.", "to": "prostate cancer", "width": 1.0}, {"from": "high-risk populations", "title": "As per Carter et al. (2013), regular prostate-specific antigen (PSA) tests are recommended for men at high risk of developing prostate cancer.", "to": "regular psa tests", "width": 1.0}, {"from": "high-soy diet", "title": "Do not demonstrate any di\ufb00erences in the recorded increases in PSA on primary prevention level", "to": "placebo", "width": 1.0}, {"from": "high-\ufb01ber lfd", "title": "Both diets were given to different groups of men in the study. No significant differences in PSA concentrations were observed between the two groups.", "to": "western diet", "width": 1.0}, {"from": "histologically confirmed pca", "title": "PCa is a type of cancer, while Stenner-Liewen refers to a study involving men with histologically confirmed PCa", "to": "stenner-liewen", "width": 1.0}, {"from": "histologically confirmed pca", "title": "Relationship between Histologically confirmed PCa and PSA concentrations in the context, as both are mentioned together in relation to fruit extracts.", "to": "psa concentrations", "width": 1.0}, {"from": "ht soy grits", "title": "the percentage change in total PSA and free/total PSA ratio di\ufb00ered between the HT soy grits arm and the control group", "to": "indicated some e\ufb03cacy", "width": 1.0}, {"from": "hyson", "title": "This review by Hyson discusses the relationship between 100% fruit juice and human health.", "to": "human health", "width": 1.0}, {"from": "incidence of pca", "title": "The incidence of PCa did not differ among men receiving GTCs, or placebo in trials reporting a PSA decline among men with high-grade prostatic intraepithelial neoplasia (HGPIN) and /or atypical small acinar proliferation (ASAP)", "to": "men with high-grade prostatic intraepithelial neoplasia (hgpin) and /or atypical small acinar proliferation (asap)", "width": 1.0}, {"from": "increased body mass index (bmi)", "title": "is associated with", "to": "lower psa concentrations", "width": 1.0}, {"from": "increased cancer risk", "title": "Related to", "to": "prostate cancer", "width": 1.0}, {"from": "increased number of men treated for pca", "title": "Relation between PSA screening and increased number of men treated for PCa in context", "to": "psa screening", "width": 1.0}, {"from": "individual counseling sessions", "title": "The study tested the effectiveness of an LFD, with a high fiber content, supplemented with soy and supported by individual counseling sessions among men at high risk for PCa recurrence after prostatectomy.", "to": "li et al. [ 219]", "width": 1.0}, {"from": "inflammation", "title": "In this study, we conducted a systematic review to examine the current state of research on inflammation.", "to": "systematic review", "width": 1.0}, {"from": "inflammation, prostatic cell growth, and stimulation of the apoptotic machinery", "title": "according to pharmaceutical industry", "to": "serenoa repens ons", "width": 1.0}, {"from": "initial psa", "title": "Mean serum PSA increased by 0.42 ng/mL in the placebo group and by 0.52 ng /mL in the ALA group (NS).", "to": "psa concentrations", "width": 1.0}, {"from": "insoluble fiber", "title": "after 4 months of intervention, serum PSA concentrations were lower in the soluble fiber groups as compared to the insoluble fiber group", "to": "soluble fiber", "width": 1.0}, {"from": "instead as control", "title": "until the date of radical prostatectomy operation", "to": "wheat bread", "width": 1.0}, {"from": "intensive lifestyle intervention supporting an lfd supplemented with soy, fish oil, and antioxidant vitamins", "title": "favorable reduction noted in the PSA concentrations of the intervention group after one year", "to": "usual treatment", "width": 1.0}, {"from": "intervention", "title": "A randomized controlled trial explored the feasibility outcomes of a presurgical intervention involving caloric restriction and increased physical activity in men electing prostatectomy for prostate cancer (Mohamad et al., 2016).", "to": "presurgical", "width": 1.0}, {"from": "intervention participants", "title": "In parallel, Ki67 proliferation rates were also greater post-intervention compared with the controls, indicating that more studies are required before recommending rapid weight loss among obese patients with PCa.", "to": "psa concentrations", "width": 1.0}, {"from": "isoflavones", "title": "Isoflavones, mainly present in soy products, are the most examined flavonoid family member in in vivo cancer research.", "to": "soy products", "width": 1.0}, {"from": "iso\ufb02avone supplementation", "title": "The meta-analysis found that there were no significant effects of iso\ufb02avone supplementation on null findings in trials related to prostate cancer.", "to": "null findings", "width": 1.0}, {"from": "iso\ufb02avone supplementation", "title": "Another meta-analysis revealed that iso\ufb02avone supplementation did not have an effect on PSA concentrations among men with localized prostate cancer, indicating a lack of efficacy.", "to": "lack of efficacy", "width": 1.0}, {"from": "iso\ufb02avones", "title": "While individual RCTs might advocate for the e\ufffdiciency of isoflavones in reducing PSA concentrations and PCa risk, a 2014 meta-analysis of RCTs indicated that the consumption of soy products or isoflavones did not induce any significant differences in the PSA concentrations between the control and intervention group among men with PCa diagnosis or a clinically identified risk of PCa.", "to": "pca", "width": 1.0}, {"from": "iso\ufb02avones", "title": "In a US double-blind study with 76 men with prostate cancer, there was no significant difference in serum PSA between the group taking 60 mg of isoflavones per day and the placebo group after 12 weeks.", "to": "placebo", "width": 1.0}, {"from": "iso\ufb02avones", "title": "Results of a randomized phase I dose-finding trial of several doses of iso\ufb02avones in men with localized prostate cancer: Administration prior to radical prostatectomy.", "to": "kumar, n.b.", "width": 1.0}, {"from": "iso\ufb02avones", "title": "Results of a randomized phase I dose-finding trial of several doses of iso\ufb02avones in men with localized prostate cancer: Administration prior to radical prostatectomy.", "to": "kang, l.", "width": 1.0}, {"from": "iso\ufb02avones", "title": "Results of a randomized phase I dose-finding trial of several doses of iso\ufb02avones in men with localized prostate cancer: Administration prior to radical prostatectomy.", "to": "pow-sang, j.", "width": 1.0}, {"from": "iso\ufb02avones", "title": "Results of a randomized phase I dose-finding trial of several doses of iso\ufb02avones in men with localized prostate cancer: Administration prior to radical prostatectomy.", "to": "xu, p.", "width": 1.0}, {"from": "iv docetaxel", "title": "taken 1 d before docetaxel in n=125 patients", "to": "placebo ons", "width": 1.0}, {"from": "iv docetaxel", "title": "double-blind 3 mo n=105 Black men NOD trial", "to": "placebo", "width": 1.0}, {"from": "kang, l.", "title": "Results of a randomized phase I dose-finding trial of several doses of iso\ufb02avones in men with localized prostate cancer: Administration prior to radical prostatectomy.", "to": "prostate cancer", "width": 1.0}, {"from": "klotz (2013)", "title": "The concept of overdiagnosis of prostate cancer was also discussed by Klotz in a publication in Current Opinions in Endocrinology, Diabetes, and Obesity (2013).", "to": "overdiagnosis of prostate cancer", "width": 1.0}, {"from": "kumar", "title": "In a US double-blind study with 39 men with prostate cancer, there was no significant difference in free or total PSA between the group consuming isoflavones and the placebo group.", "to": "placebo", "width": 1.0}, {"from": "kumar, n.b.", "title": "The specific role of iso\ufb02avones in reducing prostate cancer risk.", "to": "prostate cancer", "width": 1.0}, {"from": "kumar, n.b.", "title": "The specific role of iso\ufb02avones in reducing prostate cancer risk.", "to": "prostate cancer risk", "width": 1.0}, {"from": "kumar, n.b.", "title": "The specific role of iso\ufb02avones in reducing prostate cancer risk.", "to": "prostate specific antigen", "width": 1.0}, {"from": "landberg", "title": "In a Swedish non-randomized study with 9 men with prostate cancer, total PSA was lower at 2 weeks in the group consuming 485 g of rye whole grain and bran products per day compared to the group consuming refined wheat products with added cellulose.", "to": "rye whole grain products", "width": 1.0}, {"from": "lcd", "title": "No di\ufb00erences were observed in the PSA concentrations between patients with prostate cancer initiating androgen deprivation therapy who followed a low-carbohydrate diet (\u226420g CHO/d) plus walking (\u226530 min for\u22655 d/wk) and those who followed their usual diet and exercise patterns", "to": "usual diet and exercise patterns", "width": 1.0}, {"from": "lcd", "title": "Serum PSA concentration was lower with the low-carbohydrate than the usual diet in patients with hyperlipidemia and prostate cancer", "to": "psa concentration", "width": 1.0}, {"from": "lcd", "title": "Patients with post-prostatectomy, at high risk for recurrence who followed a low-carbohydrate diet (\u226420g CHO/d) had no signi\ufb01cant changes in PSA compared to those who followed the USDA recommended diet (low-fat diet)", "to": "psa values did not di\ufb00er between groups", "width": 1.0}, {"from": "lfd", "title": "The study tested the effectiveness of an LFD, with a high fiber content, among men at high risk for PCa recurrence after prostatectomy.", "to": "prostate study 2 (caps2)", "width": 1.0}, {"from": "lfd", "title": "The study tested the effectiveness of an LFD, with a high fiber content and supplemented with soy, among men at high risk for PCa recurrence after prostatectomy.", "to": "li et al. [ 219]", "width": 1.0}, {"from": "lfd", "title": "failed to reveal di \ufb00erences in the PSA concentrations of men receiving intensive counseling for an LFD, compared with those receiving the standard brochure on what is considered as a \u2018healthy\u2019 diet, for two years", "to": "standard brochure on what is considered as a \u2018healthy\u2019 diet", "width": 1.0}, {"from": "lfd", "title": "Eastham found no di\ufb00erence in serum PSA concentrations by dietary intervention, but the study compared an LFD high in fiber, fruits, and vegetables to a usual diet.", "to": "usual diet", "width": 1.0}, {"from": "lfd", "title": "Patients with post-prostatectomy, at high risk for recurrence who followed a low-carbohydrate diet (\u226420g CHO/d) had no signi\ufb01cant changes in PSA compared to those who followed a low-fat diet (15% fat)", "to": "low-carbohydrate diet", "width": 1.0}, {"from": "li et al. [ 219]", "title": "The study tested the effectiveness of an LFD, with a high fiber content and supplemented with soy, among men at high risk for PCa recurrence after prostatectomy.", "to": "soy", "width": 1.0}, {"from": "linseed", "title": "participants consumed bread with a similar soy grits content plus", "to": "plus 20 g of linseed", "width": 1.0}, {"from": "linseed", "title": "While linseed was used as a supplement in one of the RCTs, the control group received no intervention.", "to": "none", "width": 1.0}, {"from": "localized prostate cancer", "title": "study mentioned in Oncotarget (2020) where the relationship between localized prostate cancer and patients is described", "to": "patients", "width": 1.0}, {"from": "long-chain n-6 fatty acids", "title": "enhances prostate tumor cell growth according to animal studies", "to": "prostate tumor cell growth", "width": 1.0}, {"from": "low carbohydrate diets", "title": "In the carbohydrate and prostate study 1 (CAPS1) [ 217], Freedland et al. decided to examine the Warburg e \ufb00ect [214] on men with PCa on androgen deprivation therapy. Participants either reduced the carbohydrate content of their diets and increased their physical activity level, or retained their usual diet, for 6 months. No di \ufb00erences were exhibited in the PSA concentrations of participants in the intervention, or usual diet arms.", "to": "pca", "width": 1.0}, {"from": "low impact on mortality", "title": "Low impact of PSA screening on mortality in context", "to": "psa screening", "width": 1.0}, {"from": "low meat /dairy diet", "title": "did not affect", "to": "psa concentrations at 6 months post-intervention", "width": 1.0}, {"from": "low-carbohydrate diet", "title": "No di\ufb00erences were observed in the PSA concentrations between patients with prostate cancer initiating androgen deprivation therapy who followed a low-carbohydrate diet (\u226420g CHO/d) plus walking (\u226530 min for\u22655 d/wk) and those who followed their usual diet and exercise patterns", "to": "usual diet and exercise patterns", "width": 1.0}, {"from": "low-carbohydrate diet", "title": "Patients with post-prostatectomy, at high risk for recurrence who followed a low-carbohydrate diet (\u226420g CHO/d) supplemented with 40 g soy protein and had individual counseling sessions had no signi\ufb01cant changes in PSA compared to those who followed the USDA recommended diet", "to": "psa values did not di\ufb00er between groups", "width": 1.0}, {"from": "lower urinary tract symptoms", "title": "In the study by Foster et al. (2011), increasing doses of saw palmetto extract were found to have an effect on lower urinary tract symptoms, which is a set of medical conditions related to difficulty in passing urine.", "to": "saw palmetto extract", "width": 1.0}, {"from": "lower-dose walnut supplementation", "title": "Failed to reduce PSA among middle-aged men following a 6-month cross-over study with a 4-week washout interval and 35 g/d of walnuts", "to": "psa concentrations", "width": 1.0}, {"from": "lycopene", "title": "According to a meta-analysis of case-control studies, a relationship between high serum lycopene concentration and PCa risk could not be suggested.", "to": "pca risk", "width": 1.0}, {"from": "lycopene", "title": "According to a recent systematic review of in vivo and in vitro studies, lycopene supplementation appears to have null or little effect on androgen-related outcomes due to the inconsistent findings of the primary studies. However, some reports suggest that most of the reported significant effects of lycopene on PSA concentrations stem from observational studies.", "to": "psa concentrations", "width": 1.0}, {"from": "lycopene", "title": "Orchidectomy + lycopene ONS started on the orchidectomy day (2\u00d72 mg /d) is associated with a reduction in PSA at 6 months, and at 2 years, higher PSA concentrations are seen in both arms, but more men on lycopene had a complete PSA response.", "to": "psa concentrations among men with pca, increased pca risk, or bph", "width": 1.0}, {"from": "lycopene", "title": "decreased PSA concentrations observed in intervention group receiving lycopene supplementation in primary prevention level for men with histologically proven BPH, free of PCa. However, a Cochrane version and systematic review failed to determine any statistical difference in PSA concentrations between men receiving lycopene and placebo supplementation for PCa.", "to": "psa", "width": 1.0}, {"from": "lycopene", "title": "lack of e\ufb00ectiveness observed among studies on humans is also corroborated by systematic reviews of in vitro and animal studies, indicating that lycopene appears to be more of hype rather than hope for PCa.", "to": "pca", "width": 1.0}, {"from": "lycopene", "title": "Lycopene supplementation RCTs are highly heterogeneous in terms of design, included subjects, and administered dosage.", "to": "rcts", "width": 1.0}, {"from": "lycopene", "title": "In the PROCOMB trial, supplementation with lycopene for a year according to did not alter PSA compared with tamsulosin.", "to": "procomb trial", "width": 1.0}, {"from": "lycopene", "title": "In a comparison of green tea against placebo, lycopene-rich foods, or lycopene capsules, saw palmetto, selenium, and lycopene ONS was compared with no intervention, a reduction in PSA concentrations was reported after 6 months of supplementation.", "to": "no intervention", "width": 1.0}, {"from": "lycopene", "title": "Lycopene has been examined in several PCa-RCTs, specifically in a tertiary prevention placebo-controlled trial that demonstrated an increase in PSA doubling time among men with a history of PCa and rising PSA post-radical prostatectomy or radiotherapy.", "to": "pca-rcts", "width": 1.0}, {"from": "lycopene", "title": "Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression (context: 46)", "to": "prostate cancer", "width": 1.0}, {"from": "lycopene", "title": "A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk (context: 48)", "to": "lycopene supplementation", "width": 1.0}, {"from": "lycopene", "title": "According to a systematic review by Ilic and Forbes (2011) and Applegate et al. (2019), lycopene may have a preventive effect against prostate cancer.", "to": "prostate cancer prevention", "width": 1.0}, {"from": "lycopene", "title": "A study by Schwarz et al. (2008) found that lycopene may slow disease progression in patients with benign prostatic hyperplasia, which could potentially benefit those undergoing radical prostatectomy.", "to": "prostate cancer treatment", "width": 1.0}, {"from": "lycopene", "title": "A systematic review and meta-analysis by Chen et al. (2015) found that lycopene intake may decrease the risk of prostate cancer.", "to": "primary prevention of prostate cancer", "width": 1.0}, {"from": "lycopene", "title": "Ledesma et al. (2019) discussed the potential synergistic effects of lycopene, selenium, and vitamin E on prostate health.", "to": "selenium and vitamin e", "width": 1.0}, {"from": "lycopene (15 mg)", "title": "Supplementation with lycopene (15 mg) for 6 months did not show any significant difference in PSA concentrations between treatment arms.", "to": "psa concentrations among men with pca, increased pca risk, or bph", "width": 1.0}, {"from": "lycopene (15 mg)", "title": "Supplementation with lycopene (15 mg) for approximately 30 days before prostatectomy does not show any significant difference in PSA concentrations between treatment arms.", "to": "psa", "width": 1.0}, {"from": "lycopene (30 mg)", "title": "Supplementation with lycopene (30 mg) for 6 months did not show any significant difference in PSA concentrations between treatment arms.", "to": "psa concentrations among men with pca, increased pca risk, or bph", "width": 1.0}, {"from": "lycopene (30 mg)", "title": "Supplementation with lycopene (30 mg) for approximately 30 days before prostatectomy does not show any significant difference in PSA concentrations between treatment arms.", "to": "psa", "width": 1.0}, {"from": "lycopene ons", "title": "Consumption of lycopene ONS started on the orchidectomy day (2\u00d72 mg /d) is associated with a reduction in PSA at 6 months, and at 2 years, higher PSA concentrations are seen in both arms, but more men on lycopene had a complete PSA response.", "to": "psa concentrations among men with pca, increased pca risk, or bph", "width": 1.0}, {"from": "lycopene supplementation", "title": "Effects of lycopene supplementation in patients with localized prostate cancer (context: 49)", "to": "prostate cancer", "width": 1.0}, {"from": "lycopene-combined therapies", "title": "men with PCa failed to experience changes in PSA concentrations after 3 weeks of intervention", "to": "pca following their usual diet", "width": 1.0}, {"from": "lycopene-rich foods (unblinded)", "title": "PSA concentrations did not differ between lycopene, green tea, or placebo groups at 6 months.", "to": "lycopene (15 mg /d) caps (blinded)", "width": 1.0}, {"from": "malignancy", "title": "PCa is a type of malignancy that affects the prostate gland.", "to": "pca", "width": 1.0}, {"from": "maria g. grammatikopoulou", "title": "Co-authors", "to": "stefanos t. papageorgiou", "width": 1.0}, {"from": "marine fatty acid supplementation", "title": "Aucoin et al. conducted a systematic review examining the effects of marine fatty acid supplementation on PCa risk based on RCTs, which reported no impact on PSA concentrations among patients with PCa, although some RCTs reported a decrease in inflammatory or other cancer markers.", "to": "pca risk", "width": 1.0}, {"from": "marine fatty acid supplementation", "title": "Based on RCTs, intake of fish oil had no impact on PSA concentrations among patients with PCa, according to Aucoin et al.\u0027s systematic review.", "to": "psa concentrations", "width": 1.0}, {"from": "mc", "title": "Patients with lower urinary tract symptoms (LUTS) and multi-county (MC) locations are at a higher risk of developing prostate cancer (PCa), as LUTS may be a symptom of PCa, and MC locations have been associated with increased PCa incidence.", "to": "pca", "width": 1.0}, {"from": "mc", "title": "The presence of multifocal high grade prostatic intraepithelial neoplasia (mHGPIN) in men with lower urinary tract symptoms and multi-county (MC) locations may indicate a higher risk of developing PCa, as mHGPIN is associated with an increased risk of PCa.", "to": "mhgpin", "width": 1.0}, {"from": "meat and dairy products", "title": "For many years, meat and dairy products were considered as possible etiological factors of cancer. In the study by H\u00e9bert et al., men treated by either prostatectomy, or radiation therapy were randomized to a healthy, low meat /dairy diet.", "to": "pca", "width": 1.0}, {"from": "medicinal mushrooms", "title": "Medicinal mushrooms, such as Agaricus blazei Murill and Ganoderma lucidum, have postulated efficacy stemming from direct tumor attack capacities, indirect defense, and T helper cell (Th) 1 immune response in oncology models.", "to": "th", "width": 1.0}, {"from": "men", "title": "Identifying men most likely to have elevated levels of PSA can help in the early detection and management of PCa.", "to": "psa", "width": 1.0}, {"from": "men", "title": "Most RCTs suggested a lack of efficacy of vitamin D ONS in reducing PSA concentrations among men harboring PCa.", "to": "pca", "width": 1.0}, {"from": "men at high risk of developing prostate cancer", "title": "As mentioned in Carter et al. (2013), regular prostate-specific antigen (PSA) tests are recommended for men at high risk of developing prostate cancer.", "to": "prostate cancer", "width": 1.0}, {"from": "men at high risk of developing prostate cancer", "title": "According to Carter et al. (2013), regular prostate-specific antigen (PSA) tests are recommended for men at high risk of developing prostate cancer.", "to": "regular psa tests", "width": 1.0}, {"from": "men electing active surveillance for localized prostate cancer", "title": "A randomized controlled trial explored the feasibility outcomes of a presurgical intervention involving caloric restriction and increased physical activity in men electing prostatectomy for prostate cancer (Mohamad et al., 2016). This study did not include men electing active surveillance for localized prostate cancer.", "to": "prostate cancer", "width": 1.0}, {"from": "men on androgen deprivation therapy", "title": "Approximately 100 years ago, Otto Warburg noted that tumors demonstrate a tendency to metabolize glucose anaerobically, even when oxygen availability is adequate [ 214]. To reverse this phenomenon and subsequently, inhibit tumor growth in a multicellular environment, the intake of low carbohydrate diets was proposed as a hypothesis, based mainly on results from animal studies [ 215,216], for men with PCa on androgen deprivation therapy.", "to": "pca", "width": 1.0}, {"from": "men with biochemical recurrence of prostate cancer", "title": "Studies have shown that plasma carotenoids and tocopherols in relation to PSA levels are associated with men with biochemical recurrence of prostate cancer. (Antwi et al., 2015)", "to": "psa levels", "width": 1.0}, {"from": "men with histologic evidence of progressive androgen-independent pca", "title": "The text describes a clinical trial in which men with advanced PCa received mixed antioxidant supplementation.", "to": "mixed antioxidant supplementation", "width": 1.0}, {"from": "men with localized prostate cancer", "title": "A randomized controlled trial explored the feasibility outcomes of a presurgical intervention involving caloric restriction and increased physical activity in men electing prostatectomy for prostate cancer (Mohamad et al., 2016). This study did not include men with localized prostate cancer who were undergoing active surveillance.", "to": "prostate cancer", "width": 1.0}, {"from": "men with lower urinary tract symptoms (luts), elevated psa, but negative prostate biopsy [122]", "title": "occurs in this context", "to": "reduction in psa after 6 months of daily intake", "width": 1.0}, {"from": "men with metastatic castration-resistant prostate cancer", "title": "Brinkman et al. (2019) reported that high-grade Gleason scores and advanced stage disease at diagnosis are associated with an increased risk of metastatic progression in men undergoing radical prostatectomy.", "to": "prostate cancer", "width": 1.0}, {"from": "men with newly diagnosed prostate cancer", "title": "A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer was conducted (Wright et al., 2013).", "to": "prostate cancer", "width": 1.0}, {"from": "men with pca", "title": "Daily consumption of green tea on the weeks preceding prostatectomy induced a significant reduction in PSA compared with black tea, or water drinkers among men with PCa", "to": "psa", "width": 1.0}, {"from": "men with prostate cancer", "title": "This study focused on biomarkers in men with prostate cancer (Villanueva et al., 2017).", "to": "prostate cancer", "width": 1.0}, {"from": "men with prostate cancer", "title": "study in Journal of Nutrition (2010) where the relationship between rye whole grain and bran intake and men with prostate cancer is investigated", "to": "rye whole grain and bran intake", "width": 1.0}, {"from": "menadione", "title": "For group 1, the rise of PSA at d-15 and the fall of PSA at d 22, 29, 36, and 42 were different compared with the controls.", "to": "vitamin c", "width": 1.0}, {"from": "mixed antioxidant therapy", "title": "does not influence PSA concentrations on the primary, secondary, or tertiary prevention levels", "to": "psa concentrations", "width": 1.0}, {"from": "mixed supplementation with broccoli powder, curcumin, pomegranate, and green tea extract", "title": "induced a lower rise in PSA in the intervention compared with the placebo group", "to": "pca after 6 months", "width": 1.0}, {"from": "mol. nutr. food res.", "title": "This paper presents a meta-analysis examining the relationship between inflammation and nutrition.", "to": "meta-analysis", "width": 1.0}, {"from": "mushroom immunology", "title": "Mushroom immunology, specifically using extracts from the Agaricus blazei Murill or the Ganoderma lucidum mushroom, has been examined in a study involving men with biochemical failure after radical treatment for non-metastasized PCa, but did not induce a di\ufb00erent PSA response.", "to": "pca-rcts", "width": 1.0}, {"from": "mv", "title": "Consumption of MV (n=39) during the first month led to a decline in PSA concentrations, but by month 4, the PSA response was identical in both groups.", "to": "psa concentrations among men with pca, increased pca risk, or bph", "width": 1.0}, {"from": "negri, m.", "title": "Vitamin D-Induced Molecular Mechanisms to Potentiate Cancer Therapy and to Reverse Drug-Resistance in Cancer Cells.", "to": "vitamin d", "width": 1.0}, {"from": "no di \ufb00erences were noted in the psa concentrations of participants in both groups", "title": "Aronson [213]", "to": "pca", "width": 1.0}, {"from": "no intervention", "title": "Combined ONS of saw palmetto, quercetin, and \u03b2-sitosterol was also ine \ufb03cient in reducing PSA concentrations.", "to": "saw palmetto", "width": 1.0}, {"from": "non-prescribed antioxidant supplements", "title": "should be taken before consuming", "to": "psa concentrations", "width": 1.0}, {"from": "ns", "title": "In some cases, prostatic chronic inflammation (PCI) may not significantly impact the progression of prostate cancer (PCa), as indicated by the term \u0027not significant\u0027 (NS).", "to": "pci", "width": 1.0}, {"from": "nutrients", "title": "Influencing", "to": "psa concentrations", "width": 1.0}, {"from": "nutrients 2020", "title": "In Table 3, Nutrients 2020 presents RCTs examining the effect of curcumin ONS on PSA concentrations among men with PCa.", "to": "randomized controlled trials (rcts)", "width": 1.0}, {"from": "nutrients 2020", "title": "The article \u0027Nutrients 2020\u0027 includes a table called \u0027Table 4\u0027.", "to": "table 4.", "width": 1.0}, {"from": "nutrients 2020", "title": "Relationship between Nutrients 2020 and PCa in the context, as both are mentioned in relation to each other.", "to": "pca", "width": 1.0}, {"from": "obese men", "title": "The text suggests that when obese men are concerned, their PSA concentrations should be corrected by multiplying them by 13% for more accurate results in PCa diagnosis.", "to": "psa concentrations", "width": 1.0}, {"from": "obesity", "title": "Fowke et al. (2006) found that obesity is associated with higher PSA levels in both African-American and Caucasian men.", "to": "prostate-specific antigen (psa)", "width": 1.0}, {"from": "obesity", "title": "Obesity-Related Plasma Hemodilution and PSA Concentration Among Men With Prostate Cancer", "to": "psa concentration", "width": 1.0}, {"from": "olivares-galv\u00e1n", "title": "In this study, Olivares-Galv\u00e1n and Marina investigated the extraction and characterization of antioxidant peptides from fruit residues.", "to": "marina", "width": 1.0}, {"from": "one in seven men undergoing psa screening demonstrates increased concentrations", "title": "Increased concentrations of PSA observed in one out of seven men undergoing PSA screening in context", "to": "psa concentrations", "width": 1.0}, {"from": "oral curcumin", "title": "In Table 3, Choi et al. Compared oral curcumin (1.44 g /d) to placebo in a double-blind study.", "to": "placebo", "width": 1.0}, {"from": "overdiagnosis of prostate cancer", "title": "The concept of overdiagnosis of prostate cancer was discussed by Sandhu and Andriole in a publication in The Journal of the National Cancer Institute Monographs series (2012).", "to": "sandhu and andriole (2012)", "width": 1.0}, {"from": "overweight men", "title": "Nevertheless, in the first RCT, although a tendency for increased PSA concentrations was noted among intervention participants, in parallel, Ki67 proliferation rates were also greater post-intervention compared with the controls, indicating that more studies are required before recommending rapid weight loss among obese patients with PCa.", "to": "psa concentrations", "width": 1.0}, {"from": "paller, c.j.", "title": "A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer.", "to": "rising psa levels", "width": 1.0}, {"from": "pantuck", "title": "this refers to the condition where the level of PSA increases in men who have undergone treatment for prostate cancer", "to": "rising psa concentrations after primary pca therapy", "width": 1.0}, {"from": "pantuck, a.j.", "title": "A randomized, double-blind, placebo-controlled study of the e \ufb00ects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer.", "to": "psa levels", "width": 1.0}, {"from": "pca", "title": "Several antioxidants, including lycopene, selenium, curcumin, coenzyme Q10, phytoestrogens (including isoflavones and flavonoids), green tea catechins, cernitin, vitamins (C, E, D) and multivitamins, medicinal mushrooms (Ganoderma lucidum ), fruit extracts (saw palmetto, cranberries, pomegranate), walnuts and fatty acids, as well as combined supplementations of all, have been examined in randomized controlled trials (RCTs) in humans, on the primary, secondary, and tertiary PCa prevention level.", "to": "supplements", "width": 1.0}, {"from": "pca", "title": "The mean PSADT for the intervention participants was substantially longer in the control group with no change found in the rate of PSA increase between the two groups, but the incidence of PCa at 4 yrs was similar.", "to": "psa", "width": 1.0}, {"from": "pca", "title": "Prostatic intraepithelial neoplasia (PIN) is a precancerous condition that affects the prostate gland and can potentially lead to PCa.", "to": "prostatic intraepithelial neoplasia", "width": 1.0}, {"from": "pca", "title": "Bylund compared rye bran with wheat bread consumption among men with conservatively treated PCa and failed to report significant changes between intervention arms.", "to": "rye bran", "width": 1.0}, {"from": "pca", "title": "postulated to be a promising plant for in vivo studies, but RCTs on patients with BPH failed to reduce PSA concentrations compared with placebo or no comparator", "to": "serenoa repens", "width": 1.0}, {"from": "pca", "title": "Relationship between Vitis vinifera and PCa in the context, as both are mentioned in relation to each other because of their antioxidant content.", "to": "vitis vinifera", "width": 1.0}, {"from": "pca", "title": "Relationship between POMx and PCa in the context, as both are mentioned in relation to each other due to their postulated anticancer effects.", "to": "pomx", "width": 1.0}, {"from": "pca", "title": "PCa consumed saw palmetto, selenium, and lycopene according to the PROCOMB trial for a year.", "to": "procomb trial", "width": 1.0}, {"from": "pca", "title": "The study on men previously treated for PCa and their partners did not reveal any differences in the PSA concentrations between groups receiving a combined intervention including dietary modifications, increased physical activity and stress-reduction or standard care.", "to": "psa concentrations", "width": 1.0}, {"from": "pca", "title": "PIN is a precursor to PCa, as PIN lesions may progress to become prostate cancer over time.", "to": "pin", "width": 1.0}, {"from": "pca", "title": "The study on men previously treated for PCa and their partners did not reveal any differences in the PSA concentrations between groups receiving a combined intervention including dietary modifications, increased physical activity and stress-reduction or standard care. However, delivery of dietary and cooking classes for 3 months did not alter the rate of participants with increased PSA concentrations compared with no intervention, but e\ufb00ectively prolonged PSADT.", "to": "psadt", "width": 1.0}, {"from": "pca", "title": "Studies have shown that low levels of zinc (Zn) may be associated with an increased risk of PCa, as Zn has been found to inhibit the growth and development of PCa cells.", "to": "zn", "width": 1.0}, {"from": "pca", "title": "Simon\u2021\n[199] US NR 6 months each arm (4 month washout). Origins: Simon\u2021.\nMasking: Not reported.\nDuration: 6 months.\nPatients: 40 middle-aged men.\nInterventions: Walnut consumption (35g/day, 12% TEI), n=40;\nNo ONS, n=40.\nResults: No difference observed in the PSA concentrations.", "to": "walnut consumption", "width": 1.0}, {"from": "pca", "title": "Spaccarotella\u2021\n[198] US NR 8 weeks n=21 men at risk for PCa.\nOrigins: Spaccarotella\u2021.\nMasking: Not reported.\nDuration: 8 weeks.\nPatients: 21 men at risk for PCa.\nInterventions: Usual diet +walnut ONS (75g/day), n=21;\nUsual diet, no ONS, n=21.\nResults: Linear mixed model revealed that, although PSA was unchanged, the ratio of free:total PSA was increased.", "to": "usual diet +walnut ons", "width": 1.0}, {"from": "pca", "title": "In a subsequent trial, Aronson et al. [ 213] examined the e \ufb00ect of a high-\ufb01ber LFD against the typical Western diet among men who had not received prior therapy for PCa. A lack of signi\ufb01cance was noted concerning PSA concentrations of participants, 4 weeks after the trial.", "to": "typical western diet", "width": 1.0}, {"from": "pca", "title": "The study on men previously treated for PCa and their partners did not reveal any differences in the PSA concentrations between groups receiving a combined intervention including dietary modifications, increased physical activity and stress-reduction or standard care.", "to": "prostatectomy", "width": 1.0}, {"from": "pca", "title": "The study on men previously treated for PCa and their partners did not reveal any differences in the PSA concentrations between groups receiving a combined intervention including dietary modifications, increased physical activity and stress-reduction or standard care.", "to": "radiation", "width": 1.0}, {"from": "pca", "title": "The study on men previously treated for PCa and their partners did not reveal any differences in the PSA concentrations between groups receiving a combined intervention including dietary modifications, increased physical activity and stress-reduction or standard care.", "to": "recurrence", "width": 1.0}, {"from": "pca", "title": "Aronson\u2020[212]", "to": "radical prostatectomy", "width": 1.0}, {"from": "pca diagnosis", "title": "The text states that the reduction in PSA with increasing body weight might influence PCa diagnosis, implying a relation between PSA and PCa diagnosis.", "to": "psa", "width": 1.0}, {"from": "pca following their usual diet", "title": "failed to experience changes in after 3 weeks of intervention", "to": "tomato products containing 30 mg of lycopene or tomato products plus selenium, n-3 fatty acids, soy iso\ufb02avones, grape /pomegranate juice, and green /black tea", "width": 1.0}, {"from": "pca following their usual diet", "title": "did not alter PSA concentrations compared with the placebo", "to": "supplementation with soy protein, vitamin e, and selenium for 3 years", "width": 1.0}, {"from": "pca incidence", "title": "vitamin E supplementation was associated with an increased PCa risk, leading to the termination of the trial for ethical reasons and subsequent continuation of the study in an observational manner [ 174]", "to": "selenium ons", "width": 1.0}, {"from": "pca prevention", "title": "A placebo group (n=22) was also included in the study to compare with GTCs for PCa prevention, but no significant results were observed.", "to": "placebo", "width": 1.0}, {"from": "pca risk", "title": "According to meta-analyses of case-control studies, men with high serum selenium concentrations appear to have an inverse PCa risk, suggesting a possible protective role.", "to": "selenium", "width": 1.0}, {"from": "pca risk", "title": "lack of correlation or association", "to": "serum 25(oh)d concentrations", "width": 1.0}, {"from": "pca-mortality", "title": "Meta-analyses suggest that increased serum 25(OH)D concentrations are associated with reduced mortality risk among patients with PCa, indicating a possible mediating effect of vitamin D beyond circulating PSA concentrations. This association between 25(OH)D and PCa-mortality has also been observed in meta-analyses for PCa, suggesting its significance as a factor affecting PCa outcomes.", "to": "retropubic prostatectomy", "width": 1.0}, {"from": "pca-rcts", "title": "Silymarin is a milk thistle flavonolignan mixture that has been examined in several PCa-RCTs.", "to": "silymarin", "width": 1.0}, {"from": "pca-rcts", "title": "Soy has been examined in several PCa-RCTs, specifically in a tertiary prevention placebo-controlled trial that demonstrated an increase in PSA doubling time among men with a history of PCa and rising PSA post-radical prostatectomy or radiotherapy.", "to": "soy", "width": 1.0}, {"from": "persistent elevated psa concentrations", "title": "Follow-up of persistent elevated PSA concentrations with prostate biopsy and diagnostic imaging in context", "to": "prostate biopsy and diagnostic imaging", "width": 1.0}, {"from": "phytoestrogen ons", "title": "Both phytoestrogen oral nutritional supplements and soy isoflavones are dietary supplements derived from plant sources that contain estrogenic compounds.", "to": "soy isoflavones", "width": 1.0}, {"from": "placebo", "title": "double-blind 12 wks trial in n=119 patients with BPH", "to": "vitamin d3 analog", "width": 1.0}, {"from": "placebo", "title": "The PREVENT trial compared 400 IU vitamin E ONS with placebo among men with elevated PSA and /or abnormal digital rectal examination (DRE) on the baseline evaluation. Tocopherol supplementation for 18 months did not alter PSA concentrations.", "to": "prevent trial", "width": 1.0}, {"from": "placebo group", "title": "More frequent in the placebo group than the intervention arm (sulforaphane ONS)", "to": "psa increases \u003e20% at 6 months", "width": 1.0}, {"from": "placebo groups", "title": "During the trial, which lasted for a total of 28 days, the expression of PSA in adenocarcinoma did not differ between intervention and placebo groups.", "to": "trial", "width": 1.0}, {"from": "plant derived bioactive compounds", "title": "Poulsen et al. (2020) conducted a systematic review and meta-analysis to examine the anti-inflammatory effects of plant derived bioactive compounds.", "to": "poulsen et al. (2020)", "width": 1.0}, {"from": "polye", "title": "No di\ufb00erence was noted in PSA concentrations between groups.", "to": "psa concentrations", "width": 1.0}, {"from": "polyphenols", "title": "Resveratrol is a type of polyphenol found in grapes and red wine that has been studied for its potential cancer-preventive effects, but the evidence supporting its effectiveness is inconclusive.", "to": "resveratrol", "width": 1.0}, {"from": "pomx", "title": "POMx is a dietary supplement containing polyphenols, and this element describes the quantity consumed in the study", "to": "8 oz liquid pomx", "width": 1.0}, {"from": "pomx pills", "title": "Freedland et al. (2013) carried out a double-blind, randomized, neoadjuvant study exploring the tissue effects of POMx pills in men with prostate cancer before undergoing radical prostatectomy.", "to": "prostate cancer before radical prostatectomy", "width": 1.0}, {"from": "pow-sang, j.", "title": "Results of a randomized phase I dose-finding trial of several doses of iso\ufb02avones in men with localized prostate cancer: Administration prior to radical prostatectomy.", "to": "prostate cancer", "width": 1.0}, {"from": "prevent trial", "title": "The PREVENT trial compared 400 IU vitamin E ONS with placebo among men with elevated PSA and /or abnormal digital rectal examination (DRE) on the baseline evaluation. Tocopherol supplementation for 18 months did not alter PSA concentrations.", "to": "psa", "width": 1.0}, {"from": "prevent trial", "title": "The PREVENT trial compared 400 IU vitamin E ONS with placebo among men with elevated PSA and /or abnormal digital rectal examination (DRE) on the baseline evaluation. Tocopherol supplementation for 18 months did not alter PSA concentrations.", "to": "tocopherol supplementation", "width": 1.0}, {"from": "promotion and progression", "title": "Progress in prostate cancer chemoprevention: Modulators of promotion and progression (context: 45)", "to": "prostate cancer", "width": 1.0}, {"from": "prostate cancer", "title": "Carter et al. (2013) recommend regular prostate-specific antigen (PSA) tests for prostate cancer screening in high-risk populations.\nIlic et al. (2013) conducted a systematic review and meta-analysis that showed the effectiveness of PSA tests in diagnosing and managing prostate cancer.\nNational Institute of Healthcare and Excellence (NICE) (2019) released guidelines for the diagnosis and management of prostate cancer, which include PSA testing as part of the diagnostic process.\nIlic and Neuberger (2013) also recommended regular PSA tests for men at high risk of developing prostate cancer in their Cochrane review.\nMartin et al. (2020) discussed the use of PSA tests in the context of localized prostate cancer screening, as outlined by Institute for Quality and Efficacy in Health Care (IQWiG) (2020).", "to": "psa test", "width": 1.0}, {"from": "prostate cancer", "title": "Carter et al. (2013), Ilic et al. (2013), National Institute of Healthcare and Excellence (NICE) (2019), and Martin et al. (2020) all recommend regular prostate-specific antigen (PSA) tests for the diagnosis and management of prostate cancer.", "to": "regular psa tests", "width": 1.0}, {"from": "prostate cancer", "title": "The CAP randomized clinical trial found that a low-intensity PSA-based screening intervention for prostate cancer resulted in a decrease in prostate cancer mortality, as reported in JAMA (Martin et al., 2018).", "to": "psa-based screening intervention", "width": 1.0}, {"from": "prostate cancer", "title": "Brinkman et al. (2019) reported that high-grade Gleason scores and advanced stage disease at diagnosis are associated with an increased risk of metastatic progression in men undergoing radical prostatectomy.", "to": "prostatectomy for prostate cancer", "width": 1.0}, {"from": "prostate cancer", "title": "Studies have investigated the association between selenium and prostate cancer risk. Meta-analyses have found a possible inverse association, but the results are not consistent across studies. Further research is needed to confirm this potential protective effect of selenium against prostate cancer.", "to": "selenium", "width": 1.0}, {"from": "prostate cancer", "title": "The SELECT trial, a large clinical trial investigating the effects of selenium and vitamin E on prostate cancer prevention, did not find significant differences in prostate cancer incidence between the two supplement groups. However, some subgroup analyses suggested that men with low baseline serum selenium levels may benefit from selenium supplementation, whereas those with high vitamin E intake may have increased risk of prostate cancer.", "to": "vitamin e", "width": 1.0}, {"from": "prostate cancer", "title": "short-term intervention pilot study in European Journal of Cancer Prevention (2003) where the relationship between rye bran bread and prostate cancer is studied", "to": "rye bran bread", "width": 1.0}, {"from": "prostate cancer", "title": "Can Iso\ufb02avones Influence Prostate Specific Antigen Serum Levels in Localized Prostate Cancer? A Systematic Review.", "to": "ratha, p.", "width": 1.0}, {"from": "prostate cancer", "title": "Results of a randomized phase I dose-finding trial of several doses of iso\ufb02avones in men with localized prostate cancer: Administration prior to radical prostatectomy.", "to": "xu, p.", "width": 1.0}, {"from": "prostate cancer", "title": "Vitamin D in prostate cancer.", "to": "trump, d.l.", "width": 1.0}, {"from": "prostate cancer", "title": "Studies have shown associations between circulating 25-hydroxyvitamin D and vitamin D pathway genes with PSA progression in men with localized prostate cancer undergoing active monitoring, as well as dose-response meta-analyses demonstrating a correlation between vitamin D concentration and prostate cancer risk. (Gilbert et al., 2013; Antwi et al., 2015; Gao et al., 2018)", "to": "psa levels", "width": 1.0}, {"from": "prostate cancer", "title": "Studies have shown associations between circulating 25-hydroxyvitamin D and vitamin D pathway genes with PSA progression in men with localized prostate cancer undergoing active monitoring, as well as dose-response meta-analyses demonstrating a correlation between vitamin D concentration and prostate cancer risk. (Gilbert et al., 2013; Antwi et al., 2015; Gao et al., 2018)", "to": "vitamin d concentration", "width": 1.0}, {"from": "prostate cancer cells sensitivity to cisplatin", "title": "Bostan et al. (2020) observed that resveratrol or curcumin did not affect the sensitivity of head and neck cancer cells to cisplatin.", "to": "resveratrol", "width": 1.0}, {"from": "prostate cancer overdiagnosis", "title": "Klotz (2013) discussed the issue of prostate cancer overdiagnosis and its associated overtreatment.", "to": "overtreatment", "width": 1.0}, {"from": "prostate size", "title": "Remained unchanged in Kjaer [99] study", "to": "serum psa concentrations", "width": 1.0}, {"from": "prostate specific antigen", "title": "Can Iso\ufb02avones Influence Prostate Specific Antagen Serum Levels in Localized Prostate Cancer? A Systematic Review.", "to": "ratha, p.", "width": 1.0}, {"from": "prostate specific antigen", "title": "According to the analysis by Andriole et al. (2013), increasing doses of saw palmetto fruit extract were found to have an effect on serum prostate specific antigen, which is a protein that can be used as a biomarker for prostate cancer.", "to": "saw palmetto fruit extract", "width": 1.0}, {"from": "prostate volume", "title": "Kjaer et al. (2015) also reported that resveratrol had no effect on prostate volume in middle-aged men.", "to": "resveratrol", "width": 1.0}, {"from": "prostate-specific antigen", "title": "Maskarinec et al. (2006) found that 4 months of resveratrol supplementation did not affect serum prostate-specific antigen levels in men.", "to": "resveratrol", "width": 1.0}, {"from": "prostatectomyn", "title": "Both RCTs and prostatectomyn refer to clinical trials involving the removal of the prostate gland due to cancer or other medical conditions.", "to": "rcts", "width": 1.0}, {"from": "psa", "title": "Consumption of tomato extract (30 mg of lycopene) for 3 weeks until prostatectomy is associated with lower PSA concentrations in the intervention group.", "to": "tomato extract", "width": 1.0}, {"from": "psa", "title": "Consumption of tomato extract (30 mg of lycopene) for 3 weeks until prostatectomy is associated with lower PSA concentrations in the intervention group.", "to": "tomato extract (30 mg of lycopene)", "width": 1.0}, {"from": "psa", "title": "Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen", "to": "psa", "width": 1.0}, {"from": "psa", "title": "Remained unchanged in Adams [98] study", "to": "serum psa concentrations", "width": 1.0}, {"from": "psa", "title": "indicates an inverse relationship in some cross-sectional, nested case-control or retrospective studies examining associations between serum 25-hydroxyvitamin D concentrations and PSA", "to": "serum 25-hydroxyvitamin d (25(oh)d)", "width": 1.0}, {"from": "psa", "title": "Most RCTs suggested a lack of efficacy of vitamin D ONS in reducing PSA concentrations among men harboring PCa.", "to": "trials", "width": 1.0}, {"from": "psa", "title": "According to the Selenium and Vitamin E Cancer Prevention Trial (SELECT) however, comparing selenium to vitamin E, a combination of both, or placebo, longitudinal vitamin E ONS increased PCa risk by 17% within 7 years, without inducing significant changes in PSA concentrations.", "to": "select trial", "width": 1.0}, {"from": "psa", "title": "Similarly, no differences were noted when men with suspected PCa consumed saw palmetto, selenium, and lycopene or tamsulosin for a year according to the", "to": "saw palmetto, selenium, and lycopene or tamsulosin", "width": 1.0}, {"from": "psa", "title": "In both groups, there was no significant difference in the mean changes of PSA levels after the intervention.", "to": "tamsulosin", "width": 1.0}, {"from": "psa", "title": "Combined supplementation with selenium failed to induce changes in PSA compared with placebo in a study involving men with biochemically recurrent PCa and rising PSA.", "to": "selenium", "width": 1.0}, {"from": "psa", "title": "was compared to a low fat /\ufb01sh oil (LFFO) diet among men scheduled for radical prostatectomy by Aronson et al. After 4\u20136 weeks", "to": "typical western diet", "width": 1.0}, {"from": "psa concentrations", "title": "Relation between PSA concentrations and men remaining asymptomatic without experiencing PCa-specific mortality in context", "to": "remain asymptomatic", "width": 1.0}, {"from": "psa concentrations", "title": "Requirement of a second sample for verification purposes due to elevated PSA concentrations in context", "to": "second sample for verification purposes", "width": 1.0}, {"from": "psa concentrations", "title": "The context mentions that one RCT failed to induce any significant changes in PSA or BMI after a 50-day lifestyle intervention among men with PCa.", "to": "weight-loss", "width": 1.0}, {"from": "psa concentrations", "title": "Nevertheless, in the first RCT, although a tendency for increased PSA concentrations was noted among intervention participants, no PSA results were reported in either.", "to": "psa results", "width": 1.0}, {"from": "psa concentrations", "title": "No effect noted on PSA concentrations between intervention groups in men with high PSA concentrations.", "to": "soy protein beverages with high or low genistein and daidzein", "width": 1.0}, {"from": "psa concentrations", "title": "After 6 and 12 months of supplementation, saw palmetto did not have a significant effect on PSA concentrations.", "to": "saw palmetto", "width": 1.0}, {"from": "psa concentrations", "title": "Based on yet another Chinese meta-analysis, \u03b1-receptor blocker (\u03b1RB) was effective in reducing PSA compared with the combined therapy of tamsulosin and saw palmetto.", "to": "\u03b1-receptor blocker (\u03b1rb)", "width": 1.0}, {"from": "psa concentrations", "title": "During the trial, which lasted for a total of 28 days, the expression of PSA in adenocarcinoma did not differ between intervention and placebo groups.", "to": "trial", "width": 1.0}, {"from": "psa concentrations", "title": "The text mentions that the association between increased serum 25(OH)D concentrations and reduced PCa-mortality risk extends beyond circulating PSA concentrations, indicating a possible mediating effect of vitamin D on PCa outcomes.", "to": "retropubic prostatectomy", "width": 1.0}, {"from": "psa concentrations", "title": "In the primary prevention level, vitamin D analogs ONS failed to induce significant changes in PSA concentrations among men with BPH compared with placebo, indicating a possible lack of efficacy.", "to": "vitamin d analogs ons", "width": 1.0}, {"from": "psa concentrations", "title": "did not affect PCa incidence; however, vitamin E supplementation was associated with an increased PCa risk, leading to the termination of the trial for ethical reasons and subsequent continuation of the study in an observational manner [ 174]", "to": "selenium ons", "width": 1.0}, {"from": "psa concentrations", "title": "In a study by Paur [177], men with PCa who received tomato products (30 mg lycopene/d) did not show significant differences in PSA concentrations compared to the control group. In another study by Grainger [178], a reduction in % PSA concentrations was observed in both the tomato and soy groups, but no statistics were presented between groups.", "to": "tomato products", "width": 1.0}, {"from": "psa concentrations", "title": "Did not reduce PSA concentrations among men at risk for PCa following an 8-week dietary intervention with 75 g/d of walnuts", "to": "walnut supplementation", "width": 1.0}, {"from": "psa concentrations", "title": "was noted in the intervention group", "to": "reduction", "width": 1.0}, {"from": "psa concentrations", "title": "failed to change for men with biopsy-proven prostate adenocarcinoma and serum PSA concentrations not exceeding 10 ng /mL in the Men\u2019s Eating and Living (MEAL) study for a total of two years", "to": "telephone counseling promoting an increased vegetable intake", "width": 1.0}, {"from": "psa elevation following radical prostatectomy", "title": "Pound et al. (1999) discussed the natural history of progression after PSA elevation following radical prostatectomy.", "to": "progression after psa elevation following radical prostatectomy", "width": 1.0}, {"from": "psa levels", "title": "extraction from a study in Urology (2004) where the relationship between PSA levels and men with a history of prostate cancer is investigated", "to": "men with a history of prostate cancer", "width": 1.0}, {"from": "psa levels", "title": "Kjaer et al. (2015) reported that resveratrol did not affect prostate-specific antigen (PSA) levels in middle-aged men.", "to": "resveratrol", "width": 1.0}, {"from": "psa screening", "title": "Reduction in 10-year disease-specific mortality due to PSA screening in context", "to": "small reduction in 10-year disease-speci\ufb01c mortality", "width": 1.0}, {"from": "psa screening", "title": "Reduction in relative risk for PCa due to PSA screening in context", "to": "reduces relative risk for pca by 9%", "width": 1.0}, {"from": "psa screening", "title": "Stephan et al. (2014) discussed the relationship between PSA screening and new biomarkers for prostate cancer.", "to": "new biomarkers for prostate cancer", "width": 1.0}, {"from": "psadt", "title": "Both the total and the individual components of PSADT were mentioned in this context, indicating their relevance to PCa monitoring.", "to": "total psadt", "width": 1.0}, {"from": "psa\u22642.5ng /ml", "title": "in the intervention group, a significant reduction in PSA was observed.", "to": "se (240 \u00b5g)", "width": 1.0}, {"from": "randomized controlled trials", "title": "Based on", "to": "review", "width": 1.0}, {"from": "rct", "title": "Randomized controlled trials (RCTs) have shown that selenium (Se) may not significantly reduce the risk of PCa, as indicated by the term \u0027not significant\u0027 (NS).", "to": "se", "width": 1.0}, {"from": "rct", "title": "In this randomized controlled trial, the duration of the study will be measured in terms of time.", "to": "time", "width": 1.0}, {"from": "rct", "title": "Participants\u0027 total energy intake will be recorded during the course of this randomized controlled trial.", "to": "tei", "width": 1.0}, {"from": "rct", "title": "Time to progression (PSA \u226510 ng /mL) will be measured in this phase II trial.", "to": "ttp", "width": 1.0}, {"from": "rcts", "title": "Most RCTs, including the trial mentioned, suggest a lack of efficacy of vitamin D ONS in reducing PSA concentrations among men harboring PCa.", "to": "trial", "width": 1.0}, {"from": "resveratrol", "title": "No differences noted in PSA, circulating testosterone, or size of the prostate gland post-supplementation between high and low dose resveratrol groups in men with metabolic syndrome.", "to": "men with metabolic syndrome", "width": 1.0}, {"from": "resveratrol", "title": "A randomized soy intervention among men showed that serum prostate-specific antigen and testosterone levels did not decrease after 4 months of resveratrol supplementation, as reported in Maskarinec et al. (2006). However, another study by Kjaer et al. (2015) found that resveratrol reduced the levels of circulating androgen precursors but had no effect on testosterone or prostate-specific antigen levels in middle-aged men.", "to": "testosterone", "width": 1.0}, {"from": "resveratrol", "title": "Kjaer et al. (2015) reported that resveratrol did not affect testosterone levels in middle-aged men.", "to": "testosterone levels", "width": 1.0}, {"from": "resveratrol (1000 mg /d)", "title": "Serum concentrations of PSA, testosterone, free testosterone and DHT remained unchanged in Kjaer [99] study", "to": "resveratrol (150 mg /d)", "width": 1.0}, {"from": "rising psa level after local therapy", "title": "Zaorsky et al. (2013) discussed the dilemma of a rising PSA level after local therapy and possible options.", "to": "options", "width": 1.0}, {"from": "ryu", "title": "BPH refers to an enlargement of the prostate gland, and this element describes the condition under study", "to": "symptomatic bph", "width": 1.0}, {"from": "saw palmetto", "title": "Both groups received tamsulosin at a dosage of 0.4 mg, but one group also took saw palmetto in addition to tamsulosin and selenium, as well as lycopene.", "to": "tamsulosin", "width": 1.0}, {"from": "saw palmetto herbal blend", "title": "According to Marks et al. (2000), a saw palmetto herbal blend was found to have an effect on symptomatic benign prostatic hyperplasia, which is a specific type of benign prostatic hyperplasia that causes symptoms such as urinary frequency and urgency.", "to": "symptomatic benign prostatic hyperplasia", "width": 1.0}, {"from": "select trial", "title": "According to the Selenium and Vitamin E Cancer Prevention Trial (SELECT) however, comparing selenium to vitamin E, a combination of both, or placebo, longitudinal vitamin E ONS increased PCa risk by 17% within 7 years,", "to": "selenium", "width": 1.0}, {"from": "select trial", "title": "According to the Selenium and Vitamin E Cancer Prevention Trial (SELECT) however, comparing selenium to vitamin E, a combination of both, or placebo, longitudinal vitamin E ONS increased PCa risk by 17% within 7 years,", "to": "vitamin e", "width": 1.0}, {"from": "selenium", "title": "In the Stratton trial, one of the treatment arms was consuming twice the recommended daily intake of selenium for up to 5 years. This may have resulted in selenium overload in some participants, potentially reversing the result from e\ufb05acy to non-e\ufb05acy based on the U-shape response.", "to": "selenium overload", "width": 1.0}, {"from": "selenium", "title": "Serum selenium levels have been found to be associated with the risk of prostate cancer in some studies, suggesting a potential role for selenium in cancer prevention. However, the relationship is not straightforward and may depend on other factors such as vitamin E status.", "to": "serum selenium levels", "width": 1.0}, {"from": "selenium", "title": "Selenium and vitamin E are both antioxidant nutrients that have been suggested to have potential cancer prevention effects. However, the relationship between these two nutrients is complex and may depend on various factors such as dietary intake, supplement use, genetics, and other lifestyle factors.", "to": "vitamin e", "width": 1.0}, {"from": "selenium intake", "title": "should not exceed 400 mg daily, according to the given context.", "to": "exceeds 400 mg daily", "width": 1.0}, {"from": "selenium supplementation", "title": "according to prospective studies, supplementation with 140 \u00b5g/day or more post-diagnosis of non-metastatic PCa may augment the risk of PCa mortality as reported in [66].", "to": "pca mortality", "width": 1.0}, {"from": "serenoa repens", "title": "The study by Argirovi\u00b4c et al. (no date) investigated whether the addition of Serenoa repens (another name for saw palmetto) to tamsulosin (a drug used to treat benign prostate hyperplasia) improves its therapeutical effects.", "to": "tamsulosin", "width": 1.0}, {"from": "serenoa repens ons", "title": "compared in this context, and saw palmetto did not have a significant effect on PSA concentrations after 6 and 12 months of", "to": "tamsulosin", "width": 1.0}, {"from": "serum psa", "title": "Both serum prostate-specific antigen (PSA) and total PSA refer to the level of a protein biomarker found in blood that can indicate the presence or progression of prostate cancer.", "to": "total psa", "width": 1.0}, {"from": "serum psa concentrations", "title": "A 14% decline (NS) was observed with the high soy diet compared with the low in Maskarinec\u2021[100] study", "to": "soy pro drink", "width": 1.0}, {"from": "serum vitamin d concentrations", "title": "are used as proxy biomarkers, with higher concentrations being indicative of a greater therapy response in parallel", "to": "specific cancers", "width": 1.0}, {"from": "soy", "title": "In a study by Grainger [178], men with PCa who received tomato products (no soy) showed no significant differences in % PSA concentrations compared to the group that received soy protein (40 g/d). In contrast, a combined tomato-rich diet and soy ONS resulted in a reduction in % PSA concentrations for both groups, but no statistics were presented between groups.", "to": "tomato products", "width": 1.0}, {"from": "soy pro beverages with high micronutrient content", "title": "In a US double-blind study with 34 older men with high PSA concentrations, the changes in PSA were not significant between the group consuming soy PRO beverages twice per day with high micronutrient content and the group consuming soy PRO beverages twice per day with low micronutrient content after 6 weeks.", "to": "urban", "width": 1.0}, {"from": "synthesis of evidence", "title": "did not allow for", "to": "great heterogeneity observed in supplementation regime and design of included trials", "width": 1.0}, {"from": "systematic review", "title": "used by Ilic [ 51]", "to": "rcts as the only primary studies", "width": 1.0}, {"from": "systematic review", "title": "Based on the aforementioned trials and the findings of a relevant systematic review by Petrou and associates, most RCTs suggested a lack of efficacy of vitamin D ONS in reducing PSA concentrations among men harboring PCa.", "to": "trials", "width": 1.0}, {"from": "tagliaferri, s.", "title": "The controversial role of vitamin D as an antioxidant: Results from randomised controlled trials.", "to": "vitamin d", "width": 1.0}, {"from": "tamsulosin", "title": "given to n=196 patients", "to": "vitamin d3", "width": 1.0}, {"from": "tea catechins", "title": "Tea catechins have been found to affect cancer signaling pathways.", "to": "cancer signaling pathways", "width": 1.0}, {"from": "tei", "title": "The United States Department of Agriculture guidelines for daily caloric intake will be used to assess total energy intake in this study.", "to": "usda", "width": 1.0}, {"from": "telephone counseling promoting an increased vegetable intake", "title": "did not differ between the participating groups in the Men\u2019s Eating and Living (MEAL) study", "to": "time to progression", "width": 1.0}, {"from": "tomato oleoresin extract", "title": "In a double-blind trial with newly diagnosed men scheduled for prostatectomy, supplementation with a tomato oleoresin extract containing 30 mg of lycopene until operation significantly reduced tumor size compared with no intervention [49].", "to": "tumor size", "width": 1.0}, {"from": "vitamin d", "title": "involves cell cycle arrest, inhibition of tumor cell proliferation, growth, and invasiveness, as well as in\ufb02ammatory signaling", "to": "anti-tumor e\ufb00ect", "width": 1.0}]);

                  nodeColors = {};
                  allNodes = nodes.get({ returnType: "Object" });
                  for (nodeId in allNodes) {
                    nodeColors[nodeId] = allNodes[nodeId].color;
                  }
                  allEdges = edges.get({ returnType: "Object" });
                  // adding nodes and edges to the graph
                  data = {nodes: nodes, edges: edges};

                  var options = {
    "configure": {
        "enabled": false
    },
    "edges": {
        "color": {
            "inherit": true
        },
        "smooth": {
            "enabled": true,
            "type": "dynamic"
        }
    },
    "interaction": {
        "dragNodes": true,
        "hideEdgesOnDrag": false,
        "hideNodesOnDrag": false
    },
    "physics": {
        "enabled": true,
        "stabilization": {
            "enabled": true,
            "fit": true,
            "iterations": 1000,
            "onlyDynamicEdges": false,
            "updateInterval": 50
        }
    }
};

                  


                  

                  network = new vis.Network(container, data, options);

                  

                  
                    network.on("selectNode", neighbourhoodHighlight);
                  

                  


                  
                      network.on("stabilizationProgress", function(params) {
                          document.getElementById('loadingBar').removeAttribute("style");
                          var maxWidth = 496;
                          var minWidth = 20;
                          var widthFactor = params.iterations/params.total;
                          var width = Math.max(minWidth,maxWidth * widthFactor);
                          document.getElementById('bar').style.width = width + 'px';
                          document.getElementById('text').innerHTML = Math.round(widthFactor*100) + '%';
                      });
                      network.once("stabilizationIterationsDone", function() {
                          document.getElementById('text').innerHTML = '100%';
                          document.getElementById('bar').style.width = '496px';
                          document.getElementById('loadingBar').style.opacity = 0;
                          // really clean the dom element
                          setTimeout(function () {document.getElementById('loadingBar').style.display = 'none';}, 500);
                      });
                  

                  return network;

              }
              drawGraph();
        </script>
    </body>
</html>